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ABSTRACT 
Objective  During feeding there is an integrated ‘whole body’ response which 
endeavours to maintain energy homeostasis.  The integrated response consists of sensory, 
postingestive, postabsorptive and cognitive feedback which exerts control over ingestive 
behaviour.  It is accepted that when an imbalance in this integrated response occurs and 
may promote an increased fat mass and ultimately can lead to obesity which is known to 
play an important role in the development of IGT and type 2 diabetes.  This study 
investigated the integrated responses of a test meal to determine any differences between 
IGT, type 2 diabetics and controls in their integrated response mechanisms.  This 
knowledge may be important in both predicting the onset of these diseases and in the 
treatment of them.   
Research Design and Methods  IGT and type 2 diabetics with a BMI greater than 30 
and were recruited together with a group of healthy controls. The study assessed habitual 
energy intakes and energy expenditure in all groups.  All participants’ height, weight, 
BMI and WHR were measured.  A taste test assessed the sensory component of food 
intake.  The metabolic response and parallel changes in appetite to the meal were 
recorded at baseline and at 15, 30, 60, 90 and 120 minutes.      
Results  Control participants had significantly lower weight (p<0.01), BMI (p<0.01), 
waist (p<0.01) and hip (p<0.01) measurements compared to IGT and the type 2 diabetic 
groups.  Habitual diet diaries indicated a lower sugar intake in the type 2 diabetic group 
compared with IGT and control groups.  Percentage protein intake was significantly 
lower in control participants (14.4%, p<0.05) compared to IGT (17.2%) and type 2 
diabetics (18.5%).  Activity diaries highlighted an indication of increased 
strenuous/physical activity in the control participants compared to IGT participants 
however, this was not statistically significant.  The control group showed greater 
sensitivity to PROP followed by type 2 diabetics and then IGT participants (p<0.05).  
Throughout the study the control participants rated themselves the most hungry compared 
to IGT (p<0.05) and type 2 diabetics (p<0.01) respectively and controls were also the 
least satiated (p<0.05).  There was no difference in fullness ratings.  Control participants 
rated prospective consumption the highest compared to IGT and then type 2 diabetics 
(p<0.05) respectively.  The differences in EE measured by calorimetry when normalised 
for body weight indicated that IGT (p<0.01) and type 2 diabetic participants (p<0.01) had 
significantly lower EE than control participants.  CHO oxidation rates were significantly 
lower in IGT and type 2 diabetics (p<0.05). Investigating the blood parameters showed 
no differences in plasma ghrelin responses, that IGT participants had the highest overall 
plasma glucose (p<0.01) and insulin (p<0.05) responses.  
Conclusions  It is clear that there are subtle differences in the pathways of energy 
balance in IGT and type 2 diabetics compared to controls; including sensitivity to taste, 
subjective feelings of appetite, EE, oxidation rates and differing blood parameters.  Taste 
appears to be an important contributor to the sensory control of food intake and is 
associated with an increased sugar intake.  Furthermore, differences between IGT and 
type 2 diabetics demonstrate that the degree of management of the disease can influence 
the effectiveness of the metabolic pathways controlling food intake.  It is not clear which 
component is the most influential in the control of food intake and it is likely that the 
synergistic effects are what potentiate the diseases and make them difficult to combat.  
 1
CHAPTER 1 - INTRODUCTION 
 
1.1 FOOD INTAKE AND ENERGY BALANCE 
 
Food or energy intake is regulated by the balance of physiological mechanisms 
responsible for promoting and inhibiting intake.  This process of energy intake is 
dictated by energy requirements i.e. metabolism and physical activity which regulates 
energy expenditure.  Energy balance is thus achieved when energy intake equals 
energy expenditure.  Energy intake, a result of feeding behaviour, is regulated by the 
constant circulation of neural and hormonal (neuro-endocrine) signals and the changes 
in signalling as a consequence of intake.  Such signals are received decoded and acted 
on by appropriate tissues resulting in energy homeostasis.  The physiological systems 
involved include gastrointestinal, cardiovascular, brain, and musculoskeletal and are 
responsible for the maintenance of this complex underplay of communication.  Such 
co-ordination should ensure an appropriate supply of nutrients and the regulation of 
the episodic pattern of eating.   
 
The motivation to feed is crucial in the homeostatic control of feeding behaviour and 
is regulated centrally by two key areas, the brain stem and the arcuate nucleus (ARC) 
of the hypothalamus (Park and Bloom 2005).  The ARC receives input from the 
periphery; including incretins and hormones released during and after feeding, such as 
leptin, ghrelin, cholecystokinin (CCK), neuropeptide Y (NPY) and insulin; and other 
parts of the brain.  Within the ARC there are two interconnecting collections of 
neurons, one having a positive influence and one having a negative influence, which 
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project to the paraventricular nucleus (PVN) where the regulation of food intake and 
energy expenditure is controlled.  The homeostatic control of feeding behaviour 
should be sensitive enough to ensure that energy intake meets expenditure and 
maintains energy balance.  In disease states where neuro-endocrine regulation is 
disrupted then energy homeostasis fails.  This includes disease states such as IGT and 
type 2 diabetes.   In a similar manner to positive and negative balance of inputs 
maintaining energy homeostasis Blundell et al (2001) described appetite as a balance 
between excitatory and inhibitory processes.  The excitatory processes being ‘hunger’ 
which arises from bodily energy needs and the inhibitory process being ‘fullness’ 
which arises from postingestive physiological processing of foods consumed and 
results in satiety; the process in which further food intake is inhibited.  Both 
excitatory and inhibitory processes can be modulated by neuro-endocrine signals 
arising from the body’s energy stores.  The need to seek food arises by metabolic 
processing and is given direction through specific sensory systems, such as smell and 
taste and is driven by metabolic demand  (Freidman 1995).  
 
Current trends indicate that control of energy intake and levels of energy expenditure 
can significantly diverge so that chronic high levels of imbalance between these 
mechanisms can occur; which is either recognised as a result of low physical activity 
levels; increased energy intake; or a combination of the two (McGough 2001).  The 
resultant energy imbalance indicates that dysfunction of mechanisms that dictate 
food/energy intake are not tightly coupled with energy expenditure and therefore 
promote expansion of fat mass leading to overweight and obesity (Stubbs 1998).  
Increased fat mass and adipose tissue, in recent years, has been implicated in 
promoting an inflammatory response (Chandalia and Abate 2007).  The process of 
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increased fat mass results in decreasing concentrations of long chain polyunsaturated 
fatty acids (LCPUFA) and has a negative feedback control on inflammation  (Das 
2007).  Under normal conditions LCPUFA help to promote the mechanisms 
responsible for regulating food intake by potentiating insulin action and shifting leptin 
action.  When the actions of insulin and leptin are dysfunctional they contribute to the 
development of metabolic syndrome by promoting the inflammation process.  
Markers of inflammation are elevated in subjects with obesity, insulin resistance, type 
2 diabetes and IGT intimating that metabolic syndrome is a low-grade inflammatory 
condition (Das 2007).  Food intake is such a key element in the prevention and 
treatment of IGT and type 2 diabetes because, as discussed earlier, an imbalance can 
lead to obesity therefore, it is important to understand how the inflammatory process 
is influenced by poor dietary choices and chronic overeating.  Research therefore 
centers on the energy intake side of the energy balance equation (energy balance = 
energy intake (EI) – energy expenditure (EE)) because of the many 
factors/mechanisms which influence food intake.  However, a significant point to 
remember is that exercise is anti-inflammatory in nature suggesting that symptoms of 
the metabolic syndrome can be counteracted. 
  
 1.2 THE INFLUENCE OF TASTE IN THE CONTROL OF FOOD INTAKE 
 
One of the key mechanisms responsible for the promotion of energy intake and 
encouraging food ingestion is taste.  Promotion of food intake occurs due to the 
palatability of food (Yeomans et al.  2005) and the sensitivity of the mouth in relaying 
the attributes of the palatable food.  Palatability increases appetite and therefore food 
consumption, whereas satiety limits consumption by reducing meal size or by 
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delaying the time of the next meal (Drewnowski 1998).  Measures of palatability 
include the perceived pleasantness of a given food, intent to eat, and the amount of 
food consumed (Drewnowski 1997b).  Finally, sensory-specific satiety was 
specifically defined as reduced palatability of the just-consumed food relative to other 
foods (Rolls 1985).  Due to the opposing effects of palatability and satiety, the most 
palatable foods are by definition the least satiating, and vice versa.  Therefore, taste 
can either increase food intake or decrease it depending on the palatability of the food 
type.  Furthermore, the palatability of one food being consumed can decrease while 
simultaneously the palatability of another food increases.  For example, Snoek et al 
(2004) reported that while eating sausages, the liking for sausages strongly declined at 
the same time that the liking for other savoury foods declined to a lesser degree, and 
the liking for sweet foods increased.  The decrease in liking of a particular food is also 
associated with reduced intake of that particular food in a subsequent meal (Snoek et 
al.  2004).  Some researchers have argued that the palatability of sugar and fat 
overrides normal satiety signals, thereby leading to overconsumption and weight gain 
(Green and Blundell 1996).  Furthermore, Drewnowski and Levine (2003) found that 
a continued high fat diet affects the circuitry in the brain involving appetite, reward 
(opiate) and energy metabolism.  Sensory specific satiety is said to occur straight after 
consumption of that food, therefore before any opportunity for digestion and 
absorption of the food and so it is specific to the sensory aspects of the food i.e. 
texture, colour and flavour (Rolls 1997).  The manipulations that occur in feeding 
behaviour as a result of palatability, sensory specific satiety and taste may also affect 
energy expenditure by negatively changing the efficiency of energy utilisation. 
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Therefore taste is a fundamental influencing component of food intake.  The 
mechanisms regulating taste suggest physiological, psychological and also genetic 
factors in the homeostatic control of food intake.  Taste sensations serve as an 
indicator of a food’s nutritional value and are important in the development of food 
preferences as well as driving appetite.  Human and animal experiments show that 
there is a learned association of a food’s taste with its postingestive effects including 
salivary, gastric, pancreatic, and intestinal secretions (Booth 1982; Warwick et al.  
1990). These associations permit modulations of food choice and/or meal size, and 
will therefore initiate fullness, in anticipation of these postingestive effects.   
Therefore, it is logical to propose that eating behaviour will be directed towards foods 
which have obvious energy value i.e. sweet or fatty foods (Blundell 1991; Schiffman 
1998) which elevate opiate levels, giving a pleasurable effect.  In general most 
humans possess a strong liking for the sweet taste of foods and for fatty texture.  The 
term taste involves many sensory experiences including true taste i.e. the perception 
the primary tastes of salt, sweet, sour and bitter, retronasal olfaction i.e. the perception 
of olfactory stimuli from within the oral cavity, and oral somato-sensation which 
refers to the perception of touch, temperature and pain.  The ability to taste sweetness 
and bitterness varies.  The variability is thought to be associated with the density of 
fungiform papillae on the tongue (Drewnowski 1997).  Furthermore, taste can also be 
influenced by disease states such as exposure to pathogens; trauma and infection; 
malnutrition; medication; surgical interventions and aging.  For example the chorda 
tympani nerve functions in taste sensation and innervates taste buds of the tongue, and 
in turn interacts with signals associated with ingestive and digestive activity in the 
processing area within the dorsal medulla (Bartoshuk 2000).  Damage to this nerve 
may cause poor taste sensitivity on the anterior tongue and may also affect oral 
 6
somato-sensations due to inhibited nerve action (Dinehart et al.  2006).  Poor taste 
sensitivity can result in altered food choices.   
 
1.2.1 The Relationship between Taste and Age 
 
 
 
It is known that the CNS has a minute to minute dependence on nutrient supply and so 
can profoundly affect dietary intake.  Current theories describe functions of brain 
receptors for cholecystokinins, opioid-like endorphins, and serotonin that appear to 
influence eating behaviour and satiety (Selhub et al. 2000).  So altered eating 
behaviour and/or declining appetite, due to taste, may lead to nutritional deficiencies.  
Epidemiological evidence linking low vitamin status or intake with a decline in 
neurocognitive function in the elderly was first described by Goodwin et al (1983). 
These authors showed that healthy elderly subjects who had low blood concentrations 
or intakes of folate, vitamin B-12, vitamin C, and riboflavin scored poorly on tests of 
memory and nonverbal abstract thinking.  However, the importance of these 
observations with respect to declining appetite in the elderly is uncertain.  Sensory 
impairments may be associated with decreased appetite in older individuals including, 
declining olfactory function which may impair flavour perception and lead to a 
decreased appetite or changes in food choices. Rolls and McDermott (1991) studied 
the effects of age on sensory-specific satiety in older adults (45-60 years) and the 
elderly (65-80 years).  Rolls hypothesised that sensory specific satiety is attenuated in 
the elderly which causes them to consume a more mundane diet and therefore to eat 
less which the hypothesised that the elderly compensated for by adding flavour to 
their food.  Both Fanelli and Stevenhagen (1985) and Brown (1976) found that dietary 
variety was found to decline in the oldest participants (>65).  However, Rolls found 
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no decline in sensory specific satiety in the older and elderly participants which 
suggests that the mechanisms underlying taste are not well understood.  The 
relationship between taste and age needs further investigation.  However, analysing 
the literature surrounding the relationship between taste and age gave definition to the 
age range identifiable for the current study.     
 
1.2.2 The Genetic Sensitivity of Taste 
 
Poor sensitivity to specific taste was identified as ‘Taste Blindness’ by Fox (1931) 
who later went on to record the taste qualities of phenythiocarbamide (PTC), a bitter 
compound with the N-C=S group.  Further studies led to the conclusion by Blakeslee 
& Salmon, (1931) that PTC non-tasting is a Mendelian recessive characteristic i.e. 
individuals with two recessive alleles (tt) are non tasters and individuals with 1 
dominant allele (Tt or tT) and two dominant alleles (TT) are tasters.  More recent 
studies (Reed et al. 1999) suggested that taster status may also influence the 
phenotype of a person.  When an individual has the nontaster phenotype, and 
therefore a lack of ability to taste, it is necessary to understand if and how this alters 
food intake and also, importantly how the satiety cascade is affected because this may 
alter the process of meal cessation.  Furthermore, if an individual has a lack of taste 
which results in a lack of satiety does this lead to a tendency to overeat?   
 
Overall, taste appears to be moderately heritable.  However, the genetic and 
environmental factors that, together, add up to create the human taste phenotype make 
it difficult to assess heritability.  The most common studies are genotype-phenotype 
correlations for taste-related genes and behaviour.  On one hand, the behavioural 
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assays for sensitivity have been in widespread use since the early 1930’s however, 
results are sensitive to method as shown by Bartoshuk (2000) and the methods used to 
assess bitter sensitivity vary considerably.  The earliest studies on the genetics of taste 
perception used PTC crystals (Snyder 1931; Blakeslee 1931). Their use was later 
followed by PTC-impregnated filter paper and PTC solutions in water (Blakeslee and 
Salmon 1935).  In the 1960’s, Fischer et al (1963) was the first to substitute 6-n-
propylthiouracil (PROP) for PTC because PROP was odorless and less toxic.  Three 
criteria have been considered in the choice of PTC and PROP, the question of odor 
cues, the degree of separation of nontasters and tasters and the toxicities of the 
compounds (Lawless 1980).  PROP was found to be both odorless and less toxic and 
although PCT was found to be a better discriminator than PROP concern over the 
toxicity of PCT has led to increased use of PROP in recent years (Lawless 1980).  
Taste thresholds are now determined by using a modified up-and-down procedure that 
involves forced-choice judgments and successive serial dilutions of the bitter 
compounds. The Prop series traditionally started with solution 14, containing 1.021 g 
Prop/L (corresponding to 0.006 mol/L), with progressive dilutions down to solution 1 
(Kalmus 1971). Current methods call for 15 Prop solutions ranging in concentration 
from 0.000001 to 0.0032 mol/L that increase in one-quarter log increments on the 
molar scale (Gent and Bartoshuk 1983).  Lawless (1980) also investigated different 
methodologies (paper tests, forced choice thresholds, recognition thresholds and 
category ratings) and found that there were high rates of misclassification with paper 
tests and reported that threshold tests were accurate to a quarter log step and found no 
difference between ascending and descending threshold tests.   New methods are still 
being developed using PROP, including new methods using PROP filter paper (Zhao 
2003) and some methods simply involve tasting a solution and rating the degree of 
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liking or disliking and the intensity on labeled magnitude scales (Keskitalo et al.  
2007).  This method is particularly used for children.  In adults, threshold tests are the 
methodology of choice when assessing the detection thresholds of the bitter 
compound PROP.  The current study utilised threshold tests using the up-down 
procedure.  McBurney and Collings (1977) introduced the up-down procedure with 
forced choice into modern taste psychophysics.  Where subjects are given two stimuli 
(water and a given concentration of the tastant) and asked to choose the one with a 
taste where the concentration is either increased or decreased after non-detection or 
detection respectively.  The reversal points determine the threshold and a run is ended 
after two correct choices.  A recent study suggests that three correct choices gives 
adequate reliability of the threshold (Marks and Wheeler 1998) without risking 
subject fatigue.     Therefore, in the current study this up-down method was used with 
reliability that the correct number of choices to detect a subject’s true threshold.  If 
this procedure is used with only one correct choice and the procedure is begun below 
the subject’s true threshold, the ‘threshold’ that results can be much lower than the 
subject’s true threshold (Bartoshuk 2000). 
 
Fisher et al (1963) considered the behavioural implications of the genetic variation in 
taste and found associations between PROP tasting and drug sensitivities, personality 
type, smoking habits and, vitally, food preferences.  So far, studies investigating taste 
genetics have only considered bitterness however other studies have shown bitter and 
sweet pathways to be analogous (Drewnowski 1997b).  Increased sensitivity to PROP 
was initially linked to the enhanced perception of sweet taste and increased rejection 
of bitter PROP solutions (Drewnowski 1997b).  Increased sensitivity has also been 
hypothesised to cause a reduction in food intake associated with the perception of 
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sweet and fatty foods and therefore poor sensitivity has been linked with increased 
food intake (Drewnowski 1998).  As this body of evidence has increased, Bartoshuk 
(1991; Bartoshuk 2000; Bartoshuk et al.  1994) detected differences between taste 
perceptions in the tasters of PROP; those who perceived PROP (0.0032M 
concentration) as moderately bitter as medium tasters and those who perceived PROP 
as extremely bitter as supertasters (Bartoshuk 1991).  From then onward three 
bitterness taster groups; non-tasters, tasters, and super-tasters were referred to 
(Bartoshuk 1991).   
 
As discussed earlier the N-C=S group which categorises bitter compounds are also 
associated with containing phytochemicals or phytonutrients (Drewnowski et al.  
1997a).  These phytochemicals are plant-based phenols that are present in the 
everyday diet and are reported to have antioxidant and anticarcinogenic properities.  
Duffy (2004) studied the variation in oral sensations, dietary behaviours and 
cardiovascular (CVD) risks.     The ability to taste PROP has been linked with the 
rejection of other bitter compounds and with reduced acceptance of some bitter foods.  
The most frequently cited example of bitter food rejection is the reported avoidance 
by PTC tasters of bitter compounds found in raw cruciferous vegetables: cabbage, 
broccoli and brussel sprouts (Niewind et al.  1988). Further studies show PROP 
tasters have reduced preferences for grapefruit juice, Japanese green tea, and selected 
soy products (Akella et al.  1997; Kaminski et al.  2000).  Bitter foods contribute a 
major dietary source of bioactive phytochemicals, some of which are thought to 
reduce the risk of cancer and coronary heart disease.  This leads to the hypothesis that 
tasters and super-tasters of PROP may have reduced dietary exposure to the bitter but 
beneficial phytonutrients that are found in fruit and vegetables (Drewnowski and 
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Gomez-Carneros 2000).  As discussed earlier other differences between tasters and 
non-tasters have also been described.  Some concentrations of sucrose, neohesperidin 
dihydrochalcone and saccharin tasted sweeter to tasters than to non-tasters (Gent and 
Bartoshuk 1983) while Looy and Weingarten (1992) found that tasters were more apt 
to dislike the taste of sweet solutions.  However, Schiffman et al (1985) found no 
difference in the sensory evaluations of soft drinks whatever the sweetener between 
tasters and non-tasters so results have been conflicting.  Finally, studies with PROP 
sensitivity focused on adiposity and a study found that greater PROP bitterness was 
associated with lower fat preference and lower body mass indices in non-obese 
individuals (Hutchins et al.  2002).  Therefore, Duffy (2004) hypothesised that the 
variability in taste may explain the differences in preference for foods/beverages and 
dietary intake and ultimately chronic diseases such as obesity, IGT and type 2 
diabetes which are all known risk factors of CVD.  It is unknown, however if the 
PROP effects on adiposity, in the obese, are similar to that of non-obese individuals or 
if they are overshadowed by the multiple causes of obesity, including dysfunctional 
physiological and metabolic control mechanisms or environmental influences.   
 
The question, of course then arises about the relationship between PROP tasting and 
body mass index (BMI, kg/m²).  The association between PROP tasting and body 
weight remains unproven however, some researchers have suggested that PROP 
tasting may protect against obesity (Tepper and Nurse 1997; Tepper 1998).  Duffy et 
al (1999) found that reduced PROP sensitivity, i.e. lack of taste, resulted in an 
increased BMI in normal weight persons.  In contrast, in overweight and obese 
individuals an increased sensitivity correlated with an increased BMI.  Tepper (1998) 
found that normal weight non-tasters could not distinguish the fat content of dressings 
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(high and low fat) and liked the high-fat dressing more than the low-fat dressing, 
whereas the two taster groups gave higher ratings of fat-content to the high fat 
dressing and liked both samples equally.  The observed response to fat content may be 
analogous to the dislike of intensely sweet stimuli by PROP tasters in the sucrose 
studies by Looy and Weingarten (1992).  In general, findings provide indirect 
evidence that the dietary patterns of PROP tasters may have important implications 
for weight status, but study findings have been varied therefore require further 
confirmation.  Bartoshuk (2000) investigated the associations between PROP tasting 
and the liking/disliking for sweet/high fat foods and found a negataive association that 
was strongest in women.  Nevertheless, the association found in women support the 
hypothesis that supertaster females will eat less high sweet/fat foods compared to a 
nontaster, due to their dislike of those food types.  Long-term this may prevent 
supertasters from gaining weight.  Thus, sensitivity to taste dictates dietary intake.  
Tepper and Ullrich (1999) found both female and male supertasters were thinner in 
their sample where restrained eaters were excluded. The evidence discussed suggests 
that individuals who cannot taste well cannot make food selections based on prior 
learned associations between taste quality and the metabolic consequences of that 
food.  That is, inappropriate food selections may be made that compromise general 
health.  Therefore it could be suggested that the lack of sensitivity to the fat content of 
foods may be what leads to positive energy balance.  Furthermore, the continual 
intake of fatty foods will promote a positive energy balance and weight gain. The high 
energy density and palatability of sweet and fatty foods has been associated with 
higher energy intake (Drewnowski and Specter 2004).  Recent studies have shown 
that highly palatable, energy dense foods have been associated with reduced satiation 
and satiety and passive overconsumption of fats and sweets (Drewnowski and Specter 
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2004).  Taste status is therefore important in the integrated control of food intake and 
energy balance. 
   
1.3 MECHANISMS OF SATIETY 
 
Following ingestion of food, neural and endocrine mechanisms are responsible for the 
regulation of feeding behaviour.  Gastrointestinal chemo-receptors respond to the 
nutrient products of digestion (sugars, fatty acids and amino acids).  In addition, 
stretch and mechanoreceptors are activated by the presence of food in the stomach 
and proximal small intestine.  Signals from gastrointestinal receptors (mechano and 
chemo-receptors) are transmitted via vagal afferent nerves to the medulla and hind 
brain where integration of this visceral input occurs so that the physical and chemical 
properties of food can affect the short-term regulation of food intake i.e appetite. 
 
 Signals arise from every part of the feeding sequence involving location, selection, 
ingestion, digestion, and the absorption of nutrients, see figure 1.1.  These signals can 
be localised to sensory inputs from the nose and mouth, gastrointestinal signals, 
circulating factors, metabolic signals, nutrient stores and the postabsorptive sensory 
capabilities of the liver and the nervous system (Blundell 1992; Stubbs 1999).  These 
subsystems functionally interact to produce a feeding sequence, initiated by hunger 
and ending with satiety.  Hunger can therefore be described as the motivation to seek 
and consume food which initiates a period of feeding behaviour (Blundell and Halford 
2000).  Appetite is independent of hunger as it can be considered in the short term as 
the physiological processes which together with psychological and environmental 
factors determine the day-to-day episodic pattern of meal and snack consumption, and 
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in the long term be considered a homeostatic process that maintains the energy 
balance and ensures energy storage (Blundell and Halford 2000).   Satiation is the 
within-meal process that brings the period of eating to an end, thereby determining 
meal size whereas satiety is the process in which further food intake is inhibited and 
therefore determines the time between meals (Blundell and Halford 2000). 
 
As discussed earlier, the sensory properties of sugar and fat make them difficult to 
resist.  Fat content appears to influence palatability, and thus food choices, and 
consequently affects food consumption (Drewnowski and Rock 1995).  It is for this 
reason that fat is seen to be a weak indicator of satiety.   The effects of different 
nutrients on the capacity to satiate has undergone much investigation and the results 
have varied.  Some studies suggest that CHO is more satiating than fat (Lawton et al.  
1998) and others have indicated that  fat and CHO are equally satiating, in that 
changes in the energy content of foods associated with the modification of either the 
fat or CHO content are followed by accurate energy compensation (Rolls et al.  1991).   
More recent studies have established that protein is the most satiating nutrient 
(Paddon-Jones et al.  2008).  In substituting other macronutrients for protein, it may 
have a role in the facilitation of weight loss by promoting satiety and causing a 
reduction in energy consumption.    However, it is often assumed that the initiation of 
feeding occurs following hunger but meal initiation does not only depend on internal 
cues but also environmental cues, such as time of the day, social events and food cues, 
all of which can trigger an eating episode (see figure 1.1). 
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Figure 1.1 The Satiety Cascade.  Conceptualisation of the contributions of the 
cognitive and behavioural events, physiological and metabolic events and the brain 
interactions to the time course of satiety (Blundell et al. 2005).  PVN = 
paraventricular nucleus; NST = nucleus of the tractus solitarius; CCK = 
cholecystokinin; FFA = free fatty acids; T:LNAA = tryptophan: large neutral amino 
acids. These are the levels of psychological events (hunger perception, cravings, hedonic 
sensations) and behavioural operations (meals, snacks, energy and macronutrient intakes); the 
level of peripheral physiology and metabolic events; and the level of neurotransmitter and 
metabolic interactions in the brain. Appetite reflects the synchronous operation of events and 
processes in the three levels. Neural events trigger and guide behaviour, but each act of 
behaviour involves a response in the peripheral physiological system; in turn, these physiological 
events are translated into brain neurochemical activity. This brain activity represents the 
strength of motivation to eat and the willingness to refrain from feeding. The lower part of the 
psychobiological  system illustrates the appetite cascade which prompts us to consider the events 
which stimulate eating and which motivate organisms to seek food, those behavioural actions 
which actually form the topography of eating, and those processes which follow the termination 
of eating and which are referred to as postingestive events. Even before food touches the mouth, 
physiological signals are generated by the sight and smell of food. These events constitute the 
cephalic phase of appetite. Cephalic-phase responses are generated in many parts of the 
gastrointestinal tract; their function is to anticipate the ingestion of food. During and 
immediately after eating, afferent information provides the major control over appetite. It has 
been noted that afferent information from ingested food acting in the mouth provides primarily 
positive feedback for eating; that from the stomach and small intestine is primarily negative 
feedback. 
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1.3.1 Gastric Emptying and the effect on Satiety 
 
An important internal mechanism which can influence satiety is gastric emptying.  
Gastric emptying is the limiting step between meal ingestion and the metabolic uptake 
of nutrients at the cellular level.  As such, its role in the control of eating behaviour 
has been emphasised in health and disease (Muurahainen  et al.  1988).  Studies have 
shown that patients with anorexia nervosa have markedly delayed gastric emptying 
(Duhois et al.  1979) and obese patients have accelerated emptying (Johansson et al.  
1976) also support the existence of such a relationship and emphasise its potential 
involvement in clinical disorders such as IGT and type 2 diabetes.  Emptying of the 
stomach slows down as its energy content increases (Hunt 1980), and this process 
might prolong the duration of postprandial satiety, and thus help to regulate energy 
intake.  Gastric emptying has therefore been utilised as an internal physiological 
biomarker of satiety in research.   
 
Starchy foods are known to elicit different postprandial blood responses of glucose 
and insulin. Pasta, legumes, and products based on whole-cereal grains are slowly 
digested foods, whereas potatoes, most breakfast cereals, and conventional bread 
products elicit high metabolic responses. The glycaemic index (GI) was introduced to 
classify starchy foods according to their effect on postprandial glycaemia (Jenkins et 
al.  1981). The GI is defined as the incremental area under the curve (AUC) for blood 
glucose after ingestion of a test product as a percentage of the corresponding area for 
a reference product (glucose or white bread).  An insulinemic index can be calculated 
from the corresponding incremental insulin AUCs.  In a study of different bread 
products, postprandial glucose and insulin responses were lower after ingestion of 
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sourdough bread than after the ingestion of a corresponding yeast bread (Liljeberg 
1995).  In the same study, it was found that a bread with added sodium propionate 
also lowered blood glucose and insulin concentrations, despite its neutral pH.  In a 
study by Liljeberg and Björck (1996), the influence of sodium propionate on the 
gastric emptying rate (GER) was studied by using paracetamol as a marker. As judged 
from a lowered paracetamol concentration in the blood after ingestion of bread with 
added sodium propionate, it was concluded that the salt reduced the GER (Liljeberg 
and Björck 1996). Thus, it was suggested that the bread with added sodium 
propionate was the mechanism for the lowered metabolic response because there was 
no evidence of any effects on the rate of starch hydrolysis in similar in vitro 
experiments.  It is known that GERs are influenced by the volume, energy content, 
and density of the meal and by the particle size of the gastric contents (Horowitz et al.  
1994); however, other meal factors are likely to influence the luminal receptors of the 
small intestine, which control gastric emptying.  In the same study by Liljeberg and 
Björck (1996) satiety was reported to have lasted longer after ingestion of bread with 
added sodium propionate than after ingestion of the reference bread without sodium 
propionate.  Prolonged  post meal satiety usually occurs concomitant with low GERs 
because the extension of the stomach is one factor that promotes a feeling of satiety. 
 
Along with the influence of differing food items GER is influenced by a number of 
peripheral biomarkers such as cholecystokinin (CCK), peptide YY (PYY) and 
glucagon like peptide-1 (GLP-1).  The inhibitory effect of GLP-1 on gastric emptying 
has been reported in both normal subjects (Nauck et al. 1997) and in individuals with 
diabetes (Gutniak et al.  1996).  It has been suggested that obese individuals have 
attenuated GLP-1 response to meals.  Naslund et al (1998) infused obese men with 
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either saline or GLP-1 to determine the effects on gastric emptying.  The results of the 
study showed decreased rates of gastric emptying and hypothesised that the increased 
concentration of GLP-1 caused a prolonged effect on mechano and chemo-receptors 
in the stomach and small intestine, which relay important information to the CNS, via 
the vagus nerve.  Therefore, GLP-1 administered to obese subjects may have a 
weight-reducing and slimming effect if given over a prolonged period of time.  In 
summary, this study showed that GLP-1 administered to obese subjects induced a 
prolonged period of postprandial satiety and slower rate of gastric emptying than did 
saline infusion. This effect of GLP-1 on hunger may be mediated through central 
mechanisms or vagal afferent pathways together with prolonged gastric emptying.  
Additional gastrointestinal hormones, particularly CCK (Muurahainen  et al.  1988) 
and peptide YY (PYY) (Lin et al.  1996) are also important in mediating the slowing 
of gastric emptying induced by small-intestinal nutrients.  Previous studies showed 
that CCK (Muurahainen  et al.  1988), and PYY (Allen 1984) slow gastric emptying: 
CCK (Fraser 1993) by stimulating isolated pyloric pressure wave (IPPWs) frequency 
and inhibiting distal gastric (antral) contractions and PYY by inhibiting interdigestive 
migrating contractions in the small intestine (Lin et al.  1996).  In summary, the 
influence of gastric emptying on satiety has been established and therefore food is 
initially the most crucial component that influences the physiological mechanisms that 
indirectly control satiety. 
 
1.4 THE AUTONOMIC CONTROL OF FEEDING BEHAVIOUR 
 
The presence of food further stimulates inhibition of eating by maintaining the 
physiological mechanisms mediating satiety.  In order to achieve energy homeostasis 
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it is necessary to regulate the energy intake with energy expenditure to ensure that 
energy stores are maintained at an appropriate level. Energy balance is achieved 
through the integration of periphery signals when feeding commences.  The signals 
involved which influence feeding behaviour are located in multiple brain areas.  The 
hypothalamus plays a key role in this process.  Meal-related satiety information is 
conveyed to the nucleus of the tractus solitarius (NTS) in the medulla, on which 
converge vagally transmitted signals from the gastro-intestinal tract, including taste, 
gastric distension and portal vein glucose levels.  For example, high blood glucose, 
i.e. after feeding, facilitates efferent activity of the pancreatic and hepatic branch of 
the vagus nerve which is mediated by the intestinal peptide cholecystokinin (CCK) 
(Beglinger and Degen 2004).  CCK signals to the NTS via CCKA receptors on the 
sensory terminal of the vagus nerve and in turn causes an increase in insulin secretion 
from the pancreas and glycogen synthesis in the liver and ultimately results in 
satiation, the cessation of feeding (Fry and Ferguson 2007).  Endocrine pathways have 
been identified which activate the afferent fibres of the vagus nerve, i.e. in the action 
of ghrelin or influence hypothalamic activity directly, i.e. in the action of leptin.    The 
ventromedial hypothalamic nucleus (VMH) was long considered to be a ‘satiety 
centre’.  Stimulation of the VMH inhibits feeding (Williams et al.  2001).  Recent 
studies have shown a high abundance of leptin receptors in neurons of the VMH.  The 
VMH has direct connections with paraventricular neurons and the lateral 
hypothalamic area (LHA), where the regulation of food intake and energy expenditure 
is controlled. Low blood glucose (hypoglycaemia) activates efferent activity of the 
pancreatic, hepatic and adrenal branches of the splanchnic nerve, which results in 
increased glucagon secretion from the pancreas, release of glucose from the liver and 
secretion of catecholamines from the adrenal medulla and is the stimulation required 
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for feeding initiation (Woods and Porte 1974).  This process is mediated by 
neuropeptide Y (NPY), an orexin, which induces feeding. NPY containing neurons 
originate in the ARC of the hypothalamus and innervate the LHA which has been 
classically viewed as the ‘feeding centre’.  Stimulation of the LHA increases food 
intake and also contains large numbers of glucose-receptive neurons that respond to 
circulating glucose levels, probably mainly via pathways ascending from the 
hypothalamus.   
 
Mayer (1953) formulated the ‘glucostatic’ theory that glucose availability to specific 
glucose-sensing neurons is an important factor regulating feeding behaviour and 
ultimately body weight.  Glucose is the main metabolic fuel of the brain.  Reductions 
in blood glucose or any blockade of neuronal glucose utilisation powerfully stimulate 
feeding.  Specific parts of the central nervous system (CNS) contain neurons that can 
detect changes in ambient glucose concentration, for example glucose responsive 
neurons in the LHA and medulla oblongata (Williams et al.  2001).  However, their 
place in the hierarchy of the CNS system that regulates feeding is uncertain, although 
they may have some involvement in the modulation of the autonomic efferent 
activity.  It is becoming clear that glucose-sensing neurons may communicate 
extensively with other appetite-regulating neuronal systems.  This suggests that blood 
glucose and the activity of peripheral glucose sensors directly and indirectly affect 
feeding behaviour.  
 
There are other peripheral metabolic sensing neurons in the regulation of energy 
homeostasis and include neural afferents from the hepatic portal vein, gut, and carotid 
sinus.  The messages from these peripheral areas are all conveyed via the vagus and 
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sympathetic nervous system to the NTS in the medulla and are then relayed to a 
variety of other brainstem and hypothalamic areas.  These are joined by neural inputs 
from somatic afferents mediating sight, sound, taste, pain and touch and these 
incoming signals are integrated within clusters of neurons which are also responsive 
to metabolic and hormonal inputs from the periphery.  Therefore the CNS has an 
important role in the control of food intake.     
 
1.5 THE METABOLIC CONTROL OF FOOD INTAKE 
 
Whilst the physical properties and the endocrine responses which occur due to the 
presence of food in the gut initiate satiety responses, the consequences of chemical 
digestion and absorption of nutrients further compounds mechanisms of satiety 
enabling a metabolic control of food intake.  
 
The gastrointestinal (GI) tract processes ingested food, both mechanically and 
chemically, into small, absorbable units.  Thus carbohydrates (CHO) are processed in 
the stomach and small intestine into fatty acids and monosaccharides; fats/lipids are 
transformed into glycerol and fatty acids and finally, proteins are cleaved to amino 
acids.  The digestive end products become absorbed by the body.  The entire process 
of digestion is coordinated by interactions of the enteric nervous system that 
innervates the walls of the GI tract which cause the release of peptides from 
specialised endocrine cells into the circulation or to serve as neurotransmitters 
mediating signals from the enteric nervous system.  The GI hormones are synthesised 
and secreted from the mucosa of the stomach and upper small intestine and their 
release is mediated by both the cephalic mechanism, via the vagus nerve, and the 
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intraluminal mechanisms, via the cholinergic system (Vay et al.  1971).  These signals 
are transmitted from the gut to the brain and are interpreted in the hypothalamus, 
reflecting the load of nutrients ingested.  The gut peptides exhibit a response to food 
intake and some have been examined carefully to determine whether the response is 
of physiological relevance.  For example, there are three main GI peptides which are 
released following the ingestion of food; gastrin, whose response has been determined 
to be in gastric acid secretion (Lam et al.  1980); CCK, whose response to a meal is in 
gallbladder contraction (Byrnes et al. 1981); and secretin, whose response has been 
associated with pancreatic bicarbonate output to regulate the pH of the duodenal 
contents (Yamada 1985).  The effect that food exerts on GI hormones therefore 
depends on the macronutrient mix of the meal because separate nutrients elicit 
different responses to different peptide containing cells (Yamada 1985).  CCK, for 
example, is stimulated by fats (Matzinger et al.  2000), gastrin appears to be 
stimulated by protein and amino acids (Lichtenberger 1982) and CHO’s are known to 
stimulate other polypeptides such as gastric inhibitory polypeptide (also known as 
glucose-dependent insulinotropic peptide or GIP) and is a member of the secretin 
family of hormones (Cataland et al.  1974).  Incretins, such as GIP and GLP-1, are a 
type of GI hormone that cause an increase in the amount of insulin released from the 
β-cells of the islets of Langerhans in the pancreas.  Release of incretins can occur 
even before the presence of increased blood glucose and therefore insulin is released 
rapidly following food intake.  Incretins slow the rate of absorption of nutrients into 
the blood stream by slowing gastric emptying and therefore may play a role in 
reducing food intake (Marks et al.  1991).  Other hormones released in response to 
food include ghrelin, which is produced in both the stomach and the hypothalamus 
and hormone concentrations decrease when food is consumed.  Also, leptin is 
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produced by adipocytes in response to food intake and has a role in inhibiting food 
intake (Ahrén and Havel 1999)   As a group, the peptides of digestion are satiety 
signals because most create a sensation of fullness in humans and reduce food intake 
when administered to humans or animals (Beglinger and Degen 2006) and all play a 
potential role in the maintenance of energy balance.  There are other endocrine 
regulators of food intake such as cytokines, IL-6 (interleukin-6) and TNF-α (tumor 
necrosis factor), which also have a role in the inhibition of food intake (Havel 2001) 
and are associated with infection, inflammation and cancer (Weingarten 1996), 
glucocorticoids which increase food intake, and probably interact with insulin and 
leptin in the long-term regulation of energy homeostasis (Havel 2001), and growth 
hormone which is also associated with both increased and decreased food intake 
(Havel 2001).   
 
All this said, it is important to understand that food sources are not digested equally.  
Flatt (1996) hypothesised that fuels are digested according to their storage capacity 
i.e. alcohol will be metabolised first due to the body having no storage capacity for 
alcohol, then protein, glucose and finally fat, having the largest storage capacity and is 
therefore metabolised last.  However, fuels are also not metabolised exclusively but 
are metabolised simultaneously as a ‘mixed fuel’.  Fuels are then either oxidised or 
stored (Friedman 1998).  Friedman (1995 and 1998) suggested that the partitioning of 
metabolic fuels causes alterations in energy balance, see figure 1.2.    Neural, 
endocrine, and biochemical mechanisms determine which fuels are used through 
which pathways and in which tissues.  For example, metabolic fuels may be stored as 
fat, oxidised for energy or for heat production, or converted to milk to feed offspring.  
Because mechanisms of fuel partitioning determine whether, and in which tissues, 
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metabolic fuels are oxidised, shifts in the flux of fuels could affect eating behaviour 
by altering the metabolic signal that controls food intake.  Fuel partitioning indirectly 
effects food intake by altering the oxidation of fuels in the tissue or cells that generate 
the signal for appetite control.  The liver has an important role in monitoring the 
changes in fuel metabolism that control food intake.  Russel (1963) was the first to 
propose a role for the liver in feeding behaviour and since then a considerable amount 
of research has supported the hypothesis that satiety and hunger are influenced by 
signals elicited in changes in liver metabolism (Novin and VanderWeele 1977; 
Tordoff & Friedman 1986).  Friedman (1998) suggested that this signal is associated 
with ATP production in the liver i.e. decreases in ATP production stimulate eating 
behaviour whereas increases in ATP suppresses eating.    
 
Furthermore, Friedman (1998) went on to suggest that under normal conditions there 
is a balance between fuel storage, mobilisation and utilisation however in obesity the 
balance changes towards fat storage instead of oxidation and therefore the fuel mix 
changes and contributes towards further weight gain.  What is not clear is why this 
occurs but the shift from oxidation to storage may be linked with the increased 
concentration of free fatty acids (FFA) in plasma as a result of higher body fat 
(DeFronzo et al.  1992).  The elevated concentration of FFA attenuate glucose uptake 
in muscle by inhibiting glucose oxidation and is strongly associated with insulin 
resistance (Wolfe 2006) which is a hallmark of the metabolic syndrome. 
 
This interplay between the synergistic effects of the peripheral and central control of 
food intake, taste including palatability and sensory-specific satiety to individual 
foods, and true fullness to a mixed meal is how our body deals with the physiological 
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and metabolic consequences of food.  Thus, the body arrives at the integrated 
cognitive response to a meal.  All components are necessary but singly each 
component has a different importance within this response.  The importance that each 
component has on food intake is still to be elucidated.   
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Figure 1.2  Fuel Partitioning and Energy Intake (Friedman 1995) 
A) Relationship between fuel partitioning and energy intake control under 
normal/steady state conditions  
B) Relationship between fuel partitioning and energy intake in obesity where 
increased energy intake is associated with increased energy deposition. 
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1.6 SHORT AND LONG-TERM CONTROL OF FEEDING 
 
The satiety cascade which occurs as a consequence of feeding may suggest that only 
short term influences, lasting hours and relating to individual meals exist to promote 
inhibition of eating.  However, it is clear that metabolic control over episodic eating 
and energy intake occurs over significantly longer periods extending to days or 
months (see figures 1.3 and 1.4).  Importantly, together the short and long-term 
signals interact to regulate energy balance.  Therefore if there is dysregulation in the 
short-term feeding process(es) then it is possible that long-term homeostasis, and thus 
body weight regulation, may consequently be affected.  Inevitably, increased energy 
intake and positive energy balance results in altered body composition and the change 
alone may influence feeding behaviour.  Hormonal influence may also affect the short 
and long-term control of food intake. 
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Figure 1.3  Short-Term Signals Regulating Food Intake (Havel 2001)  
Signals from the GI tract and the liver are involved in short-term regulation.  Afferent 
signals travel in vagal nerve fibers from stretch receptors and chemoreceptors 
activated by the presence of nutrients in the stomach and proximal small intestine.  
Nutrients arriving via the portal vein may also trigger vagal afferent signals from the 
liver. 
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Figure 1.4  Long-Term Signals Regulating Food Intake (Havel 2001)  
Insulin and leptin are important long-term regulators of food intake and energy 
balance.  Both act in the CNS to inhibit food intake and to increase energy 
expenditure, most likely by activating the sympathetic nervous system. 
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1.7  THE HORMONAL INFLUENCES OF THE CONTROL OF FOOD  
INTAKE 
 
1.7.1 Ghrelin 
 
Peripheral factors that participate in the short and long term control of appetite and 
adiposity can be either anorexigenic and promote reductions in food intake and 
consequently a reduced body weight or orexigenic and promote feeding and cause an 
increase in body weight.  Ghrelin is a unique hormone in that it activates appetite and 
promotes food intake whereas all the other known GI hormones uniformly inhibit 
food intake.  Therefore ghrelin concentrations increase during fasting, and are reduced 
by the presence of food in the stomach.  Most GI hormones and their receptors are 
present in regions of the CNS involved in regulating feeding behaviour and therefore 
inhibit/promote feeding when administered both peripherally and when administered, 
at low doses, directly into the brain. (Havel 2001).  It is unclear if the primary target 
for ghrelin and other GI hormones is in the periphery, in the CNS, or in both.  It is 
likely that both peripheral and CNS production and action of GI hormones represent 
comparable pathways in the regulation of feeding behaviour.   
 
Ghrelin is a novel 28-amino acid peptide hormone that has been recognised as an 
important regulator of hormone release and feeding promotion and was first identified 
based on its stimulation of growth hormone secretion via a growth hormone 
secretagogue receptor in animals and humans (Bowers 2001).  The mammalian 
ghrelin structure has an n’octanoyl modification at its third serine residue which is 
essential for its activities to stimulate growth hormone secretion from the pituitary 
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cells.  The stomach produces three quarters of the circulating ghrelin and is the 
principal site of ghrelin synthesis.  The gastric fundus, in the stomach, is the most 
abundant source of ghrelin and produces ten times more of hormone per gram of 
tissue than does the next richest site, the duodenum (Havel  2001).  Ghrelin is 
produced in the oxyntic mucosa of the stomach by enterendocrine cells.  Therefore 
when food is ingested, there is a rapid reduction in ghrelin levels due to the close 
proximity of the ghrelin producing cells.  Concentrations of ghrelin producing cells 
decrease throughout the small intestine as the distance from the stomach pylorus 
increases.  In humans, ghrelin levels rise before meals and fall rapidly after the 
ingestion of a meal (Williams and Cummings 2005) and secretion is finely regulated 
by several factors.  The stimulatory effect of ghrelin on feeding is independent of the 
stimulation of grown hormone (Yoshihara et al.  2002) which suggests it has an 
independent role in promoting food intake.  During fasting, ghrelin stimulates the 
ARC neurons that cause an increase of two orexigenic peptides, NPY and agouti 
related protein which initiate feeding and promotes an increase in body weight.  In 
contrast both leptin and insulin, produced from adipose tissue, exerts its influence on 
the ARC and inhibit feeding and produce a reduction in body weight.  This influence 
is exerted by suppressing NPY and agouti related protein peptides.  Studies involving 
ghrelin have shown increased stimulation of GI motility, gastric acid secretions and 
pancreatic exocrine secretion (Mora et al.  2005).  The bodily changes that occur as a 
result of changes in ghrelin concentration are in anticipation of a meal and therefore 
prepare the GI tract for food processing and transport.   
 
Ghrelin’s role is therefore in the regulation of mealtime hunger regulation and meal 
initiation by influencing postingestive satiety.  This hormone is a potent stimulator of 
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short term food intake and stimulates food intake more effectively than does any 
known molecule, except NPY (Havel 2001).  Ghrelin has been attributed to 
stimulating appetite and food intake even more in obese individuals than lean (Mora 
et al.  2005).  
 
1.7.1.1 Ghrelin and Obesity 
 
Individuals with obesity have been shown to have reduced plasma ghrelin levels and 
individuals with anorexia nervosa have been shown to have increased plasma ghrelin 
levels which suggests a negative feedback mechanism is in control of energy 
homeostasis (Shiiya et al.  2002). Fasting ghrelin concentrations in obese and type 2 
diabetic patients have been shown to be negatively correlated with BMI, fasting 
insulin and fasting leptin concentrations within both groups (Shiiya et al.  2002).  This 
may suggest a role for ghrelin in long-term feeding behaviour and body weight.  
Attenuation of ghrelin has been found in obesity and may be causative of the long-
term positive energy balance that leads to obesity.  The mechanism of attenuated 
ghrelin may be linked with macronutrient intake.  The link between glucose and 
ghrelin-producing cells was originated by studies which investigated the short-term 
response to oral and intravenous administration of glucose and water to normal 
subjects.  The study found that only the glucose administration caused a reduction in 
subjects’ plasma ghrelin concentrations (Shiiya et al.  2002). Similar studies 
investigated the administration of lipids and high-fat diets and found that they 
suppress postprandial ghrelin concentrations less effectively than glucose 
(Monteleone et al.  2003) which further advocates that glucose and insulin may 
modulate the postprandial ghrelin response (Blom et al.  2005).  Therefore, the long 
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term role of ghrelin may be linked to the long-term fluctuations in glucose and insulin 
concentrations which become dysfunctional in chronic states such as obesity, IGT and 
type 2 diabetes when blood glucose and insulin levels are elevated over a long period 
of time.  Therefore, it is not only important to understand the role that circulating 
ghrelin plays in food intake from meal to meal, it is necessary to understand the 
factors which regulate plasma ghrelin levels in relation to feeding and its long term 
role in the maintenance of energy balance and also its possible link in the pathology 
of obesity and related chronic diseases such as IGT and type 2 diabetes.   
 
1.7.2 Leptin 
 
Although leptin is not directly investigated in this study it is important to discuss this 
hormone due to the antagonistic effects of leptin to ghrelin.  Leptin is a circulating 
hormone mainly secreted by white adipose tissue and influences body weight 
homeostasis by altering food intake and energy expenditure.  Leptin influences the 
activity of the hypothalamus by modulating the expression of several neuropeptides to 
promote satiety.  Leptin interacts with both components of the energy balance 
relationship by promoting satiety and also by having a stimulatory effect on energy 
expenditure (Campfield et al.  1995).  Once released into the bloodstream leptin must 
gain access to specific regions in the brain, mainly the hypothalamus, involved in the 
regulation of food intake and energy balance.  The discovery of leptin was 
revolutionary because it confirmed the hormonal link between adipocyte and the 
brain, therefore an understanding of the biology of leptin offers significant insight into 
the complex inter-relationships among adipose tissue, the nervous system and 
peripheral organs.  Leptin is also increasingly spoken of as a general ‘metabolic’ 
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hormone, in that a rapidly expanding range of processes with which it interacts are 
being documented.  These processes include the inhibition of insulin secretion from 
the ß-cells of the pancreas (Emillson et al.  1997), the stimulation of glucose 
utilisation (Kamohara et al.  1997), stimulation of sugar transport across the small 
intestine (Lostae et al 1998), and actions in the immune system (Cock and Auwerx 
2003).  So it is clear that leptin has a role in both short and long-term pathways 
controlling food intake.   
 
1.7.2.1 Leptin and Obesity 
 
Research shows that the effectiveness of the leptin receptor is reduced in obesity, 
resulting in disruption of the leptin pathway which prevents critical hypothalamic 
areas from perceiving pertinent cues on energy status (De Fanti et al. 1998).  If the 
hypothalamus does not receive, sense, or properly integrate the nutritional state, a 
superficial negative energy balance and subsequent energetic efficiency ensue, 
resulting in obesity.  Diet induced obesity in humans is associated with increased 
leptin levels (Mercer and Speakman 2001).  Although leptin levels rise proportionally 
with adiposity, the increased leptin fails to curtail the progression of obesity (Zhang 
and Scarpace 2006).  Analogous to hyperinsulinemia and insulin resistance, 
hyperleptinemia has been postulated to be indicative of ‘leptin resistance’ (Flier 
1998).  Early studies suggested that leptin crosses the blood brain barrier (BBB) by a 
saturable transport system (Banks et al.  1996).  Research has discussed the possibility 
that the leptin transport system could be saturated near physiological concentrations in 
lean individuals, implying that the elevated leptin levels observed in obesity can 
produce no biological effects because the system is no longer responding (Flier 1998).  
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Banks et al (1996) also suggested an impaired transport of circulating leptin across the 
BBB in obese CD-1 mice due to a decreased capacity of the BBB to transport leptin.  
Human parallels are now recognised with the description of obese subjects with 
mutations in leptin or the leptin receptor (Montague et al.  1997).    Zhang and 
Scarpace (2006) further postulate that a leptin resistant state disrupts normal energy 
homeostasis, favours positive energy storage, and thus leads to even greater obesity.  
Leptin works synergistically with CCK to inhibit feeding.  Leptin is an adiposity 
signal and known for its long-term role in adiposity control and its short term role in 
modulating meal size (see figure 1.4) according to changes in energy balance and 
CCK operates as a satiety signal to reduce meal size.  
 
1.7.3 Cholecystokinin (CCK) 
 
Appetite is regulated by a complex system of central and peripheral signals which 
interact in order to modulate the individual responses to nutrient ingestion.  Satiety 
signals originate from the GI tract during a meal and through the vagus nerve, reach 
the NTS in the brainstem (see figure 1.3).  From the NTS, afferent fibers project to the 
ARC where satiety signals, namely CCK, are integrated with adiposity signals, 
namely leptin and insulin, creating a final response to a meal.   
 
CCK is released from endocrine cells localised in the mucosal layer of the proximal 
small intestine and travels via the portal vein to the liver and via the systemic 
circulation to the CNS.  CCK is also produced in the CNS and is released by 
hypothalamic neurons during feeding.  CCK release is stimulated by dietary fat, 
amino acids and small peptides released during protein digestion.  CCK inhibits food 
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intake by the activation of CCKA receptor subtype.  Moran et al (1998) demonstrated 
a defect in the CCKA receptor in obese rats resulting in reduced CCK.  CCK is likely 
to transmit vagal afferent signals to the medulla in the hindbrain by acting on 
receptors located in the pylorus and liver.  CCK’s role in feeding regulation is in 
energy homeostasis and is to inhibit food intake by inducing postprandial satiety by 
communicating fullness and thereby decreasing meal size.  West et al (1984) showed 
that CCK function is in short-term satiety by repeatedly administering CCK to rats 
when meals were initiated.  This resulted in reduced meal size.  However, the 
subsequent number of meals eaten increased and after an initial period of adaptation 
overall energy intake was unaffected and weight loss was minimal.   
 
Schneeman et al (2003) hypothesised that the constituents of food  would alter the 
way in which nutrients are handled in the postprandial period and this in effect would 
be evident in the hormonal and lipid response to the meal.  This study showed that fat, 
particularly dairy fat, is a more potent stimulator of CCK than a blend of non-dairy 
fats and found increased CCK concentrations in women.  This finding is of interest 
when considering CCK function(s) and relative interactions with other hormones in 
the response to eating.  For example, CCK has also been shown to slow gastric 
emptying, thus inhibiting food intake and also to have a role controlling the glycaemic 
response to a meal by increasing the sensitivity of tissues to insulin (Schwartz et al.  
1994) to maintain consistent blood glucose levels.  CCK release has also been shown 
to induce satiety in rats (Burton-Freeman et al.  1997) however, although an 
association between CCK and satiety has been postulated, studies on humans have 
been controversial.  Some studies showed a strong relationship between CCK release 
and satiety, using VAS (Burton-Freeman et al.  2002) and others did not (Schneeman 
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et al.  2003).  This suggests that there may be other influences, overriding signals 
within the food intake regulatory system under different dietary challenges.  These 
other influences may be important when considering obesity, IGT and type 2 diabetes 
because their habitual diet has been shown to be consistently high in fat content, 
particularly saturated fat (Walker et al.  1996).    This may implicate fat in promoting 
dysfunction in the CCK pathway which normally inhibits feeding.  It is therefore 
important to know how CCK varies with these conditions and how it interacts in the 
role of energy homeostasis for the diagnosis and treatment of IGT and type 2 diabetes.   
 
1.7.3.1.  CCK and Obesity 
 
Initial studies in obese rats (De Fanti et al.  1998) investigated the hypothesis that the 
synergistic interaction between leptin and CCK in the regulation of food intake may 
be dysfunctional.  Studies on the fatty Zucker rat showed defective leptin signalling 
and has been associated with altered long-term dietary cues yet the consequences of 
this defect on short-term cues, such as CCK remain unclear.  One possibility is that 
the defect in the leptin signalling system seen in obesity, may cause a blunting of 
CCK release from the PVN and effectively abolish the ability of CCK to inhibit 
feeding and thus promoting increased meal size. (De Fanti et al.  1998).  A recent 
study by Little et al (2007) concurred with the results of De Fanti et al (1998) and 
suggested that chronically elevated plasma CCK concentrations, induced by a 
continual increased consumption of dietary fat, mediate the reduction in sensitivity to 
the inhibitory effects of CCK on food intake. Human studies have not shown 
consistent results like those involving rats.  For example, the CCK response to a high 
fat diet via lipid infusions was not affected in humans although elevated postprandial 
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CCK concentrations were reported.  It has therefore been suggested that the increased 
postprandial plasma CCK response in humans is primarily due to a greater amount of 
nutrients present in the small intestine to stimulate the localised secretion of CCK 
which is resultant of more rapid gastric emptying.  Therefore, it is still not clear 
whether CCK has a role in human obesity because some studies have shown that 
fasting concentrations of CCK have been elevated in obese subjects (Baranowska et 
al.  2000) suggesting a CCK resistance but this has not been demonstrated in all 
studies (Lieverse et al.  1994).  Any impairment in the functionality of a hormone 
involved in the control of food intake is pivotal because its influence on other 
metabolic factors, such as insulin, will also impact on metabolic control and therefore 
alter the sensitivity of endocrine factors regulating the long term control of energy 
intake.   
 
1.7.4 Insulin 
 
It was first proposed by Woods and colleagues in the 1970s that insulin is a long term 
regulator of food intake, energy balance and body adiposity (Woods et al. 1974).  
Parasympathetic nerves innervating the pancreas are activated as a direct effect of 
incoming nutrients, especially glucose and amino acids, causing the secretion of 
insulin from the islet ß-cells of the endocrine pancreas (see figure 1.4).  Fat does not 
induce insulin secretion, although some fatty acids appear to be necessary for the full 
insulin secretory response to glucose (Havel 2001).  Insulin receptors have been 
identified in a number of brain regions which are known to influence the regulation of 
feeding including the ARC of hypothalamus.  Havel (1999) studied the effects of 
body adiposity to overall insulin secretion and insulin concentration in the systemic 
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circulation and found a correlation between fasting insulin levels and the insulin 
response with body adiposity.  In addition to inhibiting food intake, insulin increases 
sympathetic neural activity and energy expenditure.  Thus, insulin can regulate energy 
balance by inhibiting energy intake and by increasing thermogenesis.  
 
CNS neurons do not produce insulin, however the hormone insulin is transported into 
the brain via a receptor-mediated mechanism that is saturated at high insulin 
concentrations and therefore this is not a rapid process.  The transport process occurs 
over a period of hours as circulating insulin concentrations rise and thus is consistent 
with the theory that insulin is a long-term regulator of feeding behaviour.  
 
1.7.4.1 Insulin and Obesity 
 
After feeding, insulin is preferentially transported into the hypothalamus, compared 
with other brain areas and so the hypothalamic insulin content is increased.  This 
increase in hypothalamic insulin occurs after a high CHO meal, but does not occur 
after a high fat meal because there is a smaller circulating level of insulin after a high 
fat meal.  The transport system in the brain which controls circulating insulin levels is 
thought to be impaired following a high fat meal.  It was demonstrated in dogs that 
chronic consumption of high fat meals impairs brain insulin transport and the 
impairment is predictive of weight gain (Kaiyala et al.  2000).  Together the effects of 
reduced insulin secretion and reduced insulin transport to the CNS may contribute to 
the increased energy intake and obesity observed in humans consuming high fat diets.  
In other words, the intake of dietary fat and therefore the fatty acid composition of 
tissues may influence insulin sensitivity.  This can potentially be changed through 
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long-term dietary modifications (Mann 2000).  Therefore, the protocol of the current 
study included the assessment of habitual dietary intake to determine if there was 
differences in content, particularly fat content as it is known to have implications in 
the functionality of insulin. 
 
Insulin and leptin act in the CNS to inhibit food intake and to increase energy 
expenditure most likely by activating the sympathetic nervous system. The long-term 
regulation of food intake is paramount because the damaging effects that long-term 
increased body weight has on the neuro-endocrine metabolic control markers is 
considerable and can result in metabolic syndrome, diabetes and other chronic 
illnesses.  
 
1.8 GLUT-4 TRANSLOCATION 
 
Insulin promotes glucose uptake by muscle and adipose tissue via the stimulation of 
GLUT-4 transporters from intra-cellular sites to the plasma membrane.  A low 
abundance of the GLUT-4 transporter has also been shown to be present in low 
abundance in the brain endothelial cells lining the BBB in rats and mice (McCall 
1997;  Sankar 2002) which facilitates glucose transportation into the CNS in an 
insulin-independent fashion (Sankar et al.  2002).  This corresponds with Mayer’s 
(1953) glucostatic theory which suggests that glucose is the preferred source of 
energy, especially for the brain and that hunger depends on the rate that glucose 
crosses the cell membrane and is actually used by the body.  Therefore satiety occurs 
when glucose utilisation is adequate and a low level of glucose utilisation causes 
hunger, regardless of blood glucose concentration.  Mayer (1953) suggested that the 
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rate of glucose utilisation is monitored by the so called ‘satiety centre’ or 
ventromedial hypothalamus (VMH) and that VMH activity increases in response to 
increased glucose utilisation leading to satiety.  Therefore, GLUT-4 mediated 
transport in the muscle and brain is essential to the maintenance of glucose 
homeostasis.   
 
Attenuated GLUT-4 translocation and glucose uptake by muscles and fat cells 
following insulin stimulation represent a prime defect in insulin resistance.  In mice, 
adipose-selective disruption of GLUT-4 leads to secondary insulin resistance in the 
liver and muscle and results in IGT (Huang et al.  2005).  Alteration of GLUT-4, i.e. 
expression or function, contribute toward the development of insulin resistance and 
diabetes.  Under normal circumstances insulin causes an upregulation of GLUT-4 
mRNA in adipocyes but this effect is dependent on glucose concentration (Bilan et al. 
1992).  The response was seen at low glucose concentrations (5.6mM) but not at high 
glucose concentrations (25mM) which suggests a suppressing effect of glucose on 
insulin induced GLUT-4 gene expression (Bilan et al. 1992).  Results have been 
controversial and not all studies concur with this assessment of suppressed GLUT-4 
transportation (McCall et al. 1997) in hyperglycaemic states.  Bilan et al (1992) 
suggested that individuals with insulin resistance will demonstrate a lack of effect of 
insulin in a high glucose environment which may be due to the impaired insulin 
signalling produced by high glucose i.e. glucotoxic effect.  Reducing the glucose 
response in hyperglycaemic states, such as IGT and type 2 diabetes, is important, 
therefore GLUT-4 translocation is an important control mechanism in these 
conditions.  In the muscle, glucose transport by GLUT-4 is insulin-stimulated.  Bilan 
et al (1992) showed that glucose transporter function but not expression was impaired 
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by high glucose concentration in diabetic rats i.e. high glucose impairs insulin action 
on transport but not via altered GLUT-4 expression, whereas,  long-term exposure to 
high glucose in combination with high insulin levels produced a reduction in GLUT-4 
abundance.  Therefore, GLUT-4 therapy has been used as a means to lower plasma 
glucose in diabetic animals (Dolan et al. 1997).  Although research is inconsistent, 
GLUT-4 has a role in the control of energy balance through the maintenance of blood 
glucose levels which provide messages of fuel availability to the brain to determine 
metabolic feeding cues.   
 
1.9 INSULIN RESISTANCE 
 
An accretion of adipose tissue, as in obesity, is associated with insulin resistance 
(Frayn 2001).  Obesity and associated insulin resistance and hyperlipidemia are 
hallmarks of the metabolic syndrome and are major risk factors for type 2 diabetes.  It 
was in 1961 that the concept of insulin resistance was applied, following the 
observation that more obese diabetics were resistant to the blood glucose-lowering 
effect of insulin (Rabinowitz and Zierler 1961).  Therefore the body’s sensitivity to 
insulin, as in insulin resistance, has known to be associated with body fat since then.  
The mechanisms by which an accumulation of fat storage can lead to widespread 
changes in glucose and lipid metabolism, insulin resistance, and other mechanisms are 
still unclear.  Insulin resistance has two important characteristics 1) decreased cellular 
responses to insulin or perturbation of the insulin signalling pathways and 2) 
mutations in the insulin receptor gene which leads to alterations of receptor synthesis, 
degradation and function, i.e. in binding and alterations in translocation and function 
of glucose transporters (GLUT4), in severe insulin resistance.  Adipose tissue plays an 
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important role in the development of insulin resistance and increased circulating 
levels of free fatty acids (FFA) derived from adipocytes are demonstrated in insulin 
resistant states (Corcoran et al.  2007).  Increased FFA have been the most 
consistently discussed associated aberration in the etiology of obesity and insulin 
resistance.  FFA cause an inhibition of glucose uptake and utilisation in muscle, 
glycogen synthesis, glycolysis and an increase in heptatic production of glucose 
(Boden et al.  1994) and an associated glucose-stimulated insulin secretion (Capentier 
et al.  1999), all of which contribute to maintaining the insulin resistant condition.  
Insulin resistance may not be the same and may not occur at the same time in all 
tissues of the body i.e. muscle is resistant very early in the progression of metabolic 
syndrome whereas adipose tissue is not resistant in the early stages of whole-body 
insulin resistance (Das 2002).  The longer term toxic effect of FFA may effect ß-cells 
in the pancreas and this may be the element which associates obesity, insulin 
resistance and the development of type 2 diabetes (Unger 1995).  
 
Associated aberrations of insulin resistance include a propensity to oxidise fat at the 
expense of glucose due to reduced glucose utilisation (Frayn 2001).  Insulin resistance 
is associated with reduced glucose utilisation at a given insulin concentration and 
failed activation of adipose tissue lipoprotein lipase by insulin.  The partitioning of 
fatty acids towards oxidative tissues such as muscle is associated with impaired 
activation of adipose tissue lipoprotein lipase by insulin. This situation leads to the 
idea that insulin resistance may be seen as an adaptation to increasing fat mass (Frayn 
2001; Flatt 1995b).  Ultimately, insulin resistance not only affects the metabolism of 
glucose, but affects lipid metabolism and is also associated with hypertension and 
endothelial dysfunction.   
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 1.10 NUTRIENT STORAGE 
 
Any energy intake in excess of total energy expenditure is stored, however there is a 
hierarchy in the extent to which the macronutrients can be stored, as discussed earlier, 
and this has implications for their metabolic fate, once ingested.  Alcohol is a toxic 
drug which cannot be stored.  The storage capacity for protein and carbohydrate is 
limited and converting these nutrients to a more readily stored form is energetically 
expensive, therefore they are selectively oxidised.  The storage capacity for fat is 
potentially very large.  In some very obese subjects body fat can exceed 40% of total 
body weight (Stubbs 1998).  However, differences between energy stored and energy 
expended and differences in the composition of the fuel mixture oxidised may lead to 
important individual differences in the metabolic fate of excess energy under 
conditions of positive energy balance.  .A positive balance of protein will lead to rapid 
metabolism of a high proportion of the amount of protein ingested, the percentage 
depending on the body’s requirements for specific amino acids.  Similarly as CHO 
intake increases, more of it is disposed of by oxidation.  Because there is a ceiling on 
adaptive changes in energy expenditure (EE)  an increased oxidation of protein and 
CHO will lead to a decrease in the oxidation of fat.  Conversely, intake of fat does not 
promote fat oxidation and actually leads to fat storage (Flatt et al.  1988).  Diet 
composition can influence total energy intake and can alter nutrient balance without 
changing energy expenditure (Tremblay et al. 1989).  The fuel mix oxidized can be 
assessed by RQ (respiratory quotient) and can be measured by indirect calorimetry.  
The RQ of fat is 0.7, Protein 0.8 and CHO 1.0.  An excess of CHO affects energy and 
nutrient balance differently than that of an excess of fat and Horton et al (1995) found 
that an excess of fat leads to more body fat accumulation than an equivalent excess of 
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CHO.  Also, an increase in the thermic effect of food was observed with an excess of 
CHO and fat.  An increase in fat content in the diet will cause a lowering of the RQ 
towards fat oxidation and a reduction in oxidation and promotion of storage (Horton 
et al 1995).  This suggests that an excess intake of fat can lead to a positive energy 
balance and may pre-dispose an individual to obesity.  Flatt’s general theory is that 
the fuel mixture oxidized must match the fuel mixture ingested by seeking to regulate 
carbohydrate.  Hill et al (1994) proposed that some individuals may be at a higher risk 
of developing obesity than others, characterised by a metabolic and/or a behavioural 
susceptibility to weight gain.  He proposed that a behavioural susceptibility to obesity 
creates the opportunity for positive energy balance to occur, such as overeating or 
lack of activity, whereas metabolic susceptibility to obesity determines the metabolic 
fate of the excess energy when positive energy balance occurs.  For example, excess 
fat leads to more body fat accumulation than does CHO (Horton et al. 1995).  
Furthermore, individuals, for example, with a high metabolic susceptibility would be 
even more inclined to accumulate more body fat but less glycogen during periods of 
positive energy balance than an individual would with a lesser metabolic 
susceptibility to obesity.  This knowledge together with the knowledge that excess fat 
affects energy and nutrient balances differently than excess CHO does (Horton et al.  
1995) provides important information about the potential impact of dietary 
composition and nutrient storage on body weight regulation and obesity development.  
Additionally, the implications of long term obesity, such as in type 2 diabetes 
necessitate investigation.  
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1.10.1 Thermic Effect of Food 
 
Diet induced thermogenesis (DIT) is the increase in energy expenditure above resting 
associated with the digestion, absorption and storage of food.  DIT accounts for 
between 5-15% of the total daily EE (Tentolouris et al.  2008).  The thermic effect of 
specific nutrients is highest for protein (20-30%), then CHO (5-10%) and finally fat 
(0-3%).  The central problem in the control of energy balance has always thought to 
have been in the regulation of energy intake, however animal studies have shown that 
in excess energy intake the regulation of thermogenesis is important for the control of 
body fatness (Miller and Payne, 1962).  This has then led to a proliferation of research 
comparing total daily EE or another component of EE such as RMR or DIT.  The 
most significant outcome from this research was that a reduced DIT may contribute to 
the development or maintenance of obesity.  However, studies examining differences 
in DIT have conflicting results.  Some studies show a reduced DIT between lean and 
obese subjects (Segal et al.  1990) and others show no differences in DIT (D’Allesio 
et al. 1988; Tentolouris et al.  2008).  The conflicting results seem to be due to a 
number of reasons including different methodologies, test meals, pre-loads, age-
related differences and daily fluctuations dependant on the amount and type of 
nutrients consumed and the type and amount of physical activity (Weststrate 1993).  
Therefore, the goal of the current study was to assess the DIT induced after a ‘normal’ 
mixed nutrient meal and compare the results of IGT, type 2 diabetics and control 
participants. 
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1.11 THE PUBLIC HEALTH BURDEN OF CHRONIC DISEASES 
 
1.11.1 Obesity 
 
 
Obesity was highlighted as a major public health problem in the UK first by a joint 
department of Health/Medical Research Council report in 1974, and then by the 1983 
Royal College of Physicians (London) Report.  Currently, in Scotland 44% of adult 
men are overweight with a body mass index (BMI) of 25.9-29.9 and a further 14% are 
obese (BMI>30).  In women 32% are overweight and of that figure 17% are obese 
(SIGN, Obesity in Scotland).  Thus half of the adult male population and a third of the 
female population are at risk because they have gained excess weight.  Furthermore, 
about 20% of children are overweight.  Overweight children are found particularly in 
families where both parents are overweight or obese.  The younger an individual 
develops weight gain and obesity, the greater the long-term morbidity. 
 
As demonstrated already body weight is regulated by powerful physiological signals 
which change appetite and satiety to a far greater extent than is recognised.  However, 
only a small persistent discrepancy between daily intake and energy output is required 
to induce substantial weight gain over time.  Metabolic responses to overeating play 
only a modest role in buffering changes in energy balance.  The metabolic rate relates 
to the body weight of an individual, but there are substantial differences between 
individuals.  Many factors interact to induce weight gain, including behavioural, 
physiological, genetic, medical, therapeutic and psychological causes.  To try to 
identify a single factor as the cause of obesity in a patient oversimplifies a complex 
process. 
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The two major factors now being shown to be conducive to weight gain in western 
populations are 1) a reduction in activity levels, which decreases the total energy 
expenditure per day and 2) the ingestion of high-fat, energy dense foods, which 
facilitates excess energy intakes (Prentice and Jebb 1995). 
 
1.11.2 Impaired Glucose Tolerance 
 
IGT is conventionally defined as a plasma glucose level of ≥7.8 and<11mmol/L 2 
hours after ingestion of 75g glucose (WHO 1999).  IGT is a strong predictor of type 2 
diabetes and so it is important to clarify the determinants of IGT.  A few 
epidemiological studies have reported an association between greater abdominal 
obesity, measured by waist circumference or waist-to-hip ratio, and the risk of IGT.  
Progression from normal glucose tolerance to IGT is mostly due to deterioration of 
early-phase insulin secretion and to a lesser degree is the contribution of insulin 
resistance (Suzuki,  2003).  Individuals with IGT are at increased risk of developing 
type 2 diabetes (Yudkin and Coppack 1994).  However, IGT may revert to normal 
glucose tolerance and may not progress inexorably to diabetes.  Indeed, a great deal of 
heterogeneity exists in the rates of progression to diabetes in different populations and 
is higher in non-white racial/ethnic groups.  IGT is not only associated with 
progression to type 2 diabetes but is independently a risk factor for coronary heart 
disease (Califf et al.  2008).  IGT and type 2 diabetics have a number of common risk 
factors including obesity, advancing age, gestational diabetes, family history, 
dyslipidemia and insulin resistance.  Thereby arguing that IGT is a precursor of type 2 
diabetes, however it has not been quantified what factors contribute to the progression 
from IGT to type 2 diabetes.   
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1.11.3 Type 2 Diabetes 
 
In the UK there are approximately 2 million people who are diabetic and, in Scotland 
diabetes is rapidly becoming a health problem as over 170,000 people are diagnosed 
as diabetic (Scottish Government 2006).  Furthermore, research would indicate that 
thousands more have the condition but have not yet been diagnosed (Scottish 
Government 2006). Diabetes UK claim that this figure will double in the next 25 
years (Diabetes UK 2008).  The Scottish Diet report highlighted obesity as a growing 
problem of relevance to the high rates of type 2 diabetes, hypertension and 
hypercholesterolaemia in Scotland (SIGN 1995).  In fact 8 out of 10 type 2 diabetics 
are obese (Diabetes UK 2008).  The increased prevalence of childhood obesity is also 
precipitating type 2 diabetes in children (McGough 2001).   
 
The pathology of type 2 diabetes occurs when ßeta cells within the islets of 
langerhans, in the pancreas may be reduced in number and in chronic states of type 2 
diabetes this may result in fibrosis and deposition of amylin polypeptide within the 
islets. (Halton et al.  2006).  Concurrent with aberrant changes in insulin, as discussed 
above are other known mechanisms (sensory, physiological and psychological) which 
are dysfunctional in obesity and type 2 diabetes.  It is unclear which of the known 
mechanisms influence food intake to the greatest degree and this has never been 
investigated but it is probably due to the implications of the numerous tests that would 
need to be incorporated into the study design.  It is, of course, likely that it is the 
synergistic effect of these dysfunctional mechanisms which causes the progression of 
obesity and type 2 diabetes and which makes it so difficult to reverse the damage and 
effects of these chronic illnesses.  History shows, for example, it is difficult for 
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individuals to lose weight and to maintain weight loss (Tate et al.  2007; Johnstone et 
al.  2008).  This may be an effect of dysfunctional pathways brought about by 
consistent positive energy balance.  The increased knowledge earned by 
understanding the integrated response to food intake could potentially help in the 
prediction of obesity, IGT and type 2 diabetes. 
 
1.12 OBESITY AND CHRONIC INFLAMMATION 
 
The presence of inflammation in obesity has clearly been demonstrated (see figure 
1.5).  The common feature in each investigating article is the inflammation–obesity–
insulin resistance connection.  Specifically, the study of Ortega Martinez de Victoria 
et al (2009) comments on factors related to macrophage activation in adipocytes as a 
source for cytokines for systemic inflammatory effects. In contrast, the study of Haus 
et al (2009) provides data on systemic effects resulting from inflammatory activation, 
namely, the relationship of cytokines with circulating lipid intermediates.  The 
evidence is  accumulating that adipose tissue plays a major role in the production of 
cytokines like interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor 
(TNF)-α, which, in turn increases the production of C-reactive protein (CRP) from the 
liver.  In addition, data from the West of Scotland Coronary Prevention Study 
(Freeman et al.  2002) showed that C-reactive protein predicted the development of 
type 2 diabetes in middle-aged men independently of established risk factors.  This 
long-term alteration in production may adversely affect the sensitivity and/or 
effectiveness of physiological systems controlling long-term energy balance.  The 
long-term effects of this dynamic system are not well documented.     
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Dietary factors, in particular dietary carbohydrates, have been considered in the 
aetiology of inflammation.  It is thought that dietary carbohydrates characterised by 
different postprandial insulin responses, may influence plasma cytokine 
concentrations and gene expression in adipose tissue.  This of course implicates 
glycaemic index in the control of inflammation which mediates the insulin response.  
Therefore, diets containing a high proportion of high glycaemic index foods (i.e. high 
in energy dense, fatty foods) are known to produce a heightened insulin response may 
be implicated in the promotion of inflammation .  A hypothesis has been made that 
ingestion of high glycaemic foods results in initial hyperinsulinaemia and a 
subsequent transient drop in glycaemia below fasting concentrations.  This is thought 
to activate cortisol and catecholamines, which restore fasting glucose concentrations 
and increase nonesterified fatty acid (NEFA) concentrations, which reflects increased 
mobilisation from adipose tissue and stimulation of lipolysis.  Sustained increases in 
plasma FFA can cause insulin resistance (Frayn, 2001).  Moreover, increased 
concentration of TNF-α and IL-6 are associated with insulin resistance (Ruderman, 
2006). 
 
Diet is a significant contributor to adiposity and is therefore an important component 
in the investigation of inflammation.  Dietary fat and plasma fatty acid composition, 
which is at least in part influenced by diet, are related to insulin sensitivity, blood 
pressure, plasma lipid profile and inflammation.  In obese individuals there is a strong 
association between IL-6 and TNF and obesity (Das 2002; Hotamisligil et al.  1993).  
Increased CRP is secondary to increased IL-6 secretion.  Leptin causes an 
upregulation in the production of IL-6 and also induces release of IL-1 in CNS.  The 
effects of leptin on food intake and body temperature are mediated by IL-1.  Thus 
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leptin’s influence is to further augment the synthesis and release of pro-inflammatory 
cytokines (i.e. IL-6).  The result of elevated pro-inflammatory cytokines in the 
hypothalamus may damage the specific neurons that sense plasma glucose levels and 
control the secretion of insulin from the pancreas, affecting glucose metabolism and 
potentially triggering positive energy balance and obesity.  These observations 
provide the link between an increase in the expression, and the plasma concentration 
of a proinflammatory cytokines and insulin resistance (see figure 1.5).  Subsequently, 
other metabolic sites may also be involved during the progression of complications 
i.e. hepatic and skeletal muscle insulin resistance.  It has been shown that adipocyte 
precursors and diverse immune cells such as T lymphocytes and macrohages possess 
similar potentials in escalating inflammatory cytokine production (Rosen et al.  1989).  
Thus, it appears that obesity is associated with a ‘local’ low-grade inflammation 
characterised by increased macrophage infiltration of adipose tissue and the 
production of inflammatory cytokines such as IL-6 and TNF which in turn causes an 
increased CRP concentration.  This may lead to endothelial dysfunction and 
perpetuate insulin resistance and then eventually atherosclerosis and cardiovascular 
disease (CVD).  It is not clear if the inflammatory response is the primary or 
secondary event that causes these diseases.  However, it is clear that study findings 
have important clinical and public health implications (Martin et al.  1992). Insulin 
resistance is a major risk factor for type 2 diabetes, coronary heart disease, stroke, and 
kidney disease.  Identifying risk factors for insulin resistance is important in the 
development of strategies for the prevention and treatment of insulin resistance.  
Inflammatory markers such as tumor necrosis factor, interleukin-6 and C-reactive 
protein have been associated with an increased risk of diabetes (Hu et al.  2004).  In 
addition, inflammatory factors such as C-reactive protein and fibrinogen have been 
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found to play an important role in the pathogenesis of cardiovascular disease (Danesh 
et al.  2004; Ridker et al.  2000). Prospective epidemiologic studies have indicated 
that C-reactive protein has additive effects on the risk of cardiovascular disease 
among patients with insulin resistance (Ridker et al.  2003).  Treatment of 
inflammation may reduce the risk of insulin resistance, diabetes, and related 
cardiovascular disease. 
 
Generally, the acute inflammatory response causes a reduction in appetite (Black 
2006) but with a chronic inflammatory response, as in type 2 diabetes, there appears 
to be no such change in feeding behaviour.  Black (2006) suggested that one reason 
for this could be because the IL-6 response is not strong enough.  It is not known if 
the long-term increase in cytokine levels causes permanent damage to glucose sensing 
neurons and the resultant poor insulin control.  However, this being the case, damage 
to glucose sensing neurons may influence glucose uptake from the blood which may 
have an array of effects including altered ATP levels, altered fuel mix, and therefore 
changes in storage and utilisation which ultimately may be the reason for further 
weight gain in already obese individuals. 
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Figure 1.5 Schematic representation of the relationship between adipose tissue and 
the various components of the metabolic syndrome:  the concept of adipose tissue 
dysfunction, IGT (impaired glucose tolerance, IFT (impaired fasting glucose), GDM 
(gestational diabetes mellitus), HTN (hypertension) (Chandalia and Abate 2007).  
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1.13 PHYSICAL ACTIVITY 
 
As discussed in the very first chapter the importance of maintaining energy balance is 
paramount in leading a healthy lifestyle.  The key to this is to match energy intake 
with energy expenditure.  The relationship between physical inactivity and various 
health problems is well established (Blair et al.  1996; Hardman 1996).  The body of 
evidence over the past half century has led to the consensus that sedentary living leads 
to coronary artery disease and perhaps to some cancers, stroke, non-insulin-dependent 
diabetes mellitus and other health problems (Bouchard et al.  1994).  Overweight and 
obesity accentuate all the manifestations of metabolic syndrome and their 
development may be related to sedentary living; therefore, some discussion of the 
potential of exercise to influence weight regulation is necessary and it is consequently 
important to recognise what the differences in physical activity are between the three 
groups in the current study.  Biological mechanisms that contribute to the lower risk 
associated with activity include improved lipoprotein profile, insulin action, glucose 
tolerance, lower blood pressure and the loss of total weight and body fat (Williams 
2001).  Lower death rates associated with regular physical activity are consistent in 
different populations (Blair et al. 1996; Blair & Connelly 1996).  The level of physical 
activity has been identified as one factor which may exert a beneficial effect on 
insulin and glucose dynamics.  For example, one study of 70-89 yr old men found that 
insulin concentrations during an oral glucose tolerance test were lowest in men with 
the highest physical activity levels, undertaken mainly by walking, cycling, and 
gardening (Feskens et al.  1994).  The findings are similar for women:  in a 
prospective study of 87,000 middle-aged women, those taking part in vigorous 
exercise had only two-thirds the risk for developing type 2 diabetes when compared to 
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inactive women (Manson et al. 1991).  The positive effects following an acute bout of 
exercise include an enhancement in glucose uptake into skeletal muscle, via the 
GLUT-4 facilitated diffusion; this is partly an insulin-independent contractile effect, 
which persists for several hours after the cessation of exercise (Young et al.  1987).  
In addition, the response of the glucose transport system to insulin is enhanced; 
usually lasting about 48 hours (Mikines et al.  1988).  The enhanced transport system 
is important for individuals who have dysfunctional glucose and insulin regulation as 
exercise may help to improve the effectiveness of mechanisms where glucose and 
insulin are involved, most importantly energy metabolism.  Beneficial metabolic 
changes are correlated with the loss of body weight and body fat due to increasing 
energy expenditure with exercise.   This has been reported to be regardless of exercise 
intensity (Bouchard et al.  1993).  Exercise over months and years, may well stimulate 
long-term effects on whole-body insulin sensitivity, which are independent of 
qualitative changes in insulin-mediated transport in muscle, due to body composition 
changes i.e. decreased adipose tissue and increased muscle mass.  The positive effects 
of exercise are well documented and have consequently resulted in reduced appetite 
sensations in lean and obese rats (Ramirez et al.  1997.  Short and long-term effects of 
exercise facilitate to improve energy expenditure by acting on the hypothalamus to 
coordinate the neuro-endocrine and appetite responses to exercise (Engler 2007) and 
therefore maintain energy balance.   
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1.14  METHODS FOR MEASURING ENERGY INTAKE AND ENERGY 
EXPENDITURE 
 
One of the major obstacles in nutritional epidemiology research has been uncertainty 
about the validity of existing dietary assessment methodologies (Block 1982).  The 
doubly labeled water method for measuring total daily energy expenditure can serve 
as a reference for assessing the accuracy of conventional dietary intake methodologies 
(Schoeller 1990). This concept is based on the premise that the measurement of total 
energy expenditure in free-living individuals can serve as a proxy measure of energy 
intake when subjects are in energy balance (Poehlman 1992).  Studies measuring 
energy intake have found that self-reported food intakes underestimated habitual 
energy intakes (Livingstone et al.  1992; Bandini et al.  1990).  However, they lend 
themselves better to large epidemiological studies due to their advantages; such as 
low cost, ease of completion and they are adaptable to most research settings.  Self-
reported measurements of energy intake include weighed records, 24-hour recall, food 
frequency questionnaires.  There are other methods of estimating energy intake such 
as prediction equations which measure energy expenditure and are used on the 
premise that the measure of EE can serve as a alternative measure of energy intake 
when individuals are in energy balance (Johnson et al.  Although, accuracy is 
questionable and there is no gold standard method of measuring energy intake in free 
living subjects, a protocol which validated the 4-day weighed intake (Bingham and 
Day 1997) made this the method of choice in the current study. 
  
There are many different methodologies for measuring energy expenditure.  
Measurements of daily energy expenditure (EE) are made to estimate energy 
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requirements.  Measurements are either 1) continuous i.e. direct and indirect 
calorimetry, 2) factorial i.e. activity diaries, accelerometers, 3) heart rate monitoring 
and the determination of individual oxygen consumption, 4) doubly labeled water or 
5)  energy intake in conjunction with changes in body composition.  Continuous 
measurements of EE would give the most reliable results however are not feasible for 
studies on free living individuals.  For this reason the current study utilised factorial 
methods for the measurement of EE.   
 
1.15 SUMMARY OF THE CURRENT RESEARCH IN FOOD INTAKE 
 
Body weight should be well regulated through biological control of food intake.  The 
regulation of food intake is often seen to be controlled via the brain, as a monitor of 
peripheral body fat stores via messages such as leptin, insulin and acetylation-
stimulation protein (Levitsky 2005), initiating a set of peptide and neuro-endocrinal 
events that constitute the neural substrates of eating behaviour and energy 
expenditure.  Therefore biologically, it is clear that body weight is not well regulated.   
There is a failure in one or more of the feedback systems which controls energy 
balance that leads to the development of obesity.  Research into feeding behaviour 
and body weight control has taken two approaches; appetite and energy balance. In 
the research of appetite the area measured is normally food intake and is often 
concerned with the qualitative aspects of eating such as food choice, preferences and 
the sensory aspects of food, together with the hunger, fullness and the hedonic 
sensations which accompany eating.  Among energy balance research the area 
measured is usually energy intake and is concerned with the quantitative aspects of 
eating and with the energy value of food i.e. macronutrient composition of food and 
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its impact on energy balance.  Research on appetite control has been heavily 
influenced by psychologists and energy balance research has been the spectrum of 
physiologists, biochemists and nutritionists.  These two approaches to research into 
‘feeding behaviour’ conflict when explaining abnormal eating and the consequences 
for weight gain. It is unclear whether obesity is brought about by enhanced feelings of 
hunger, ill-judged food choices, weakened satiety, sensorily induced over-
consumption, from inadequate oxidation of fuels, or different neuro-endocrine 
responses to dietary intake.  The divergent approach into the investigation of feeding 
behaviour reveals that the mechanisms controlling feeding are, not only biological 
but, mutifactorial and complex and are characterised by the on-going interaction 
between peripheral and central mechanisms that sense and respond to changes in the 
external environment i.e. nutrient supply and temperature, and to the internal 
environment i.e. changes in plasma glucose.  It seems apparent that the homeostatic 
control of feeding behaviour is less well designed to cope against an excessive 
environmental supply of energy and nutrients (Blundell and Stubbs 1997).  
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Figure 1.6  Modified schematic diagram illustrating that the pattern of eating 
behaviour arises from an interaction between biological regulation and environmental 
adaptation. (Blundell and Tremblay 1995).  IGT and Type 2 Diabetes affects the 
physiology of metabolism, appetite may affect afferent brain signals, and taste 
sensitivity may affect eating behaviour, all denoting  a complex interplay of 
mechanism controlling the homeostasis of food intake. 
Appetite 
Taste 
IGT
Type 2 Diabetes 
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1.16 GENERAL AIMS OF THE THESIS 
The aim of the study was to investigate the components involved in the metabolic 
handling of food and how the responses differ between IGT, type 2 diabetic and 
control participants.   
 
1.16.1 Objectives of the Thesis: 
 
• To determine anthropometric measures in IGT, type 2 diabetics and a healthy 
control group and compare differences. 
 
• To investigate differences in habitual energy intake and energy expenditure 
and compare the differences between IGT, type 2 diabetics and control 
participants.  
 
• To measure taste in IGT, type 2 diabetics and a healthy control group. 
 
• To investigate subjective ratings of appetite including; hunger, satiety, fullness 
and prospective consumption. 
 
• To measure energy expenditure and diet induced thermogenesis in IGT, type 2 
diabetics and a healthy control group. 
 
• To determine fasting and postprandial rates of substrate oxidation in IGT, type 
2 diabetics and a healthy control groups. 
 
• To determine the integrated response to a test meal measuring glucose, insulin 
and the novel hormone ghrelin. 
 
• To identify any associations between taste, appetite, blood profiles and food 
intake. 
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CHAPTER 2 - METHODS 
 
 
2.1 PARTICIPANTS 
 
 
Participants eligible for recruitment were between the ages of 20 and 70 years in 
accordance with the inclusion criteria. Impaired glucose tolerant (IGT) and type 2 
diabetic participants’ blood glucose levels must have been taken within the last 12 
months and must have still been within the range for diagnosis of that disease, see the 
diagnosis range below.  The participants blood glucose concentrations determined 
whether they were placed into the type 2 diabetic group or the IGT group.  IGT and 
type 2 diabetic participants were recruited having a body mass index (BMI) of greater 
than 30, were not taking any antihyperglycemic medication, and were free from any 
other metabolic disease as per the inclusion criteria. 
 
Table 2.1  Definition and Diagnosis Criteria for IGT and Type 2 Diabetes  
 IGT Type 2 Diabetes 
Fasting <7.0 mmol/l ≥7.0 mmol/l 
2 Hour/Random ≥7.8 and ≤11.1 mmol/l ≥11.1 mmol/l 
WHO 1999   
 
A group of healthy control subjects were also recruited who had no diagnosed 
metabolic disorder.  Exclusion criteria included patients who were claustrophobic 
because they had to undergo tests which involved being covered by a hood and 
patients must have been free from any other metabolic disease.  
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2.1.1 Recruitment 
 
Patients at the Western General Hospital (WGH) in Edinburgh were recruited by 
screening patient records to identify their eligibility as type 2 diabetic participants.  
When they attended their outpatient appointment at the diabetic clinic within the 
WGH, subjects were then approached and were informed about the study and 
provided with an information sheet.  Participants were given one week to read the 
study information before they were contacted by telephone where the content of the 
study was discussed further and participants were recruited if willing.  Both 
appointments for the study were made with the participant at this stage.  IGT 
participants were recruited from the same diabetic clinic although it was also 
necessary to involve GP practices in Lothian.  This was done by sending letters out to 
GP practices outlining the study and asking for access to their patients (appendix 1).  
Patients meeting the inclusion criteria were identified by searching on GPASS and 
then by mailing the study information to those patients on behalf of the practice.  
Participants completed and sent back a ‘patient details’ form (appendix 2) to become 
involved in the study and then contact was made by telephone to discuss the study.  
At this stage if the participants were willing to be involved in the study both 
appointments were made.  Control participants were recruited by advertisement in 
Queen Margaret University.  All subjects were provided with verbal and written 
information regarding the study and informed consent (appendix 3) was obtained 
from all participants.  Participants were provided with the name, telephone number 
and email address of the study’s independent advisor.  Once recruited, participants 
were requested to attend 2 sessions with less than 1 month between the initial and 
second test day.  The first session was simply introducing the participants to the 
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environment, nursing staff and to equipment that would be used on the main study 
day, particularly the calorimeter to ensure they felt comfortable with it and all the 
other procedures.  Height, weight and BMI were recorded at the first session and 
subjects were instructed to complete diet and activity diaries to bring along to their 
second session and finally to complete a 24 hour urine sample to be collected on 
arrival for their second session.  The second session was when the test procedures 
were carried out.  Participants were asked to avoid alcohol for the 24 hours prior to 
the study days to ensure a normal hydration status and were also asked to avoid 
exercise the day before the study days to ensure a normal metabolic status. 
Participants were also instructed to fast for 12 hours prior to commencing the second 
study day (water was allowed during this period) to allow for fasting data to be 
collected. 
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2.1.2 Experimental Protocol 
 
 
 
 
 
 
Figure 2.1  Schematic Diagram of the Study Protocol 
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The study was approved by the Wellcome Trust Clinical Research Facility (WTCRF) 
following a proposal and application for clinical assistance.  A feasibility review was 
undertaken by them to determine costs and approval was granted for 1 year, subject to 
ethical, and research and development (R&D) management approval from both 
Lothian Primary Care Trust (LPCT) and Lothian University Hospital Trust (LUHT).  
R&D management approval was subsequently given by both trusts (LUHT and 
LPCT) and an ‘honorary contract’ and a ‘Disclosure Scotland’ check was obtained 
before research could commence.   All participants attended the Wellcome Trust 
Clinical Research Facility at the Western General Hospital, Edinburgh on two 
occasions to complete the study.   
 
2.1.2.1 Participant – Session 1 
 
On the first occasion participants were familiarised with the facility, the study 
protocol was explained and patients were shown all equipment to be used and then 
written consent was obtained.   Anthropometric tests were completed i.e. height, 
weight, BMI, waist and hip measurements.  Participants were instructed on the 
successful completion of the 4-day diet and activity diaries and were given verbal and 
written instructions (appendix 4) on the successful completion of a 24-hour urine 
collection, all of which had to be completed for attendance at their second session.   
 
 
 
 67
 
2.1.2.2 Participant – Session 2 
 
On admission into the unit for session two, general practitioner, medical history and 
current medications were recorded for each participant.  Initial blood pressure (BP) 
was recorded.  To facilitate blood taking a cannula was placed in the brachial vein 
along with a minimal infusion of normal saline to ensure the cannulas’ patency and 
then baseline blood samples were recorded.  At this stage, guidance was given on 
successful completion of the Visual Analogue Scales (VAS) and all terms were 
explained e.g. hunger, satiety, fullness and prospective consumption.  Baseline VAS 
measurements were recorded and time was given for the patient to relax into the 
environment.  Each participant then underwent an initial period of indirect calorimetry 
for 30 minutes, with the first 10 minutes of results being discarded to allow the 
participant to acclimatise to the calorimeter.  Subjects were asked to lie at rest in a 
supine position, with their arms away from their body and palms facing upwards, with 
their legs slightly apart, and to remain awake during the recording period.  
Immediately after this, participants were given a breakfast equal in calorific value 
including: 1 x 30g box of Kellogg’s cornflakes, 200g of semi-skimmed milk, 1 piece 
of white toast with a portion of butter and a 200ml carton of freshly squeezed orange 
juice.  The time taken to eat the breakfast was recorded.  At specific time points 
throughout the morning, BP and pulse, VAS, bloods and 10 minutes indirect 
calorimetry were recorded.  At 120 minutes the timer was stopped and the cannula 
was removed.   
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2.2 BODY COMPOSITION MEASUREMENTS 
 
2.2.1 Height and Weight 
 
Subjects’ height and weight were measured.  Subjects were asked to remove their 
shoes, heavy outer garments and jewellery, loose change, keys and mobile phones.     
Height was measured using a stadiometer (wall fixed height measure, CMS Weighing 
Equipment Ltd, London, UK) to the nearest 0.1 cm.  Weight was measured to the 
nearest 0.1 kg (Seca 761, Birmingham, UK).  Body Mass Index (BMI) was calculated 
by the division of weight (kg), by height (m²). 
 
2.2.2 Waist and Hip Measurements 
 
Waist is defined as the point midway between the iliac crest (superior border of hip 
bone) and the costal margin (lower rib).  Hip is defined as the widest circumference of 
the buttocks and below the iliac crest.  Subjects were asked to remove all outer layers 
of clothing, shoes, belts and any tight garments intended to alter the shape of the 
body.  Waist and hip were measured twice to the nearest 0.1 cm using a tape measure.   
 
2.2.3 Waist: Hip Ratio 
 
Waist: hip ratio (WHR is defined at the waist circumference divided by the hip 
circumference).  It is a measure of the distribution of abdominal fat (central obesity) 
Raised WHR has been shown to be associated with certain health risks and may be a 
stronger predictor than BMI of the risk of diabetes or insulin resistance.  A high WHR 
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has been taken to be 0.95 or more in men and 0.85 or more in women (Department of 
Health 1995). 
 
2.3 PHYSIOLOGICAL PARAMETERS 
 
Blood pressure and pulse rate were also measured throughout the study period at the 
six determined timepoints.  These were recorded using a Dinamap Compact Vital 
Signs Monitor 9000EM04 (Johnson & Johnson Medical Ltd, Gwent, UK) on the arm 
which was not cannulated for blood letting. 
 
2.4 TASTE TEST 
 
A taste test was used to examine how individual sensitivities to bitter-tasting 
compounds affects food intake by determination of the detection threshold for the 
taste of 6-n-propylthiouracil (PROP).  PROP taste thresholds were determined using a 
series of 15 PROP solutions that ranged in concentration from 1.0 x 10-6mmol/l to 3.2 
x 10-3mmol/l PROP.  This range of concentrations increases in quarter log steps as per 
Drewnowski (Drewnowski et al.  1991; Drewnowski et al.  1997a and 1997b) as 
shown below: 
Log (1.0 x 10-6) = -6 to Log (3.2 x 10-3) = -2.5 mol/l PROP 
i.e. (-6.0, -5.75, -5.5, -5.25, -5.0, -4.75, -4.5, -4.25, -4.0, -3.75, -3.0, -3.25, -3.0, -2.75, 
-2.5). 
170g PROP =  1L = 1mmol/l 
170mg PROP = 1ml  1mmol/l =  170 x 3.2g = 0.0032 = 544mg 
     170 x 1.8g = 0.0018 = 306mg 
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The highest concentration, solution no. 15 contained 0.5446 g/l; the next 
concentration, solution no. 14 contained 0.3064 g/l and so on.  The 4 stock solutions 
(15, 14, 13 & 12) were diluted by 10 times to make the less concentrated solutions.  
The PROP chemical was purchased from Pfaltz & Baver, Waterbury, CT, USA as per 
Drewnowski (1997).  The solutions were prepared and numbered at least one day 
before testing with tap water and stored at 4oC.  
 
2.4.1 Testing procedures 
 
Tests were always performed in the morning of the study, either in session 1 or 2.  
Subjects were requested to abstain from eating, drinking and brushing their teeth for 1 
hour prior to the test.  Each subject was given verbal instructions (Keller et al.  2002) 
on the correct completion of the taste test prior to starting the test and was standing 
alone with the experimenter in a hospital room.  The sip-swirl-and-spit method was 
used and a rinse with tap water separated the sampling of the pairs of stimuli.   
 
2.4.2 Detection Threshold Determination 
 
Subjects were first presented with the reference solution (tap water) and then with two 
identical glasses, one containing a solution of the tastant (about 10ml of solution) at 
an intermediate concentration and the other containing tap water.  Solutions were at 
room temperature.  The participant was asked “Do you taste anything?” and if the 
response was “no” the participant was presented with a higher concentration and the 
result was recorded (see appendix 5).  If they answered “yes”, participants were 
required to indicate which of the two samples was identical to the reference.  Wrong 
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answers led to the presentation of a higher concentration again paired with tap water, 
and correct answers to a lower concentration.  Detection thresholds were measured 
using an up-and-down procedure with a forced choice pair presentation method 
(Dixon and Massey 1960).  PROP tasters were defined as having thresholds of <1.0 x 
10-4mmol/l (equivalent to solution 9) and non-tasters as having thresholds in excess 
of 2.0 x 10-4mmol/l (equivalent to solution 10).  This separation criteria was similar 
to that adopted by Fischer et al (1963) who regarded the concentration of 1.88 x 10-
4mmol/l as the threshold, and to that of Bartoshuk (1993) who used threshold values 
of 2.0 x 10-4mmol/l to separate tasters from non-tasters. 
 
2.4.3 Suprathreshold Scaling 
 
For each tastant to be scaled, subjects were asked to taste and rate PROP solution 12.  
The subjects were required to rate the intensity of bitterness using the labelled 
magnitude scale (LMS) with 6 categories (appendix 5) from ‘barely detectable to 
‘strongest imaginable’.  Verbal instructions were given on the use of the LMS 
(Appendix 6).  Green’s strategy was to include only as many descriptors as subjects 
could comfortably use, as too many may confuse subjects and too few may leave gaps 
in the scale and thus reduce its usefulness (Newstead and Griggs 1984).   The LMS is 
a quasi-logarithmic scale with semantic descriptors that is equivalent to magnitude 
estimation scaling (Green et al.  1993).  The placement of semantic descriptors along 
the length of the scale makes this scale easy for subjects to understand and use.  The 
scale (see figure 2.2) is 165 mm in length and is anchored at the bottom with the 
phrase ‘barely detectable’ and at the top with ‘strongest imaginable’.  The top of the 
scale, ‘strongest imaginable’, on the LMS refers to the strongest oral sensation an 
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individual has been exposed to in everyday life (Tepper and Ullrich 2002).  This 
general description of descriptors has revealed no discernable differences in the 
ratings for PROP than when an explicit definition was used (Sposato et al.  2001) i.e. 
‘strongest imaginable oral sensation’ as opposed to ‘strongest imaginable sensation of 
any kind’.  The scale is particularly useful for collecting intensity responses to strong 
stimuli such as PROP because it permits an individual to rate a stimulus based on the 
full range of his/her everyday experiences rather than truncating the individual’s 
response to a standard descriptor (i.e. very strong).  Since the intensity of PROP to 
supertasters can exceed the limits of a standard rating scale, the LMS avoids ceiling 
effects often associated with the use of standard, scaling techniques (Prutkin et al. 
2000).  
 
Participants rinsed their mouth with tap water before they began and between each 
sample.  They were required to place the whole sample in the mouth (10ml), 
expectorate it and rate its intensity by making a single mark on the scale.  Subjects 
could then rinse their mouth.   
 
Subjects were independently classified by the one-solution test.  For non-tasters, the 
upper limit of the confidence interval reached a value of 15.5, approximately 
‘moderate’ on the LMS (Tepper 2001).  The lower limit for supertasters occurred at a 
value of 51, corresponding to ‘very strong’ on the scale.  Medium tasters fell within 
the intermediate range, >15,5 and <51.  Some subjects gave borderline ratings for 
PROP.  When this occurred, the individual’s detection threshold determination results 
were considered. 
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Figure 2.2  The Labelled Magnitude Scale used for the PROP Taste Testing for a 
Single Solution Test devised by Green et al (1993).  The version used by the 
experimenter includes a numerical scale (Appendix 5)  
 74
2.5 FOOD INTAKE AND ENERGY EXPENDITURE MEASUREMENTS 
 
2.5.1 Diet Diary 
 
Subjects completed a 4-day food diary (Bingham et al.  1994) so that food intake 
could be measured in kilocalories per day.  Subjects were given verbal and written 
instructions on successful completion of the diary and were also given a telephone 
number to contact with queries regarding the diary (appendix 7).  Subjects were asked 
to complete the diary within the course of one week and to record three week days 
and 1 weekend day.  This would take into account the day of the week variations.  It 
has often been stated that there is no gold standard that can be used to validate 
prospective methods of dietary assessment carried out in free living subjects however, 
a validation protocol (Bingham and Day 1997) specified a 4 day weighed food record 
was developed to minimise the burden on volunteers asked to weigh and record their 
food for prolonged periods.  Subjects also received a portion sizes photograph book 
(Nelson et al.  2002) to help estimate weights while out with the home.  To assess the 
validity of the weighed-food records, average dietary nitrogen intake from the 4-d 
weighed food record was compared with average urinary nitrogen output from the 24-
hr urine collection.  All diet diaries were analysed by the author using the dietary 
analysis computer programme, Comp-eat 5 (Carlson Bengston Consultants Ltd, 
London, UK).  The reported intake was analysed and percentage energy provided 
from fat, carbohydrate and protein was assessed.  
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2.5.2 Activity Diary 
 
Subjects were asked to complete a 4-day activity diary (appendix 8) so that energy 
expenditure including activity could be estimated in kilocalories per day.  Again, 
subjects were given verbal and written instructions on successful completion of the 
diaries and were also given a telephone number to contact with queries regarding the 
diaries.  Subjects were required to keep a detailed record of all activities carried out 
during the day, including, showering, eating, walking, sitting at work/in front of the 
television, doing housework and also of any leisure or sporting activity.  The time of 
day, the amount of time spent carrying out the activity and the intensity of the activity 
were noted in the diary.  Physical activity levels (PAL) (WHO 1985) were calculated 
by giving ‘weights’ to activities depending on their intensity, e.g. sleep/rest is given a 
weight of 1.0 whereas heavy activity is 7.0.  Energy expenditure was then calculated 
for each activity within the 24 hours by multiplying the total time and intensity for 
each activity by the calculated hourly basal metabolic rate (BMR).  BMR was 
calculated using the equations of Schofield et al (1985) which utilise height and 
weight as an indicator of BMR.  Total daily metabolic expenditure was then 
calculated by adding the sum of the energy expended for each activity (Gerrior et al.  
2006). 
 
2.6 TEST MEAL 
 
On study days participants were booked in to arrive at their preferred time between 8-
9am therefore breakfast was used as a test meal in this study.  This time was booked 
in with the WTCRF so that they could arrange parking (if necessary) and greet the 
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participant on their arrival.  An identical, isocaloric meal was used for all subjects so 
that the difference between the groups could be identified.  Each test meal was made 
immediately prior to consumption by the researcher.  The subjects were instructed to 
consume the test meal as quickly as was comfortably possible and the importance of 
finishing the meal was stressed.  Time taken to finish the breakfast was recorded.  The 
composition of the test meal is provided below: 
 
Table 2.2  Composition of the Test Meal and Energy Value of each Component 
 
Food Item Quantity
Energy 
value 
from 
CHO 
(kcals) 
Energy 
Value 
from Fat    
(kcals) 
Energy 
Value from 
Protein 
(kcals) 
Total 
Energy 
Value 
kcals 
Kellogs Cornflakes 30g 100.8 2.43 9.48 112.8 
Semi-skimmed Milk 200 ml 35.25 30.6 27.2 93.1 
Brown bread toasted 25g 46.125 6.25 11.2 63.75 
Butter 15g 0.34 110.97 0.36 111.69 
Fresh Orange 250ml 75.94 trace 0.36 82.5 
Totals (kcals) 
Macronutrient (%) 
 
258.45 
(56%) 
150.25 
(32.5%) 
48.6 
(10.5%) 
463.84 
 
 
2.7 MEASURES OF APPETITE BY VISUAL ANALOGUE SCALES 
 
Visual analogue scales (VAS) measures a characteristic or attitude that ranges across 
a continuum of values and is a 100mm in length anchored by word descriptors at each 
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end.  VAS were used to measure subjective sensations of hunger, satiety, fullness and 
prospective food consumption (see appendix 9).  Each subject was given verbal 
instructions on the correct completion of the VAS and the four subjective measures of 
appetite were explained.  Hunger was classified as the subjective desire to consume 
food, satiety as the subjective feeling of ‘satisfaction’ from food and was classed as a 
positive feeling.  Subjects were asked to differentiate between the fullness sensation, 
which was described as a ‘gastric’ or ‘stomach bloated ness’ feeling and could be 
classed as a negative feeling.  Prospective consumption was described as the ability to 
consume more food, which subjects had to quantify using the scale.   Subjects were 
asked to mark the scale at the point which best described the extent of their feelings 
for each category.  The visual analogue scales were quick and easily scored, 
measuring the distance along the 100 mm line to the mark the subject made.  VAS 
rating scales were used as they are more sensitive and less restrictive than category 
scales, which may produce bias.  VAS have previously been shown to encompass 
some ability to predict aspects of feeding behaviour and act as a useful adjunct to 
measures of food, energy and nutrient intake.  VAS have also been shown to be 
sensitive to experimental manipulations, provided those manipulations exceed or 
disrupt the effects of the habituated motivation to eat (e.g. hunger at meal-times), and 
they have been shown to have good reproducibility (test-retest reliability) under 
controlled conditions provided that they are used in within-subject designs (Stubbs et 
al.  2000).    Limitations of the VAS were that the subjects were still restricted by the 
end dimensions of the scale and that assessing the validity was difficult because they 
could not be compared with an objective physical measure (Maxwell 1978).  The 
latter can be overcome if examining the VAS for the hunger measurement before and 
after a meal as it was in this study.  The scales were used to analyse fasting (baseline) 
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levels and at 5 further points throughout the study period (see figure 2.1).  At each 
timepoint a fresh VAS was used so that comparisons could not be made with previous 
results. 
 
2.8 INDIRECT CALORIMETRY 
 
Indirect calorimetry was used to determine energy expenditure and substrate oxidation 
in the study.  Following the study protocol, indirect calorimetry was used on each 
subject at regular intervals of the 3½ hour study period using an indirect calorimeter 
(Datex  Deltatrac Metabolic Monitor, Hatfield, Hertfordshire, UK).  A known rate of 
airflow through the hood (at steady state conditions air flow is set to maintain a 
concentration of carbon dioxide (CO2) in the chamber of approximately 0.5%) enables 
the gas analysers to interpret oxygen consumption and carbon dioxide production.  
Deltatrac analysers measure the volume of oxygen consumed, using a paramagnetic 
sensor, as oxygen has a large paramagnetic susceptibility.  Carbon dioxide produced 
was measured using an infrared sensor.   
 
2.8.1 Operation of the Calorimeter 
 
Before initiation of the current study the calorimeter was serviced by a Datex 
engineer.  Regular calibration of the flow rate and respiratory quotient (RQ) of the 
Deltatrac calorimeter was performed using an alcohol burn kit in accordance with the 
manufacturer’s instructions.  Flow was checked by burning a known amount of pure 
ethanol in a Deltatrac designed alcohol burner.  This check of the flow rate enabled 
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adjustments to be made to the calorimeter and also checked accuracy of the RQ 
(Ethanol RQ = 0.67) for any problems with the linearity of the gas sensors.   
 
The calorimeter was switched on, in the morning of the study, at least 30 minutes 
prior to the commencement of the study.  Before usage, the gas sensors were 
calibrated using a gas mixture of 5% carbon dioxide and 95% oxygen (Quick CAL, 
calibration gas, Datex, Helsinki, Finland).  Calibration for atmospheric pressure was 
also performed using a barometer as this may contribute to drifts in the gas sensors.  
Prior to the initial calorimetry measurement, subjects were informed of the basic 
procedure for using the calorimeter and the duration of each measurement.  To ensure 
the subjects were in a stable state, a 10 minute acclimatisation period was included at 
the start of each test day.  Subjects were measured in a quiet, private room and were 
given no stimulus.  To ensure accurate readings, subjects remained awake throughout 
measurement periods and the researcher or research nurse stayed with the subject at 
all times throughout the measurement periods. Indirect calorimetry measurements 
were taken in a fasted state for 30 minutes, and then at 15, 30, 60, 90 and 120 minutes 
following the test meal, with the measurement lasting for 10 minutes on each occasion 
over the study period.  
 
2.8.2 Limitations of Calorimetry 
 
Limitations of indirect calorimetry are that the data gives no information about the 
substrates being oxidized in individual organs and tissues.  Furthermore, indirect 
calorimetry assumes a single value for the volumes of O2 (oxygen) consumed and 
CO2 (carbon dioxide) produced during the complete oxidation of one gram of each of 
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the substrates.   However, these values depend very much upon the type of substrate 
being oxidised (Table 2).  For example, oxygen consumption depends on whether the 
sugar is a mono, di, or polysaccharide.  The carbohydrate energy source of the body in 
the postabsorptive state is glycogen, which will consume 829 ml of O2 per gram of 
glycogen oxidised.  If however, one is studying a subject or patient who is receiving 
glucose, carbohydrate oxidation expressed as glucose will be underestimated by 11% 
if the starch (glycogen) value is used in the calculations.  Protein oxidation holds 
similar limitations in that the volume of oxygen consumed per gram of protein will 
change depending on whether the protein is primarily a meat, milk or cereal.  Unlike 
protein and carbohydrates, the amount of oxygen consumed per gram of fat oxidised 
varies little depending on its source. 
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Table 2.3  Oxygen Consumption for Nutrient Oxidation (Jequier et al.  1987) 
 
Oxygen consumed per gram of nutrient 
Oxidised (litres) 
Protein 0.966 
Beef muscle 1.008 
Casein 1.008 
Zein (Maize Protein) 1.052 
Carbohydrates  
Starch 0.829 
Sucrose 0.786 
Lactose 0.786 
Glucose 0.746 
Fat 2.019 
Corn Oil 2.015 
Pig fat 2.037 
 
 
Also, hyperventilation during indirect calorimetry can influence the measured O2 
consumption, CO2 production, and the respiratory quotient.  During hyperventilation 
CO2 is eliminated in excess of that produced by oxidative metabolism and there is a 
decrease in the bicarbonate pool.  CO2 elimination increases rapidly and exceeds 
concomitant O2 consumption which results in a respiratory quotient greater than 1.0.  
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Hyperventilation is normally followed by a compensatory period of hypoventilation 
during which metabolically produced CO2 is stored to re-equilibrate the bicarbonate 
pool (Jequier et al.  1987).  To overcome this limitation it was ensured that no 
participants were claustrophobic and that all participants were given time to relax 
before the procedure commenced.  Jequier et al (1987) stated that the mean values for 
carbohydrate and fat oxidation will be correct provided that the respiratory exchange 
measurements encompass these transient changes.   
 
Lastly, the calculation of energy expenditure in indirect calorimetry cannot take into 
account any of the oxygen and carbon of amino acids that remain combined with 
nitrogen, and excreted as nitrogenous products in the urine.  To overcome this 
limitation, urine was collected to measure urinary nitrogen and estimate the 
contribution of protein oxidation to the O2 and CO2 measurements. 
 
2.9 RESPIRATORY QUOTIENT  
 
Respiratory quotient (RQ) was calculated through the measurement of oxygen 
consumption and carbon dioxide production.   RQ is the ratio of moles of carbon 
dioxide produced to the moles of oxygen consumed on oxidation of a given amount of 
each nutrient.  These values are close to 0.7 for fat, 0.8 for protein, 1.0 for 
carbohydrate and 0.8 for a mixed macronutrient meal.  Energy expenditure per litre of 
oxygen consumed is very similar for all three major nutrients, however RQ can be 
used to determine substrate oxidation (when urinary nitrogen is also calculated).   
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2.9.1 Non-protein Respiratory Quotient 
 
With the knowledge of RQ, non-protein respiratory quotient (NPRQ) and substrate 
oxidation rates could be determined.  NPRQ was estimated by subtracting the volume 
of oxygen consumed and carbon dioxide produced per gram of protein oxidised, from 
the total volume of oxygen consumed and carbon dioxide produced as shown in the 
equation below: 
 
NPRQ = VCO2 – PVCO2 
        VO2 – PVO2 
Whereby  PVCO2 = N x 6.25 x 0.774 
  PVO2 = N x 6.25 x 0.966 
And  N = Urinary nitrogen (g/day) 
 
2.10 URINARY NITROGEN 
 
Participants were asked to bring a 24 hour urine collection along on the morning of 
the second session at the WGH which was collected in the 24 hours prior to 
commencement of session 2.  Urine was collected for a period of 24 hours to 
determine nitrogen excretion and permit calculation of the NPRQ (non protein 
respiratory quotient).  Total urine was measured and 2 aliquot samples were frozen (-
40oC freezer) for later analysis.   
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Urinary nitrogen was also used as an indicator of the validity of dietary intake 
(Bingham & Cummings, 1985) and as such was built into the methodology of the 
current study to objectively verify the diet diaries because it is independent of the 
techniques used to test dietary intake.  Even with the daily variation of dietary intake 
the average nitrogen output was reported to be a constant fraction of nitrogen input 
(Bingham & Cummings, 1985).     
 
2.10.1 Procedure for determination of Urinary Nitrogen 
 
Urine was analysed using a Leco-FP328 protein/nitrogen analyser.  The Leco was 
calibrated following the manufacturers instructions on a daily basis.  Initially power-
up checks were performed by the Leco after it was switched on.  Blanks were inserted 
to assess the percentage of nitrogen and argon impurities in the oxygen gas used and 
finally EDTA was used for calibration as the nitrogen content of this is known 
precisely at 9.59%.   
 
A 200 µl specimen was pipetted and weighed into a tin foil sample cup to be 
analysed.  The Leco then performed its 3 phase analyse cycle.  Phase 1 purged the 
sample of atmospheric gases, phase 2 burned the sample in an 850oC furnace flushed 
with oxygen to ensure rapid combustion.  The combusted products (mainly CO2, H2O, 
NOx and N2) were then passed through a thermoelectric cooler to remove most of the 
water.  In phase 3 a piston was forced down on the gas products and a 10 cc aliquot of 
the sample mixture was collected through a valve.   This was then swept through hot 
copper to remove oxygen and change NOx to N2 then, through lecosorb and 
anhydrone to remove CO2 and water respectively.  The product remaining was 
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nitrogen contained in a helium carrier and this was measured by a thermal 
conductivity cell.  The result is displayed as a percentage of nitrogen.  Total urinary 
nitrogen can then be calculated by multiplication of this figure by the subjects’ total 
urine volume over 24 hours. 
 
2.11 SUBSTRATE OXIDATION RATES 
 
Indirect calorimetry measures the volume of CO2 produced and O2 consumed by 
oxidative processes, and for each litre of oxygen consumed there is a known amount 
of heat released.  This is not constant but depends on the type of nutrients oxidised.  
By measuring oxygen consumption, carbon dioxide production, and urinary nitrogen, 
the proportion of different oxidative fuels can be calculated.  The rate of substrate 
oxidation for each study period was calculated by the following formulas based on 
oxygen consumption (VO2), carbon dioxide production (VCO2), and urinary nitrogen 
excretion (Nu) and was calculated using the equations shown below (Suen et al.  
1998): 
 
Lipid oxididation (g/d) = 1.67 x (VO2 –VCO2) – 1.92 x Nu 
Glucose oxidation (g/d) = 4.09 x (VCO2 – 2.88) x (VO2 – 2.59) x Nu 
Protein oxidation (g/d) = 6.25 x Nu 
 
2.12 BLOOD ANALYSIS 
 
An indwelling cannula was placed in the brachial vein of each subjects arm at least 15 
minutes prior to the beginning of the study.  The cannula was kept patent with a 5ml 
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infusion of normal saline over the length of the protocol.  Blood samples were 
withdrawn at various timepoints throughout the study period.  To avoid any dilution 
effect, the first 2 millilitres (ml) of blood from each withdrawal were discarded.  At 
each of the 6 timepoints for blood sampling 4 samples were withdrawn.  These 
samples were withdrawn into blood tubes containing heparin, 
ethylenediaminetetraacetic acid (EDTA) and fluoride.  These were inverted and 
placed into ice. 
 
All blood samples were then centrifuged at 2500 rpm for 10 minutes (4oC), providing 
a relative centrifugal force of 1328.  Plasma was then stored in a -80oC freezer at the 
Wellcome Trust research facility for subsequent batch analysis.  All samples were 
centrifuged and stored within 30 minutes of blood letting.  Analysis of Glucose, 
Insulin and Ghrelin concentrations were performed at the laboratory in QMUC. 
 
2.12.1 Glucose 
 
Glucose was analysed using the Glucose Liquid Reagent Hexokinase Method 
(Randox, United Kingdom).   This method is totally enzymatic utilising both 
hexokinase and glucose-6-phosphate dehydrogenase enzymes.  This is the principle 
reaction: 
Glucose + ATP  G-6-P + ADP 
G-6-P + NAD+  gluconate-6-P + NADH + H+ 
 
In this procedure 10µl of sample or standard was added to 1000µl of buffer solution 
and mixed and the absorbance (A1) was measured at 340 nm wavelength as per the 
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method instructions.  The enzyme reagent was then added (10µl) and the tubes were 
mixed again and incubated for 10 minutes at +20 - +25OC.  The absorbance (A2) was 
then measured within 30 minutes.  The result of the following calculation was then 
calculated: A2-A1 = ∆A sample/standard.  This test is linear up to a glucose 
concentration of 38.9 mmol/l.  All tests were completed in duplicate and the average 
of the sample/standard was used in the following final calculation: 
Glucose concentration (mmol/l) = ∆A sample/standard x 16.2 
 
2.12.2 Insulin 
 
Insulin was analysed using the Insulin Ultrasensitive ELISA kit EIA-2337 (DRG 
Diagnostics, Germany).  This is a solid phase two-site enzyme immunoassay and it is 
based on the direct sandwich technique in which two monoclonal antibodies are 
directed against separate antigenic determinants on the insulin molecule.  In this 
procedure the microtiter wells, previously coated with a mouse monoclonal anti-
insulin antibody, had 25µl of calibrator/samples and 100µl of enzyme conjugate 
added, and was incubated on a plate shaker for 1 hour at room temperature.  During 
incubation insulin in the sample reacts with peroxidase-conjugated anti-insulin 
antibodies and anti-insulin antibodies bound to microtitration well.  A simple washing 
procedure then removes any unbound enzyme labelled antibody.  Then 200µl of 
substrate 3,3’,5,5’,-tetramethylbenzidine (TMB) is added and the samples are 
incubated for a further 30 minutes at room temperature.  The bound conjugate is 
detected by the reaction with TMB.  The reaction is stopped by adding acid (0.5M 
H2SO4) to give a colorimetric endpoint and then shaken to ensure mixing.  A 
microplate reader MRX (Dynex Technologies (UK) Ltd, Sussex, UK) with a 
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reference filter of 450nm was used to determine the absorbance as per the Elisa kit 
instruction guidelines.  A standard curve was drawn for each kit and used the 
corresponding regression equation to determine results.  All samples were measured 
in duplicate.  The detection limit is <0.07 mU/l calculated as two standard deviations 
above the Calibrator 0. 
 
2.12.3 Ghrelin 
 
Ghrelin was analysed using the Human acylated Ghrelin enzyme immunoassay kit 
A05106 (Bertin Technologies, France).  This EIA (enzyme immunometric assay) is 
based on a double-antibody sandwich technique.  In this procedure the microtiter 
wells, previously coated with anti-ghrelin mouse monoclonal antibody (specific to the 
C-terminal part of ghrelin), had 100µl of standard/quality control/1:5 diluted samples 
and 100µl of anti-acylated ghrelin-AChE (acetylcholinesterase) tracer added (which 
recognises the N-terminal part of acylated ghrelin) and was incubated for 20 hours at 
+4OC.  This long immunological incubation allows the increase of assay sensitivity: 
0.3 pg/ml versus 0.8 pg/ml for rapid  (3 hrs at room temp) immunological incubation.  
This incubation period allows the two antibodies to form a sandwich by binding on 
different parts of the human acylated ghrelin.  The sandwich is immobilised on the 
plate so a simple washing procedure allows the excess reagents to be washed away.  
The concentration of the human acylated ghrelin is then determined by measuring the 
enzymatic activity of the immobilised AChE. 200µl of Ellman’s Reagent is added, 
which acts with AChE to form a yellow compound, and incubated in darkness at room 
tempterature for 30 minutes.  A microplate reader MRX (Dynex Technologies (UK) 
Ltd, sussex, UK) with a reference filter was used to determine the absorbance at 
 89
405nm as per the kit A05106’s instruction guidelines.  A standard curve was drawn 
for each kit and used the corresponding regression equation to determine results.  The 
limit of detection in the samples is 1.5 pg/ml due to the minimal plasma dilution.   
 
2.13 ETHICAL APPROVAL 
 
Ethical approval for the recruitment of control participants at QMU was approved on 
the 26th of June 2003.  The study was approved by the Lothian Health Ethics 
Committee, Orthopaedic Surgery/Surgery Research Ethics Sub-Committee, 
Deaconess House, Edinburgh on 4th December 2003 and a subsequent amendment 
was approved on the 19th of January 2005 which approved an amendment in the 
criteria to the inclusion age changing it initially from 18-60 years to 18-70 years.  
Subsequent LPCT research and development committee approved the study on the 4th 
of November 2003 and LUHT research and development committee approval was 
gained on 24th November 2003.  The honorary contract was gained on the 12th of 
December 2003 and from here Dr. John McKnight who is the consultant at the 
diabetic centre within the metabolic unit at the WGH and Dr. Casey Stewart, the 
consultant of OPD2 at the Royal Infirmary in Edinburgh were both contacted and 
consent was given to access patient records within both hospitals.  Dr. Ewan 
Crawford who was at that time clinical director of north west Edinburgh LHCC at 
Corstorphine hospital became the study’s independent advisor for the IGT and type 2 
diabetic patient groups and he gave instruction as to which GP practices to contact 
regarding the study. 
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2.14 DATA ANALYSIS 
 
2.14.1 Area Under the Curve (AUC) 
 
AUC was used as a summary measure of some of the data such as, appetite 
parameters, EE and blood responses.  AUC can be interpreted in these circumstances 
as the cumulative response from a series of measurements on each individual.  In this 
study parameters were recorded at fixed time points and were calculated as per 
Altman (1991).  The data are joined by straight lines to get a ‘curve’.  The AUC is 
usually calculated by adding the areas under the curve between each pair of 
consecutive observations.  In the current study it was desirable to identify a single 
measure of primary interest to be able the comparison between the components of 
energy intake.  AUC as a single measure enabled this to be done and was used to 
observe the total sensitivity or cumulative response of particular energy intake 
components.  Interpretation is simplified by having one ‘unit of measurement’ per 
subject as opposed to many different time points. 
 
2.14.2 Timepoints 
 
Timepoints were used to demonstrate intensity at a certain time i.e. blood 
concentrations, RQ, EE and substrate oxidation.  Timepoints give a record of how the 
intensity changes over time.  In comparison to an AUC response with one value, 
timepoints will give information about where the changes in intensity lie. 
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2.15 STATISTICAL ANALYSIS 
 
Statistical analysis was performed using the Statistical Package for Social Sciences 
(SPSS, Version 15.0).  To determine whether the study data was normally distributed 
the Shapiro-Wilks’ test was used.  Results with a value of p<0.05 were considered 
significant and in these cases data was analysed using the non parametric, Kruskal 
Wallis test and results with a value of p>0.05 were considered non-significant and in 
these cases data was analysed using parametric tests.  Descriptive data has been 
expressed as mean ± standard error of the mean (SEM).  Where data was found to be 
normally distributed the three groups of subjects were compared using analysis of 
variance (ANOVA) to reveal any statistically significant differences between groups.  
Subsequent Bonferroni adjustment tests were made to assess where the differences 
between groups occur.  Repeated measures ANOVA were used to determine whether 
there was any statistical difference within groups over the study period.    
 
Spearman’s correlation was used to determine the strength and direction of the linear 
relationship between energy intake components and Pearson’s correlation was used 
when the data was considered non parametric. 
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CHAPTER 3 - RESULTS 
 
3.1 PARTICIPANTS 
 
Forty-six participants were recruited for the research study; 11 impaired glucose 
tolerant participants from the diabetic clinic at the Western General Hospital and from 
GP practices, 17 type 2 diabetics from the Western General Hospital and 18 control 
participants from Queen Margaret University (QMU).  The mean age of IGT 
participants was 51 years, type 2 diabetic participants were 53 years, and control 
participants were 39 years. Age (yrs) was measured for comparison between groups 
and showed a significant difference between control and IGT participants (p=0.014) 
and control and type 2 diabetics (p<0.001). Gender profiles within the groups in the 
study included 5 males and 6 females within the impaired glucose tolerant 
participants, 8 males and 9 females in the type 2 diabetic group and 4 males and 13 
females in the group.   
 
3.1.1 Intergroup Comparisons of Anthropometric Characteristics  
 
Anthropometric data collected included height (m), weight (kg), body mass index 
(BMI) (wt/ht²), waist and hip measurements (cm) and waist to hip ratio.  Intergroup 
comparisons of anthropometric characteristics were analysed using ANOVA with 
Bonferroni post hoc tests (Table 3.1).  Height (cm) was measured for comparison 
between groups and as expected indicated no differences.  Weight was significantly 
lower in control participants (65.2kg) compared with IGT participants (92.5kg), 
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p=0.002 and type 2 diabetic participants (91.6kg), p=0.005.  BMI was significantly 
lower in the control group when compared with IGT participants (p=0.002) and type 2 
diabetics (p = 0.000); see figure 1.  Similarly, there were no differences between IGT 
and type 2 diabetic groups for weight or BMI.  There were significantly higher waist 
and hip measurements in both IGT participants (waist, p=0.002 and hip, p=0.002) and 
type 2 diabetic participants (waist, p<0.0001 and hip, p<0.0001) compared to 
controls.  IGT and type 2 diabetic participants did have higher waist-to-hip ratios 
(WHR) compared to control participants but there was no significant difference 
between groups.  IGT and type 2 diabetics have been implicated in having impaired 
taste sensitivity because of the association with obesity and these two diseases (Mattes 
et al.   1990).  However,  it is not sufficiently known if the disease states of IGT and 
type 2 diabetes affects the sensitivity of taste to a greater degree as to alter the ratios 
of nontasters:tasters:supertasters.   
 
Table 3.1  Anthropometric Measurements of IGT, Type 2 Diabetic and Control                    
Participants 
 
Characteristic IGT n=11 
Type 2 Diabetic 
n=17 
Control 
n=18 
Height (m) 1.68 (0.22) 1.62 (0.26) 1.67 (0.29) 
Weight (kg) 92.5 (7.10) 91.6 (6.13) 65.2 (3.64)* 
Body Mass Index (wt/ht²) 32.6 (2.23) 34.7 (2.02) 23.3 (0.80)* 
Waist (cm) 108.1 (5.77) 110.8 (4.95) 83.6 (2.83)* 
Hip (cm) 112.4 (4.94) 114 (4.62) 89.75 (2.41)* 
Waist to Hip Ratio  0.96 (0.17) 0.97 (0.15) 0.93 (0.15) 
Values are means ± SEM 
*   p < 0.01 compared to the other groups Bonferroni Pairwise comparison 
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Figure 3.1  Mean Body Mass Index (BMI) of IGT, Type 2 Diabetic and Controls 
* p<0.01 Control group significantly different from other 2 groups 
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3.2 TASTE 
 
The protocol for the taste test is described in the methods chapter, but for clarity is 
described in brief below.    The values used for this analysis are from the rating of 
PROP solution 12 (5.75x10-4mmol/l).  Each person rated this solution on a 9-point 
category scale ranging from 1 = barely detectable to 9 = strongest imaginable taste.  
The mean scale tasted was analysed using Kruskal-Wallis tests to determine 
intergroup comparisons and Mann-Whitney tests were performed between nontasters, 
tasters and supertasters to determine where the differences lay between the taste 
groups.  Furthermore, Mann-Whitney tests were also performed between IGT, type 2 
diabetic and controls to determine where the differences lay between the study 
groups.   
 
3.2.1 Intergroup Comparisons between Nontasters, Tasters, and Supertaster 
Groups  
 
As expected non tasters rated the bitter PROP solution the lowest on the taste scale 
(barely detectable to strongest imaginable taste) and supertasters rated it the highest 
on the taste scale, close to the strongest imaginable taste.  There was a significant 
difference between supertasters and both tasters (p<0.0001) and nontasters 
(p<0.0001), see figure 3.2. There was also a significant difference between tasters and  
nontasters, p=0.013.   
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3.2.2 Intergroup Comparisons between IGT, Type 2 Diabetic and Control 
Groups 
 
The Kruskal-Wallis test showed a p value close to significance, p=0.064 when using 
participants as a whole group and to detect an interaction with taste sensitivity rated 
on the taste scale.  Therefore Mann-Whitney Tests were completed between the study 
groups.  The subjective ratings of bitterness on the taste scale show that IGT 
participants rated the bitter taste the lowest (figure 3.3) and this was significantly 
different from type 2 diabetic participants and control participants (p<0.05).   
 
Additionally, the taste detection test, which determined what concentration the bitter 
compound was first tasted, demonstrated that IGT participants first tasted the bitter 
solution PROP at the highest concentration when compared to the control group.  The 
control participants were the most sensitive to PROP and first tasted the bitter solution 
at the lowest concentration (figure 3.4).  To detect the interaction between the 
participants as a whole group and PROP taste detection a Kruskal-Wallis test was 
performed and showed significance at p<0.01.  Therefore subsequent Mann-Whitney 
tests were performed.  Results show that IGT participants’ detection of the PROP 
solution was at a significantly higher concentration than control participants (p<0.01).  
There was no significant difference between type 2 diabetics and either IGT or control 
participants.   
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Figure 3.2  Taste Scale for bitter compound PROP for Nontasters, Tasters and                 
Supertasters 
Values are Median and Upper and Lower Quaritiles 
*p<0.05 when compared to the tasters 
**p<0.0001 when compared to nontasters and tasters 
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Figure 3.3  Mean values on PROP Taste Scale for IGT, Type 2 Diabetic and Control 
Participants 
Values are Median and Upper and Lower Quartiles  
*p<0.05 when compared to type 2 diabetics and controls 
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Figure 3.4  Concentration that PROP was detected by IGT, Type 2 Diabetic and 
Control Participants  
Values are Median and Upper and Lower Quartiles 
*p<0.01 when compared to control participants 
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3.3 HABITUAL FOOD INTAKE RECORDED BY DIET DIARIES  
 
Diet diaries were recorded for 4 days in the week between the participant’s 
introduction session and the test day.  Results for each day of the diet diary recording 
were averaged to represent a single day’s intake and are shown in table 3.2.  The 
results are presented as basic macronutrient groups (protein, fat and carbohydrate 
(CHO)) and energy intake and expenditure.  To facilitate the evaluation of the type of 
macronutrients consumed the fat content of the diet was fractioned into 
polyunsaturated fatty acids (PUFA), monounsaturated fatty acids (MUFA), and 
saturated fatty acids (SFA) and the CHO content was fractionated into starch and 
sugar.  The results indicate averages over a 24-hour period.  Due to underreporting 
one control subject was withdrawn from the results.  Guidelines for cut off values to 
identify suspected underreporters has been developed using EI:BMR ratio in a series 
of publications (Black et al.  1991; Goldberg et al.  1991).  EI:BMR is based on the 
assumption the total energy expenditure (TEE) is equal to EI and where 
TEE=BMRxPAL (physical activity level).  Therefore, underreporters in the current 
study were identified by multiplying an individuals BMR, calculated using equations 
by Schofield et al (1985)  by 1.2 which is the minimum EI:BMR ratio for survival and 
not compatible with long term health (WHO 1985).    
 
The results in table 3.2 show that there was no significant difference in the average 
energy intake (k/cal), total fat (g/day), protein (g/day) or CHO (g/day) intake between 
groups, although the type 2 diabetic group tended to have the lowest intake of fat, 
CHO (g/day) and total energy (k/cals).  Total fat (g/day) intakes, including MUFA, 
PUFA and SFA, were lowest in the type 2 diabetic participants compared to the other 
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participant groups, but this was not statistically significant.  The type 2 diabetic 
participants were shown to have significantly lower intakes of sugar (g/day) compared 
with the control (p=0.013) and IGT groups (p=0.026) respectively.  Starch intake was 
highest in the IGT group compared with the type 2 diabetic group and control groups 
respectively, but this was not statistically significant.  Non-Starch Polysaccharide 
(NSP) intakes were lowest in the type 2 diabetics (g/day) and highest in the IGT 
participants, however there were no significant differences between groups.  
Conversely, alcohol intake (g/day) was highest in the type 2 diabetic group but no 
differences were found between groups. 
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Table 3.2  Nutrient Intakes in IGT, Type 2 Diabetic and Control Participants  
Macronutrient Group IGT 
n=11 
Type 2 Diabetic 
n=17 
Control 
n=17 
Energy Intake 
(kcal/day) 
 
2068 (176.12) 1729 (166.8) 1980 (179.5) 
Energy Expenditure 
(kcal/d) 
 
2666 (204.02) 2683 (131.15) 2210 (119.14) 
Protein (g/day) 87.77 (7.0) 77.0 (6.46) 70.28 (5.98) 
Fat (g/day): 81.55 (10.64) 65.32 (7.68) 81.61 (10.35) 
            PUFA (g/day) 15.31 (3.0) 11.07 (1.21) 17.21 (3.35) 
            MUFA (g/day) 26.28 (3.54) 21.96 (2.61) 25.86 (3.79) 
            SFA (g/day) 29.53 (3.71) 23.67 (3.51) 27.94 (4.44) 
CHO (g/day): 243.55 (19.81) 196.78 (13.57) 237.03 (22.15) 
           Sugar (g/day) 111.26 (10.03) 71.74 (5.46)* 110.05 (11.91) 
           Starch (g/day) 126.05 (17.81) 120.99 (10.38) 118.16 (14.35) 
NSP (g/day) 13.6 (0.83) 12.46 (0.77) 14.06 (1.55) 
Alcohol (g/day) 9.41 (4.21) 13.53 (7.12) 10.64 (2.85) 
Values are means ± SEM  
* p<0.05 compared to the other groups Bonferroni Pairwise comparison 
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Table 3.3  Percentage of Energy Intake from each Macronutrient 
 
Values are Mean ± SEM 
*p<0.05 control group different from type 2 diabetic group 
 
 
 
Macronutrients were also presented as percentages of total energy intake, see table 
3.3.  Macronutrients were divided into protein, fat (PUFA, MUFA, and SFA), CHO 
(sugar and starch) and alcohol.  Again, the results shown indicate averages over a 24 
hour period.  The control group had a significantly lower percentage of energy from 
protein compared to type 2 diabetic participants (p=0.016).  The percentage intake of 
CHO, fat, and alcohol were similar in all 3 groups.  The type 2 diabetic participants 
had the lowest percentage intake of sugar and the highest starch intake but this was 
not significantly different from the other groups.   
 
Macronutrient Group IGT Type 2 Diabetic Control 
% Energy Protein 17.24 (1.03) 18.55 (1.24) 14.43 (0.76)* 
% Energy Fat: 34.77 (1.78) 33.31 (1.51) 35.68 (1.73) 
       % Energy PUFA 6.44 (0.82) 5.86 (0.53) 7.15 (1.01) 
        % Energy MUFA 11.16 (0.62) 11.31 (0.69) 11.04 (0.89) 
    % Energy SFA 12.72 (1.06) 11.89 (0.87) 12.10 (0.99) 
% Energy CHO: 44.58 (1.64) 44.40 (1.96) 45.50 (2.03) 
    % Energy Sugar 21.04 (2.17) 16.66 (1.25) 21.55 (1.48) 
    % Energy Starch 22.35 (1.28) 27.0 (1.53) 22.21 (1.88) 
% Energy Alcohol 3.32 (1.41) 3.70 (1.61) 4.32 (1.19) 
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Figure 3.5 shows the percentage intake of each of the main macronutrients. A noted 
difference was in the protein intake where IGT participants had 17% intake, type 2 
diabetics had a 19% intake and control participants had a 14% protein intake.  Type 2 
diabetics, IGT and then control participants respectively showed an increasing 
percentage of fat intake and there was a significant difference between control and 
type 2 diabetic participants (p<0.05)..    
 
Diet diaries gave an indication of habitual intake but the experimental protocol 
required expression of short term intakes to investigate how the episodic ingestion of 
food contributes to overall habitual intakes.  Therefore the short term effects of a test 
meal were investigated in the current study.   
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Figure 3.5  Main Macronutrients which make up 100% of Energy Intake in IGT, 
Type 2 Diabetic and Control Participants 
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3.3.1 Meal Consumption 
 
The test meal consisted of 56% CHO, 32.5% fat and 10.5% protein and was of low 
calorific value to ensure a complete postprandial response within the 120 minute test 
period.  The meal was presented when participants were 12 hours fasted.  It consisted 
of cereal with semi skimmed milk, toast with full fat butter and freshly squeezed 
orange juice.  Subjects were given as much time as they required to consume the 
meal.  The length of time taken to consume the meal, see figure 3.6, was covertly 
recorded and participants were requested to consume all the contents of the meal.  
This was to ensure that all participants were consuming an equal quantity of food.  
Results indicate the length of time taken to consume the meal (mins) for each group.  
The average time to consume the test meal did not differ between groups.  The 
average time to eat the meal was 10.63 minutes for IGT and control participants and 
11.07 minutes for type 2 diabetics. 
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Figure 3.6  Length of time for IGT, Type 2 Diabetics and Control Participants to 
Consume the Test Meal 
Values are Mean ± SEM 
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3.4 SUBJECTIVE MEASUREMENTS OF APPETITE  
 
Visual analogue scales (VAS) were used to assess subjective measures of appetite 
using four parameters, hunger, satiety, fullness, and prospective consumption (PC).  
Each of these parameters were measured at regular intervals throughout the test 
periods as shown in figure 2.1.  In order to analyse differences within groups 
(intragroup comparisons) repeated measures ANOVA with post hoc test comparisons 
were used.  This measured differences over time.  Subsequent pairwise comparisons 
were done where differences were identified, using independent t-tests.  ANOVA 
with Bonferroni post hoc tests were used to analyse results between groups 
(intergroup comparisons).   
 
3.4.1 Hunger  
 
3.4.1.1 Intragroup Comparisons 
 
For all groups the levels of hunger changed significantly throughout the study day.  
Following the meal there was a drop in hunger ratings in all groups.  By 120 minutes 
after the meal was consumed levels of hunger had increased again.  Repeated 
measures ANOVA analysed hunger across time (from fasting until 120 minutes after 
the test meal).  There was a significant difference within-groups in all three groups 
(p<0.0001) across time.  The result of this test also demonstrated that there were 
differences between the control group and both IGT  and type 2 diabetic participants,  
(p<0.01) therefore ANOVA with Bonferroni post hoc tests were performed to 
determine at which timepoints the differences lay between groups.   
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Figure 3.7  Hunger ratings for IGT, Type 2 Diabetic and Control Participants over the 
Study Period 
Values are Means and SEM 
* p<0.05 when compared to the other 2 groups 
** p<0.05 when compared to type 2 diabetics 
*** p<0.01 when compared to type 2 diabetics 
+ p<0.05 when compared to IGT group 
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Figure 3.8  Hunger ratings for IGT, Type 2 Diabetic and Control Participants 
represented as the Amount of Change from Baseline Levels 
Values are Means and SEM 
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3.4.1.2 Intergroup Comparisons 
 
The hunger ratings were significantly different at baseline (fasting) levels between 
control participants (p<0.05) and the other 2 groups (figure 3.7).  Due to the 
difference in baseline values hunger ratings were also represented as change from 
baseline (figure 3.8).  It was important to observe the change over time because the 
starting point (fasting level) for hunger was different between groups.  After the test 
meal subjective ratings of hunger decreased sharply in all groups but decreased the 
most in the control group and resulted in no significant differences between subjective 
ratings of hunger at 15 minutes post-meal.  At 30 minutes post-meal IGT participants 
hunger ratings remained steady, type 2 diabetic participants reported a further 
reduction in subjective ratings whereas control participants reported an increase in 
hunger ratings resulting in a significant difference between control participants and 
type 2 diabetic participants, p = 0.017.  All 3 groups then reported increasing levels of 
hunger at 60, 90 and 120 minutes following the test meal.  There was significant 
differences between control and type 2 diabetics at 60 mins (p<0.05), 90 mins 
(p<0.01) and 120 mins (p<0.05) and there was significant differences between control 
and IGT participants at 60 mins (p<0.05) and 90 mins (p<0.05).  At 120 minutes IGT 
participants reported a sharp increase in subjective levels of hunger, to a level higher 
than their fasting measurement, therefore there was no significant difference between 
IGT and control participants at this timepoint.  Control and type 2 diabetic 
participants’ hunger levels at 120 minutes did not reach as high as fasting levels. 
   
 
 
 112
3.4.1.3 Hunger Area Under the Curve  
 
The AUC value was utilised to observe the whole hunger response, recorded by a 
single value.  It is a useful tool to analyse the difference between groups for a whole 
response.  The mean AUC response for subjective ratings of hunger was significantly 
different between IGT and controls (p<0.05) and type 2 diabetics and control 
participants (p<0.01), see figure 3.9.  Control participants had the overall greatest 
hunger response compared to both IGT and type 2 diabetics.  There was no difference 
between the 2 latter groups. 
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Figure 3.9  Visual Analogue Scales: AUC for Hunger 
Values are Means and SEM 
* p<0.05 when compared to controls 
** p<0.01 when compared to controls 
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3.4.2 Satiety 
 
3.4.2.1 Intragroup Comparisons  
 
Repeated measures ANOVA demonstrated that for all 3 groups there was a significant 
difference in the subjective ratings of satiety over time (p<0.0001).  All groups 
followed a similar pattern as fasting subjective levels of satiety were midrange then 
15 minutes following the meal there was an increase in satiety ratings for all groups 
and then a gradual decrease in levels until 120 minutes for all groups.  The satiety 
ratings at 120 minutes did not fall to the same level as fasting levels for any of the 
three groups.  The IGT participants recorded the highest level of satiety, followed by 
type 2 diabetics and then control participants.  The result of this test also shows that 
there were differences between the control group and both IGT and type 2 diabetic 
participants therefore ANOVA with Bonferroni post hoc tests were completed to 
establish at what timepoints the differences were and this can be observed on figure 
3.10.  
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Figure 3.10  Satiety Ratings for IGT, Type 2 Diabetic and Control Participants over 
the Study Period 
Values are Means and SEM 
* p<0.05 when compared to type 2 diabetics 
+ p<0.05 when compared to IGT group 
++p<0.01 when compared to IGT group 
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3.4.2.2 Intergroup Comparisons 
 
Fasting satiety ratings were lower in control participants but this was not significantly 
different, see figure 3.10.  At 15 minutes post meal there was an increase in subjective 
levels of satiety resulting in a significant difference between IGT and control 
participants, p<0.01 and control and type 2 diabetic participants, p<0.05.  In all 
groups there was a gradual decline in subjective levels of satiety at 30 minutes, with 
control participants recording significantly lower levels of satiety at this timepoint 
compared to IGT participants, p<0.05.  At 60 minutes there was no significant 
differences between satiety levels and at 90 minutes there was a significant difference 
again between control and both IGT and type 2 diabetic participants, p<0.05 with 
control participants again still recording the lowest levels of satiety.  There were no 
significant differences between participants at the final, 120 minute timepoint. 
 
3.4.2.3 Satiety Area Under the Curve 
 
The mean area under the curve (AUC) for subjective ratings of satiety was 
significantly different between control participants and both IGT participants 
(p=0.016) and type 2 diabetics (p=0.032), see figure 3.11.  The control participants 
reported the lowest feelings of satiety and therefore had the lowest overall satiety 
response.  There was no difference in satiety ratings between IGT and type 2 
diabetics. 
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Figure 3.11 Visual Analogue Scales Intergroup Comparisons: AUC for Satiety 
Values are Means and SEM  
* p<0.05 when compared to other 2 groups 
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3.4.3 Fullness 
 
3.4.3.1 Intragroup Comparisons 
 
For all 3 groups fasting subjective levels of fullness were low.  At 15 minutes 
following the meal there was a sharp increase in fullness ratings.  The 2 patient groups 
(IGT and type 2 diabetes) fullness levels increased slightly at 30 minutes, whereas the 
control group decreased slightly.  Then there was a gradual decrease in subjective 
levels of fullness until 120 minutes in all groups. There was a significant difference 
over time within all 3 groups, p<0.0001.  On the whole IGT participants reported the 
highest levels of fullness until 60 minutes when a large drop meant that their levels 
were slightly below the type 2 diabetic participants.  Control participants recorded the 
lowest levels of fullness throughout the study period.  The repeated measures 
ANOVA indicated that there were differences between groups, therefore ANOVA 
with bonferroni posthoc tests was performed to determine where the differences lay, 
see figure 3.12.  
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Figure 3.12  Fullness Ratings for IGT, Type 2 Diabetic and Control Participants over 
the Study Period 
Values are Means and SEM 
* p<0.05 when compared to type 2 diabetics 
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3.4.3.2 Intergroup Comparisons 
 
At baseline the fullness ratings were lower in control participants but this was not 
significantly different.  At 15 minutes post meal there was an increase in subjective 
levels of fullness in all groups,  again there was no significant differences between 
IGT, type 2 diabetic and control groups.  In all groups there was a gradual decline in 
subjective levels of fullness at 30 minutes and 60 minutes, although IGT participants 
demonstrated the largest decline in fullness ratings at 60 minutes, and all groups 
levelled off at 120 minutes. At 90 minutes control participants recorded significantly 
lower levels of fullness when compared to type 2 diabetics, p=0.048. 
 
3.4.3.3 Fullness Area Under the Curve 
 
Control participants tended to report the lowest rating for fullness, see figure 3.13.  
This resulted in the AUC response in control participants to be the smallest, however 
this was not significantly different.  Therefore control participants felt the least full 
throughout the study period whereas IGT participants felt the most full. 
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Figure 3.13 Visual Analogue Scales Intergroup Comparisons: AUC for Fullness 
Values are Mean and SEM 
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3.4.4 Prospective Consumption (PC) 
  
3.4.4.1 Intragroup Comparisons 
 
For all 3 groups the fasting (baseline) subjective levels of prospective consumption 
were high.  Levels started highest in the IGT participants and were lowest in the type 
2 diabetic participants.  Again, the recorded levels of prospective consumption 
followed a similar pattern in all three groups.  At 15 minutes following the meal there 
was a sharp decrease in prospective consumption ratings, as expected.  This reduction 
in levels was most pronounced in the IGT participants whose levels then fell below 
that of the control participants and remained intermediate for the rest of the study 
period.  At 30 minutes IGT and type 2 diabetic participants reported a further 
reduction whereas control participants reported an increase in prospective 
consumption.  From there, for the rest of the timepoints, all groups reported a gradual 
increase in prospective consumption until 120 minutes post meal.  Type 2 diabetic 
participants recorded the lowest levels at all timepoints.  The control participants 
came closest to reaching fasting values of prospective consumption.  Across time 
there was a significant difference between type 2 diabetic participants and control 
participants (p<0.05). The repeated measures ANOVA indicated that there were 
differences between groups therefore ANOVA with Bonferroni post hoc tests was 
performed to determine where the differences lay. 
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Figure 3.14  Prospective Consumption Ratings for IGT, Type 2 Diabetic and Control 
Participants over the Study Period 
* p<0.05 when compared to type 2 diabetic participants 
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3.4.4.2 Intergroup Comparisons 
 
At baseline there was no significant difference between subjective levels of 
prospective consumption (figure 3.14).  Fifteen minutes post meal there was a sharp 
decrease in subjective levels of prospective consumption in all groups and there 
remained no significant difference between IGT, type 2 diabetic and control groups.  
In IGT and type 2 diabetic groups there was a further decrease in levels of prospective 
consumption but in control participants there was a small increase in subjective levels 
of PC at 30 minutes, resulting in a significant difference (p<0.01) between type 2 
diabetics and control participants.  All 3 groups then recorded a gradual increase in 
levels of prospective consumption at 60 minutes until 120 minutes.  There was a 
significant difference between type 2 diabetics and controls at 60 minutes (p<0.01).  
There was no significant difference at the 90 minute timepoint. There was no 
significant difference between IGT participants and either type 2 diabetic or control 
participants. 
 
3.4.4.3 Prospective Consumption Area Under the Curve 
 
The mean AUC for the subjective rating of prospective consumption was significantly 
lower in type 2 diabetic participants when compared to control participants (p=0.016) 
meaning they had the lowest desire to eat throughout the study period, see figure 3.15.  
There was no difference in PC between IGT and control or type 2 diabetic 
participants.   
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It is the change in appetite following a meal which allows increased energy intake.  
Therefore, it was an important part of this protocol that habitual energy expenditure 
was also recorded to determine if participants were in energy balance.    
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Figure 3.15 Visual Analogue Scales Intergroup Comparisons: AUC for Prospective 
Consumption  
Values are Mean and SEM 
* p<0.05 when compared to control participants 
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3.5 ENERGY EXPENDITURE 
 
3.5.1 Activity Diaries 
 
Energy expenditure was measured by activity diaries over 4 days.  All subjects were 
instructed to keep the diaries.  Results of the activity diaries were averaged and are 
shown in figure 3.16.  Results are also normalised for body weight by dividing energy 
expenditure (kcal per 24 hrs) values with body weight for each subject and are 
graphically illustrated (figure 3.17).  This was done to determine differences in daily 
EE that were independent of weight. 
 
Average mean energy expenditure from the activity diaries shows that IGT and Type 
2 Diabetic participants have a similar EE and both have a higher mean EE than 
control participants (figure 3.16).  The result is not statistically significant.  However, 
once these results were normalised for body weight all 3 groups had a similar mean 
EE (figure 3.17).  Table 3.4 shows the average time (hrs) each day spent doing 
specific activities to determine if there was a difference in the type and amount of 
activity undertaken throughout the day.  One control participant failed to record their 
activity and therefore is discounted from this result only.  The time spent doing non-
physically active activities like sleeping, lying awake, sitting, sitting activities and 
standing were all very similar between groups.  The time spent in light activity, for 
example standing activities, was higher in the IGT participants than in the control and 
type 2 diabetic participants.  However, the type 2 diabetic participants spent the most 
time doing moderate activity such as walking and partaking in personal needs 
(showering, bathing, dressing etc).  IGT and type 2 diabetic participants did 
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considerably more housework than control participants but when examining the 
strenuous activity (gym work, aerobic activity, cycling, martial arts etc) the control 
participants did twice as much as the IGT participants and a little more than the type 2 
diabetic participants.  Overall there were no significant differences between groups 
for any of the activities although it is noteworthy that the IGT participants spent more 
of their time doing light to moderate activity and the control participants spent more 
of their time doing light and strenuous activity whereas the type 2 diabetic 
participants spent an even amount of time doing light, moderate and strenuous 
activities. 
 
The measurement of energy expenditure including activity in this type of protocol was 
important to assess the habitual activity of participants.  However, resting energy 
expenditure was also measured using indirect calorimetry.  This was important to 
assess the relationship between direct and indirect measurements of EE and also to 
compare resting EE between IGT, type 2 diabetic and control participants to 
determine differences in EE resultant of the disease status. 
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Figure 3.16  Mean Energy Expenditure recorded by Activity Diaries (kcals/day)  
Values are Mean and SEM 
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Figure 3.17  Mean Energy Expenditure (kcals) per Kilogram Body Weight 
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Table 3.4  Activity Diaries: Amount of time (hours) recorded doing common activities in IGT, type 2 diabetic and control participants. 
 
 
 
 
 
 
 
 
 
 
Values are Means and SEM 
 
 
 
Group Sleep 
Lying 
Awake Sitting 
Sitting 
Activity Standing
Standing
Activity 
Personal 
Needs Walking Housework
Strenuous
Activity 
IGT 
7.59 
(1.54) 
1.05 
(0.93) 
3.95 
(3.22) 
5.06 
(3.53) 
0.21 
(0.35) 
2.16 
(2.72) 
0.75 
(0.28) 
1.51 
(1.29) 
1.20 
(1.73) 
0.52 
(0.62) 
Type 2 Diabetic 
7.76 
(1.55) 
0.89 
(0.89) 
4.04 
(2.20) 
4.67 
(2.27) 
0.66 
(0.67) 
1.50 
(1.41) 
1.07 
(0.64) 
1.56 
(0.99) 
0.94  
(0.87) 
0.93 
(0.85) 
Control 
8.15 
(1.42) 
0.73 
(0.59) 
3.36 
(2.85) 
6.01 
(1.32) 
0.40 
(0.46) 
1.67 
(0.85) 
0.73 
(0.37) 
1.38 
(0.69) 
0.48 
(0.51) 
1.09 
(0.89) 
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3.5.2 Indirect Calorimetry 
 
Resting energy expenditure was measured 6 times throughout the test period using an 
indirect calorimeter.  Intergroup comparisons were assessed for all subjects.  Results 
shown are normalised for body weight by dividing energy expenditure (kcal per 24 
hrs) values by body weight (kg) for each subject and expressed as kilocalories per 
kilogram bodyweight (kcals/kgBW), see table 3.5.  Energy expenditure is also 
illustrated at individual timepoints throughout the test period.  Results are shown as 
mean resting energy expenditure and later as percentage change from resting energy 
expenditure, to indicate the diet induced thermogenesis (DIT) of the specific meal, 
see figure 3.19.  Results are also graphically illustrated as area under the curve, 
figure 3.18, so that the magnitude of the response across time could be observed.  
Results were analysed using analysis of variance (ANOVA) with Bonferroni post 
hoc test. 
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Table 3.5  Energy Expenditure Normalised for Body Weight (kcals/kgBW) 
 
Energy Expenditure 
 
IGT 
(n-11) 
 
 
Type 2 Diabetic 
(n-17) 
 
 
Control 
(n=16) 
 
 
Fasting 
 
18.72 (0.67) * 
 
18.73 (0.64) ** 
 
21.8 (0.76) 
 
15 Minutes post meal 
 
20.62 (0.47) ** 
 
21.80 (0.85) * 
 
25.13 (0.87) 
 
30 Minutes post meal 
 
20.43 (0.42) ** 
 
21.17 (0.74) ** 
 
24.78 (0.86) 
 
60 Minutes post meal 
 
20.45 (0.51) ** 
 
20.94 (0.74) ** 
 
24.88 (0.95) 
 
90 Minutes post meal 
 
20.05 (0.74) ** 
 
20.28 (0.73) ** 
 
24.12 (0.87) 
 
120 Minutes post meal 
 
20.06 (0.73) * 20.54 (0.81) * 23.42 (0.80) 
 
Values are means ± SEM 
*    p <0.05 significantly different from control participants 
**  p <0.01 significantly different from control participants 
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Figure 3.18  Area Under the Curve for Resting Energy Expenditure (kcals)  
Values are Mean and SEM 
* p< 0.01 significantly different from the other 2 groups 
 135
Resting energy expenditure data was collected and averaged to show differences 
between groups (table 3.5).  There were significant differences between control 
participants and both IGT and type 2 diabetic participants at all timepoints after 
normalising for body weight.  There was no significant difference between IGT and 
type 2 diabetic participants at any of the timepoints.  The AUC response shows that 
control participants had a significantly higher EE response to the meal than IGT and 
type 2 diabetic participants.  The AUC results are shown per kilogram body weight 
to achieve one value for each group.  Both IGT and type 2 diabetic participants have 
a lower AUC value than control participants.  This was statistically significant, 
p<0.01 (figure 3.18).   
 
Percentage change from fasting was measured for energy expenditure to determine 
the DIT of the meal.  On average the biggest change in energy expenditure (a 14.58% 
increase) for all groups was 15 minutes post meal.  Intergroup comparisons showed 
no significant difference between groups in the change from fasting levels.  Energy 
expenditure values for IGT and type 2 diabetic participants’ then gradually declined 
throughout the other 4 timepoints (30, 60 90 and 120 mins) to 7.23% (IGT) and 
9.62% (type 2 diabetics) above fasting levels.   Control participants’ energy 
expenditure remained at a higher level for 30 and 60 minutes post meal and then 
reduced at 90 and 120 minutes progressively to a level 7.68% above fasting levels.  
None or the three groups reached fasting levels of resting EE.  
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Figure 3.19  Percentage Change from Resting Energy Expenditure 
Values are Mean and SEM 
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Energy expenditure results were integrated using correlative statistical analysis to 
indicate associations between the results.  The integrated results assessed trends 
between predicted fasting EE and fasting EE measured by indirect calorimetry 
(figure 3.20), which is shown in the form of a Bland Altman plot, which is a 
statistical measure to compare two statistical methods (Bland and Altman 1986).  In 
this method the differences between the two techniques are plotted against the 
averages for each technique.  Horizontal lines are drawn at the mean difference 
between the techniques and the limits of agreement, which are defined as the mean 
difference plus and minus 1.96 times the standard deviation of the differences (Bland 
and Altman 1986).  The integrated results also investigated correlations between 
predicted fasting EE using Schofield equations and measured total daily EE by diet 
diaries (figure 3.21), fasting EE measured by indirect calorimetry measured and total 
daily EE by diet diaries (figure 3.22), and finally the relationship between BMI and 
EE (figure 3.23).  As all the results were considered normally distributed Pearson’s 
correlation was used for analysis.   
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Figure 3.20  Bland Altman Plot of Predicted EE measured by the Schofield 
Equations and EE Measured by Indirect Calorimetry for IGT, type 2 diabetics and 
control participants.  Lines include;              the mean difference between the two 
methods;             and both the upper and lower limits of agreement.     
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Figure 3.21  Pearsons Correlation between Predicted EE measured by the Schofield 
equations and EE recorded from Diet Diaries in IGT, type 2 diabetic and control 
participants.  The line represents the linear trend.  The intercept and slope of line are 
given on the graph. 
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Figure 3.22  Pearsons Correlation between EE measured by Indirect Calorimetry 
(kgBW) and EE recorded from Diet Diaries (kgBW) for IGT, type 2 diabetics and 
control participants.  The line represents the linear trend.  The intercept and slope of 
line are given on the graph. 
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Figure 3.23  Pearsons Correlation of BMI and Fasting Resting Metabolic Rate 
measured by Indirect Calorimetry for IGT, type 2 diabetics and control participants.  
The line represents the the linear trend.  The intercept and slope of line are given on 
the graph. 
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Results show a strong positive correlation between EE predicted by the Schofield 
equations and calorimetry measured EE (kcals/day) as expected, p<0.01 (fig. 3.20).  
Therefore as predicted EE increases so does EE measured by calorimetry.  The Bland 
Altman plot shows that most participants fall within the limits of agreement.  There 
are 2 outliers, one IGT participant above the upper limit of agreement and one type 2 
diabetic participant below the lower limit of agreement.  Furthermore, as predicted 
EE increases so too does total EE measured by diet diaries, p<0.01 (fig 3.21). A 
correlation between EE measured by activity diaries and EE measured by calorimetry 
was done (figure 3.22).  The rational for this test was to assess the association 
between subjective measures and indirect measures of EE which has not, to my 
knowledge, been done before.  For the purpose of this measurement, the AUC 
measurement for calorimetry gave a single value to allow comparison between 
measurements.  This association was assessed independently of body weight to 
determine if there was a correlation between direct and indirect measurements of EE 
when evaluating individuals with a metabolic disease such as IGT or type 2 diabetes.  
A significant positive correlation, p<0.001 was found between the two EE 
measurements therefore as EE recorded by diet diaries increased there was an 
evidenced increase in EE recorded by calorimetry also, independent of weight.  In 
general, when observing the control participants in figure 3.22, they tended to be 
located further up the scale and therefore appeared to have a higher EE whereas 
IGT’s and type 2 diabetics were more towards the left of the figure, indicating a 
lower EE.  Lastly, a positive correlation was observed between resting RMR 
measured by calorimetry and BMI, p<0.05.  The control participants tended to be 
towards the left of the figure 3.23 whereas type 2 diabetics and particularly IGT 
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participants tend to be at the higher end of the graph indicating a higher BMI and 
resulting in a higher fasting RMR.   
 
3.6 RESPIRATORY QUOTIENT 
 
RQ was measured at each timepoint by calorimetry to determine fasting and 
postmeal values, so that an assessment could be made about the fuel mix being 
oxidised.  The RQ values were analysed using repeated measures ANOVA with 
Bonferroni posthoc tests.  Intragroup comparisons demonstrated that there was 
significant differences within groups across time for all three groups (p<0.0001) as 
expected.  The results show that the RQ of all groups rose from fasting and did not 
revert to fasting levels before the end of the test period.  The greatest rise from 
fasting levels was observed in the control group between fasting and 30 minutes and 
their RQ remained higher than the other two groups until the end of the test period.  
At 30 minutes the spread of the control group was large, indicating that there were 
many data points far from the mean.  A possible result of this has meant there is no 
significant difference between groups at this timepoint.  The Bonferroni post hoc 
tests suggested there were no significant intergroup differences.   
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Figure 3.24  Intragroup and Intergroup Comparisons in RQ over the Study Period 
Values are Mean and SEM 
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3.7 SUBSTRATE OXIDATION/NPRQ 
 
Respiratory quotient was measured at each timepoint by indirect calorimetry and was 
combined with nitrogen analysis, to indicate the non-protein respiratory quotient 
(NPRQ).  NPRQ was calculated using equations from Jequier, 1987.  To determine 
an association between protein intake from individuals’ habitual diet and nitrogen 
excreted in the urine, a Pearson’s correlation was completed (figure 3.25).  This 
would permit assumptions to be made about the accuracy of the completed diet 
diaries.     
 
This would permit assumptions to be made about the accuracy of the completed diet 
diaries.  A positive correlation was found between energy intake (r=0.337), derived 
from the measurement of food intake from diet diaries and urinary nitrogen.  The 
result allows the assumption to be made that the diet diaries were recorded 
accurately.  However, the r value shows that the degree of correlation, although 
significant was low.   As discussed earlier, the accuracy of diet diaries is always in 
question.  Therefore, an investigation as to the accuracy of energy intake recorded by 
diet diaries was undertaken.  Urinary nitrogen is a well known and established 
biomarker for protein intake (Tasevska et al.  2006).  Therefore, total urinary 
nitrogen (TUN) can be used to calculate protein intake, perhaps with more certainty 
than diet diaries.  Urinary nitrogen was used to calculate protein intake on the basis 
that:  
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protein intake (g/day) = total urinary nitrogen (g/day) x 6.25 (because 1gN – 6.25g 
protein) + 10 (g) (insensible losses such as fecaes, skin, fluids etc).   
 
This calculation allowed assumptions to be made as to the level of accuracy of 
protein and also to make generally assumptions as to the accuracy of other nutrients.  
Figure 3.25.1 gives a clear indication of any outliers within each group.   The control 
group are the only group to have a significant p value (p=0.01) indicating that they 
are the only group to have a significant correlation between the two measurements of 
protein intake.  The IGT group appear to have number of participants below the 
correlation line indicating an under-reporting of protein intake by diet diaries and one 
outlier over-estimated their protein intake by 2 times.  The type 2 diabetic group 
appears to be sporadically arranged and have the lowest correlation value, with no 
significance.  Two of the diabetic group in particular under reported their protein 
intake by 50%, however some also grossly over estimated their protein intake.   
 
Figure 3.25.2 shows that most participants fall within the limits of agreement, thus 
suggesting that urinary nitrogen is a plausible method for estimating energy intake.  
There are 3 outliers; 1 IGT participant and 2 type 2 diabetic participants.  This may 
indicate that the methods of estimating energy intake are not as reliable for these 
groups as the control group.  This figure may even show that energy intake, 
estimated by urinary nitrogen may be more useful than diet diaries because it 
eliminates the process of under reporting food stuffs.  However, it must be used with 
caution, particularly in obese participants because the variety of fat intake ranges 
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considerably, the current study ranges between 21% and 42% fat intake for the two 
overweight groups.  
 
Substrate oxidation rates were measured in the morning by indirect calorimetry after 
an overnight fast, with the patient awake, at room temperature.  One control patient 
did not manage to complete the 120 timepoint in this study and is therefore 
eliminated from these results.  At this time of the day and under these conditions, 
energy expenditure best represents resting metabolic rate (RMR) (Haugen et al.  
2003).  Results are shown with a correction for body weight so the observed 
aberrations were as a result of the disease status.  See figures 3.26  and 3.26.1 for 
CHO and fat oxidation rates respectively.  
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Figure 3.25  Pearson’s Correlation of Nitrogen Intake recorded by Diet Diaries and 
Nitrogen Excreted in Urine, both in grams/day for IGT, type 2 diabetics and control 
participants.  The lines represent the linear trend for each group and the slope and 
intercept is recorded for trend line. 
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Figure 3.25.1  Pearson’s Correlation of Protein intake (g/day) estimated from Diet 
Diaries and Calculated Protein Intake using Urinary Nitrogen for IGT, type 2 
diabetic and control participants.  The lines represent the linear trend for each group.   
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Figure 3.25.2 Bland Altman Plot of two methods of estimating Protein Intake; 1) 
Protein intake measured from diet diaries and 2) Protein intake measured from 
Urinary Nitrogen.  A value of 15% protein intake was used as an average percentage 
intake of the 3 groups and was used to reveal the relationship between the differences 
and the averages and to identify possible outliers.  The lines represent;               the 
mean difference between the two methods;               and both the upper and lower 
limits of agreement. 
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Figure 3.26  CHO Oxidation Rates in IGT, Type 2 Diabetic and Control Groups 
Values are Mean and SEM 
* = p<0.05 IGT group is significantly different from control group 
x = p<0.05 Type 2 Diabetic group is significantly different from the control group 
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Figure 3.26.1  Fat Oxidation Rates in IGT, Type 2 Diabetic and Control Groups 
Values are Mean and SEM 
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Figures 3.26 and 3.26.1 indicate the metabolic response to the test meal in all three 
groups.  In each group initial substrate oxidation rates indicated comparable fat and 
CHO oxidation rates as may be expected in individuals after an overnight fast.  
Figure 3.26 shows at 15 minutes post meal CHO oxidation increased in all groups 
however to a significantly higher level in control participants (p<0.05).  At 30 
minutes post meal CHO rates began to decrease in all groups but to a lesser degree in 
control participants resulting in significantly higher CHO rates when compared to 
IGT participants (p<0.05), who had the lowest levels of CHO oxidation at that time.  
At 60 minutes this decrease continued in type 2 diabetic and control participants but 
increased slightly in IGT participants however there was no significant difference.  
There was a significant difference between type 2 diabetic and control participants at 
90 minutes post meal when type 2 diabetic and control participants’ CHO oxidation 
rates increased slightly as IGT participant levels decreased.  At 120 minutes there 
was a further increase in oxidation rates in type 2 diabetic and control participants’ 
CHO oxidation rates and a further decrease in IGT participants although this was not 
statistically significant.   
 
Figure 3.26.1 illustrates large decreases in fat oxidation at 15 minutes post meal and 
then rates began to increase at 30 minutes for all groups.  At 60 minutes post meal 
type 2 diabetic and control participants increased further however the IGT 
participants fat oxidation rates reduced slightly.  At 90 minutes post meal all 3 
groups’ fat oxidation rates reduced and type 2 diabetic and control participant levels 
continued to reduce until 120 minutes whereas IGT participant levels increased 
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slightly at 120 minutes.  There were no significant differences between groups at any 
timepoint throughout the study period for fat oxidation.  
 
CHO (figure 3.26.2A) and fat (figure 3.26.2B) substrate oxidation rates were also 
expressed as the amount of change (g/day) at each timepoint following the test meal.  
Control participants appeared to show the greatest reduction in fat oxidation rates 
following the meal, followed by IGT and type 2 diabetic participants however this 
result was not significant.   Control participants also demonstrated the greatest 
increase in CHO oxidation rates postmeal. 
 
Protein Oxidation rates are also illustrated independent of body weight.  Results are 
shown as milligram of protein oxidised per kilogram body weight per minute, see 
figure 3.26.3.  IGT participants demonstrated the lowest levels of protein oxidation 
followed by type 2 diabetic participants with control participants exhibiting the 
highest protein oxidation rates.  No significant differences were observed between 
IGT, type 2 diabetic and control groups. 
 
Differences in oxidation rates signify dysfunctional processes in the control of food 
intake.  It has been hypothesised that insulin and glucose levels affect oxidation rates 
following the ingestion of food.  Therefore, the protocol of this study incorporated 
the measurement of blood parameters such as ghrelin, glucose and insulin.   
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Figure 3.26.2  Change (g/day) in Substrate Oxidation in IGT, Type 2 Diabetic and 
Control Participants,  (A) CHO Oxidation and (B) Fat Oxidation 
Values are Mean and SEM 
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Figure 3.26.3  Protein Oxidation Rates in IGT, Type 2 Diabetic and Control 
Participants 
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3.8 BLOOD ANALYSIS 
 
Blood sample aliquots were taken on 6 separate occasions throughout the study day.  
Blood was taken and analysed for glucose, insulin and ghrelin.  These samples were 
assessed using intergroup comparisons.  Results are expressed in standard 
international units and will be indicated on the individual graphs.  Results were 
analysed as described in the methods chapter.   
 
3.8.1 Glucose 
 
Fasting blood glucose results indicated that the control group had significantly lower 
blood glucose than IGT (p=0.0001) and type 2 diabetic (p=0.0001) participant 
groups (figure 3.27). All 3 groups’ plasma glucose levels increased 30 minutes 
postmeal and while control participants glucose levels reduced 60 minutes postmeal, 
IGT and type 2 diabetic participants’ plasma glucose levels continued to rise.  The 
results show that control participants had statistically lower glucose levels at 30 and 
60 minutes between than both IGT and type 2 diabetic groups.   
 
Glucose parameters were also shown as AUC (figure 3.28)  and confirmed the 
difference in glucose response between groups as again control participants had a 
significantly lower blood glucose response when compared to IGT (p=0.0001) and 
type 2 diabetic (p=0.0001) participants. 
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Figure 3.27  Plasma Glucose Concentrations in IGT, Type 2 Diabetic and Control 
Participants 
Values are Mean and SEM 
* p<0.0001 Control group significantly different from other 2 groups 
**p<0.001 Control group significantly different from other 2 groups 
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Figure 3.28  Glucose AUC Response in IGT, Type 2 Diabetics and Control 
Participants 
Values are Mean and SEM 
* p<0.0001 Control group significantly different from other 2 groups 
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3.8.2 Insulin 
 
Fasting insulin levels indicated that control participants had a significantly lower 
insulin concentration than IGT (p<0.05) and type 2 diabetics (p<0.01), see figure 
3.29.  Thirty minutes postmeal showed an increase in insulin levels in all groups but 
to the greatest degree in the control participants.  Control participants had 
significantly higher concentrations when compared to IGT participants at this stage 
(p<0.01) but there was no significant difference between control and type 2 diabetics.  
As insulin levels continued to rise at 60 minutes post meal control participants again 
had significantly higher levels than both IGT and type 2 diabetic groups (p<0.05).    
 
Insulin parameters were also shown as AUC (figure 3.30) and the values show that 
the overall insulin response was significantly greater in control participants when 
compared to IGT (p<0.05) participants and the insulin response of type 2 diabetics 
was very similar to that of control participants.  There was no significant difference 
between IGT and type 2 diabetic participants.  
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Figure 3.29  Plasma Insulin Concentrations in IGT, Type 2 Diabetic and Control 
Participants 
Values are Mean and SEM 
* p<0.05  significantly different from control group 
** p<0.01 significantly different from control group 
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Figure 3.30  Insulin AUC Response in IGT, Type 2 Diabetic and Control 
Participants  
Values are Mean and SEM 
* p<0.05 IGT group significantly different from control group 
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3.8.3 Ghrelin 
 
Table 3.6 demonstrates that fasting ghrelin results indicate no statistical differences 
between groups throughout the test period.  IGT participants showed a reduction in 
ghrelin levels between fasting and 30 minutes and then a further reduction from 30 to 
60 minutes (4.32%). The type 2 diabetic participants’ ghrelin concentrations reduced 
from fasting to 30 minutes and then levels rose between 30 and 60 minutes post meal 
by 4.77%.  Finally control participants demonstrated an increase in plasma ghrelin 
levels 30 minutes post meal and then ghrelin concentrations reduced at 60 minutes 
following the test meal. 
 
 
Table 3.6  Mean Percentage Change from Fasting Ghrelin Levels 
% change IGT Type 2 Diabetic Control 
 
Fast to 30 mins 
 
-3.87% (0.05%) 
 
-1.10% (0.06%) 
 
4.69% (0.07%) 
Fast to 60 mins -8.19% (0.07%) 3.67% (0.06%) 1.98% (0.07%) 
Values are Mean Percentage Change ± SEM 
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3.9 INTEGRATED ANALYSIS 
 
This protocol involved undertaking integrated analysis between the mechanisms 
contributing to the control of food intake.  The integrated responses were extremely 
important to investigate because they depict what is actually happening in the body 
after the consumption of food.  They give an indication about what mechanisms are 
strongly linked and what mechanisms may only be weakly linked.    
 
3.9.1 Taste and Habitual Diet 
 
To establish whether there was an association between taste status and habitual food 
intake a correlation between subjective ratings of bitterness on the taste scale and 
sugar intake measured by diet diaries was performed using Spearman’s correlation 
(figure 3.31).  A significant correlation was found demonstrating that as the 
sensitivity to the bitter compound PROP increases, i.e increasing sensitivity from 
nontaster to taster to supertaster, the corresponding sugar intake decreases.   
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Figure 3.31  Spearman’s Correlation Demonstrating the Association between Sugar 
Intake and Bitter (PROP) Taste Sensations Recorded on the Taste Scale  
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3.9.2 Appetite and Taste Analysis 
 
Correlations were completed where earlier results showed significant differences 
between groups.  Results were integrated using correlative statistical analysis to 
indicate associations between results.  Pearson’s correlations were used where the 
data was parametric and Spearman’s correlations were utilised in situations where 
the data was considered non-parametric.   
 
 
3.9.2.1 Correlation of Appetite Parameters versus Bitter PROP Taste Scale 
 
A correlation between subjective ratings of appetite the PROP taste scale was done 
using Spearman’s correlations (figures 3.32 to 3.32.3).  There were no significant 
correlations between appetite parameters and the tasting of the bitter compound 
PROP.  As the subjective rating of PROP increased, hunger (r=0.187) and PC 
(r=0.035) both increased indicating that the more sensitive an individual is to PROP 
the more hungry they will be and the tendancy to consume food earlier increases.  
This relationship was not anticipated even though it is not a significant result. 
Figures 3.32.1 and 3.32.2 show the relationship ratings of PROP on the taste scale 
and satiety and fullness.  Both appetite parameters (satiety and fullness) indicate a 
reduction as taste sensitivity increase, although the relationship’s are not significant.  
Therefore, as the sensitivity to PROP increases (i.e. non tasters are the least sensitive 
and supertasters are the most sensitive), levels of satiety and fullness decrease.  
Again, this deviates from the anticipated results, although the results are not 
significant.   
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Figure 3.32  Spearman’s Correlation between the AUC for Hunger and Bitter 
(PROP) Taste Sensations Recorded on the Taste Scale for IGT, type 2 diabetics 
and control participants.  The line represents the linear trend and the slope and 
intercept are recorded on the graph. 
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Figure 3.32.1  Spearman’s Correlation between the AUC for Satiety and Bitter 
(PROP) Taste Sensitivity Recorded on the Taste Scale for IGT, type 2 diabetics 
and control participants.  The line represents the linear trend and the slope and 
intercept are recorded on the graph. 
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Figure 3.32.2  Spearman’s Correlation between AUC for Fullness and Bitter (PROP) 
Taste Sensations Recorded on the Taste Scale for IGT, type 2 diabetics and control 
participants.  The line represents the linear trend and the slope and intercept are 
recorded on the graph. 
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Figure 3.32.3  Spearman’s Correlation between AUC for Prospective Consumption  
and Bitter Taste Sensations recorded on the Taste Scale for IGT, type 2 diabetics and 
control participants.  The line represents the linear trend and the slope and intercept 
are recorded on the graph. 
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3.9.3 Appetite and Oxidation Analysis 
 
The present study investigated the relationship between appetite sensations and 
oxidation rates to determine if there is a relationship between the two because the 
effects of this relationship may stimulate important signals which are necessary to 
evoke the satiety cascade and would result in the cessation of feeding.  Without this 
relationship feeding may continue for a longer duration and this may be what results 
in the maintenance of obesity.  The results of CHO oxidation were integrated as 
AUC from baseline to the end of the study period.  Appetite parameters assessed 
were hunger, satiety, fullness and prospective consumption, and were correlated with 
CHO and fat oxidation.    
 
3.9.3.1 Intergroup Comparisons 
 
Comparisons were done between appetite parameters and CHO oxidation.  CHO 
oxidation AUC was corrected for body weight to ensure that any differences 
observed were as a result of the disease state and not the differences in body weight.   
 
The results show that IGT participants consistently differed from type 2 diabetic and 
control participants.  As CHO oxidation increased, hunger (see figure 3.33) and 
prospective consumption (see figure 3.33.3) also increased for type 2 diabetics 
(hunger, r=0.217, p=0.0419; PC, r=0.302, p=0.255) and control (hunger, r=0.112, 
p=0.641; PC, r=0.134, p=0.609) participants whereas the IGT participants 
demonstrated a negative association meaning that as CHO oxidation increased, 
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hunger (r=-0.330, p=0.332) and prospective consumption (r=0.170, p=0.616) 
decreased. The results were not significantly different.  As expected, opposing results 
were found for CHO oxidation and satiety (see figure 3.33.1) and fullness (see figure 
3.33.2) however the type 2 diabetic (satiety, r=-0.476, p=0.063; fullness, r=-0.215, 
p=0.425) and control (satiety, r=-0.223, p=-0.390; fullness, r=-0.362, p=0.153) 
groups still differed from the IGT participants.  As satiety and fullness increased, 
CHO oxidation decreased showing a negative relationship, whereas in IGT 
participants as satiety (r=0.237, p=0.483) and fullness (r=0.621, p<0.05) increased so 
did CHO oxidation.  The positive relationship between fullness and CHO oxidation 
in IGT participants was significant (see figure 3.33.2).   
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Figure 3.33  Pearsons Correlation of CHO Oxidation and Subjective feelings of 
Hunger  for IGT, type 2 diabetic and control participants.  The lines represent the 
linear trend for each group and the intercept and slope is recorded for each line. 
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Figure 3.33.1  Correlation of CHO Oxidation and Subjective Feelings of Satiety for 
IGT, type 2 diabetics and control participants.  The lines represent the linear trend for 
each group and the intercept and slope is recorded for each line. 
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Figure 3.33.2  Correlation of CHO Oxidation and Subjective Feelings of Fullness for 
IGT, type 2 diabetics and control participants.  The lines represent the linear trend for 
each group and the intercept and slope is recorded for each line. 
* significance association at the level p<0.05 
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Figure 3.33.3  Correlation of CHO Oxidation and Subjective Feelings of Prospective 
Consumption for IGT, type 2 diabetics and control participants.  The lines represent 
the linear trend for each group and the intercept and slope is recorded for each line. 
 177
Similar correlation tests were completed for fat oxidation and the same four appetite 
parameters.  The trend observed between fat oxidation and hunger in type 2 diabetic 
(r=-0.445, p=0.084) and control (r=-0.105, p=0.689) participants was negative, 
therefore as fat oxidation increased, levels of hunger decreased, whereas in IGT 
participants (r=0.106, p=0.756) as fat oxidation increased, levels of hunger increased 
(figures 3.34).  The p values show that the associations were not significant.  As fat 
oxidation increased so did satiety (figure 3.34.1) in type 2 diabetics (r=0.207, 
p=0.443) and control (r=0.183, p=0.481) participants.  In IGT (r=-0.003, p=0.992) 
participants as fast oxidation increased levels of satiety reduced.  Fullness levels 
followed a similar pattern to that of satiety where as fat oxidation increases, fullness 
increased in type 2 diabetic (r=0.102, p=0.708) and control (0.210, p=0.419) 
participants (see figure 3..34.2).  The association in IGT participants again differed to 
the other two groups.  As fat oxidation increased, fullness decreased (r=-0.492, 
p=0.124) in IGT participants.  The results of the association between PC and fat 
oxidation deviated from the pattern observed in the other relationships between 
oxidation rates and appetite parameters.  As fat oxidation increased, PC increased in 
IGT participants (r=0.014, p=0.968) and control participants (r=0.005, p=0.985) 
whereas in type 2 diabetic participants as fat oxidation increased the levels of PC 
decreased (r=-0.452, p=0.079), see figure 3.34.3.  The associations between fat 
oxidation and appetite parameters were not significant.   
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Figure 3.34  Correlation of Fat Oxidation and Subjective Feelings of Hunger for 
IGT, type 2 diabetics and control participants.  The lines represent the linear trend for 
each group and the intercept and slope is recorded for each line. 
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Figure 3.34.1  Correlation of Fat Oxidation and Subjective Feelings of Satiety for 
IGT, type 2 diabetics and control participants.  The lines represent the linear trend for 
each group and the intercept and slope is recorded for each line. 
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Figure 3.34.2  Correlation of Fat Oxidation and Subjective Feelings of Fullness for 
IGT, type 2 diabetics and control participants.  The lines represent the linear trend for 
each group and the intercept and slope is recorded for each line. 
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Figure 3.34.3 Correlation of Fat Oxidation and Subjective Feelings of Prospective 
Consumption for IGT, type 2 diabetics and control participants.  The lines represent 
the linear trend for each group and the intercept and slope is recorded for each line. 
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3.9.4 Appetite and Blood Parameters (Glucose and Insulin) 
 
A correlation of appetite parameters and blood plasma measurements was done to 
determine if there was an association between subjective measures of appetite and 
the corresponding biological measures following a meal.  The glucose and insulin 
results were separated by group into IGT (table 3.7), type 2 diabetic (table 3.8) and 
control participants (table 3.9).  Both the glucose and insulin parameters were 
correlated using AUC values and were corrected for differences in body weight to 
ensure that any differences observed were as a result of the disease status.   
 
 
Table 3.7  IGT Participants: Correlation between Glucose and Insulin and 
Subjective ratings of Hunger, Satiety, Fullness and Prospective Consumption. 
 
Glucose AUC Insulin AUC  
R-value p-value R-value p-value 
Hunger -0.210 0.536 -0.122 0.721 
Satiety -0.486 0.129 0.141 0.680 
Fullness 0.221 0.514 -0.137 0.689 
Prospective Consumption -0.196 0.564 0.179 0.599 
 
 
There were no significant differences between glucose or insulin and any of the 
appetite parameters in IGT participants  (table 32.7) suggesting that the differences 
observed in the AUC response for glucose and insulin between groups had no 
resultant effect on subjective appetite parameters.  
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Table 3.8  Type 2 Diabetic Participants: Correlation between Glucose and 
Insulin and Subjective ratings of Hunger, Satiety, Fullness and Prospective 
Consumption. 
 
Glucose AUC Insulin AUC  
R-value p-value R-value p-value 
Hunger 0.143 0.583 -0.523 0.031* 
Satiety -0.436 0.080 0.421 0.092 
Fullness -0.335 0.189 0.146 0.577 
Prospective Consumption 0.280 0.276 0.516 0.034* 
* significance at the level of p<0.05 
 
  
In type 2 diabetic participants there was a significant positive correlation between 
hunger and insulin levels (r = -0.523, p < 0.05) so as insulin levels increased, hunger 
reduced.  Alternatively, a greater overall insulin response is associated with reduced 
feelings of hunger.  There was also a positive relationship between insulin and 
prospective consumption which suggests that as the complete insulin response 
increases so does the desire to consume more food.  This is contradictory to the 
relationship between insulin and hunger and will be discussed further in the 
discussion chapter.   
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Table 3.9  Control Participants: Correlation between Glucose and Insulin and 
Subjective ratings of Hunger, Satiety, Fullness and Prospective Consumption. 
 
Glucose AUC Insulin AUC  
R-value p-value R-value p-value 
Hunger 0.193 0.474 -0.220 0.413 
Satiety -0.508 0.045* 0.147 0.587 
Fullness -0.424 0.102 -0.389 0.136 
Prospective Consumption 0.132 0.626 0.033 0.902 
* significance at the level of p<0.05 
 
 
The control participants demonstrated a negative relationship between the overall 
glucose response and satiety (p = -0.508, p < 0.05).  The results denote that as the 
glucose response increases, satiety levels decrease.  Therefore, it is necessary for 
blood glucose to be increased to maintain a satiety response, which is what would be 
expected.   
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CHAPTER 4 - DISCUSSION 
 
This study investigated the integrated responses to a meal and the differences found 
between IGT, type 2 diabetic and control participants.  It is accepted that an 
imbalance in the integrated response of food intake can result in a positive energy 
balance and over time this may lead to obesity and associated chronic disease.  The 
results have shown differences between control participants and both IGT and type 2 
diabetes and differences have also been established between IGT and type 2 diabetic 
participants.  This is important as it will confer an insight as to how the progression 
of disease affects the already dysfunctional mechanisms involved in the process of 
food intake.  Definate differences observed may assist to identify individuals who are 
likely to develop IGT and type 2 diabetes, using a specific set of physiological, 
psychological and biological markers.  Once a diagnosis of IGT and type 2 diabetes 
is made, counteracting the mechanisms which contribute to a dysfunctional satiety 
cascade and which affect feeding behaviour is essential and may prevent further 
progression of the disease.   
 
4.1 SUBJECT CHARACTERISTICS 
 
4.1.1 Age Differences between Groups 
 
In the current study subjects were recruited between the ages of 20 and 70 years.  In 
this study the IGT groups had ages ranging from 28 to 65 years, the type 2 diabetic 
participants age ranged from 36 to 66 years.  There was no significant differences 
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between the mean age of these two groups.  However, the control participants, who 
were recruited from the University population, were aged from 20 to 57 years (being 
the oldest participant) and this group were younger in age to the two patient groups.  
In the current study the control participants were not age matched.  The primary 
reason is linked with the timescale of the study data collection period.  The type 2 
diabetic and IGT participants were recruited over the course of a year.  Recruitment 
was based upon recruiting 1 patient per diabetic clinic.  Therefore it would not have 
been feasible to recruit all the patients before advertising for all control participants 
as this would have taken the data collection period past the planned time period.     
 
Studies comparing the results of type 2 diabetes and IGT with control participants 
often encounter similar age-related differences (Wolever and Mehling 2002).  The 
age differences may be explained by: 1) the nature of the disease state because type 2 
diabetes was commonly known as late-onset type 2 diabetes (Hansen et al.  2000) 
and so was initially identified as being an age-related illness, therefore older 
participants were expected and 2) the older range of the population had less time 
constraints i.e. less work or family commitments and therefore found it easier to 
dedicate time to be involved in the study.  Some investigators have reported 
significant changes or differences in body composition with advancing age (Steen 
1988) however studies primarily focus on subjects over the age of 70 years (Newman 
et al. 2005 & Ding et al. 2007) which discounts the participants in the current study 
as the maximum inclusion age was 66 years.  Hughes et al (2008) investigated body 
composition changes in participants up to the age of approximately 60 years, with a 
10 year follow up, and noted an increase in adipose tissue resulting in changes in 
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regional body composition such as increased waist and hip measurements.  This age 
related body composition change is symptomatic of the diseases that are being 
studied.  Therefore differences would be expected between the groups facilitating the 
requirement for the measurement of WHR as it is an indicator of body composition 
which is independent of body weight.   
 
There are known changes in nutrient handling and metabolism in the elderly; namely 
changes in fuel utilisation, reduced responsiveness to energy imbalances, changes in 
energy expenditure, reduced dietary variety, impairments in hormonal mediators and 
reduced hunger and increased satiation (Roberts and Rosenburg 2006).  In 
longitudinal studies, Keys et al (1973) recorded that basal metabolic rate (BMR) 
reduced 1-2% per decade over the ages of 20 to 75 yrs.  However, what is not clear is 
whether body composition changes are reflected in metabolic responses and if so 
when the metabolic changes start to manifest.  The World Health Organisation 
(WHO 1995) consider that ‘elderly’ is 65 years and above and this distinction is 
accepted in most developed countries.  Delacourte et al (2004), reported older 
subjects in an experimental underfeeding study experienced significantly less 
frequent symptoms of hunger (assessed using visual analogue scales) than young 
subjects, despite the fact that the older subjects lost significantly more weight and 
would therefore be expected to experience more frequent hunger.  The altered hunger 
versus satiety regulation seen in the study by Delacourte et al (2004) may be due to 
altered glucose homeostasis in old age i.e. blood glucose is regulated over a broader 
range (MacIntosh et al.  2001).  Melanson et al (1997) reported persistently elevated 
postprandial glucose and insulin in older women following consumption of 2,092- 
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and 4,184-kJ test meals compared with younger women. Provided that central 
mechanisms for converting a signal of energy status into a sensation of hunger are 
intact in older individuals, as one study (Brand et al.  1982) but not some others 
(Marker et al.  1999; Meneilly et al.  1994) indicated.  The elevated postprandial 
blood observed by Melanson et al (1999) could potentially lead to an attenuated 
return of hunger in the postprandial period.  Melanson (1997) also reported that in 
old age there is a reduced insulin sensitivity resulting in elevated circulating insulin 
which accompanies the high postprandial glucose levels in the body and the result of 
this may contribute to the delayed return of hunger.  The mechanism is thought to 
involve a central satiety effect of high insulin levels or by altering central sensitivity 
to other components in the cascade of mechanisms that regulate food intake such as 
cholecystokinin (CCK) and neuropeptide Y (NPY).  Although, as aforementioned, 
the subjects, except one, in the current study were below that which were considered 
‘elderly’ (WHO 2002), the age-related changes will be considered along with the 
continuing discussion of the current study.   
 
4.1.2 Gender Differences between Groups 
 
Significant differences were observed between males and females for a number of 
anthropometric measurements.  Males were significantly taller and heavier than 
females and there was no difference in BMI or age between the sexes.  These results 
were all expected and are consistent with other European studies (de Jong et al.  
2001).  Male participants had significantly larger waist measurements and waist to 
hip ratios when compared to female participants, however this could be attributed to 
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the gender split within groups i.e. the low number of male control participants.  The 
two patient groups had a similar number of male and female participants but the 
control group was skewed towards females (76%).  These findings do provide 
evidence for the need of combined sex and age-specific reference data.  The severity 
of the problems concurrent with type 2 diabetes and IGT identifies the need for 
specific data relating to the diseases and is therefore important for future research. 
For example, it has been recorded (WHO 1995) that a larger proportion of females 
reach older, old age (+85yrs) than males and so it is important to understand the 
metabolic consequences surrounding this age range and the differences between 
males and females.  Acquiring this data can provide important information for further 
research and may result in more specialised care and treatment of the diseases at 
pertinent points of the ageing process and allow an understanding of the metabolic 
changes that occur over time as type 2 diabetes and IGT progress.   
 
4.2 ANTHROPOMETRIC CHARACTERISTICS  
 
Control participants had significantly lower weight, BMI, waist, and hip 
measurements compared to the other two participant groups.  The age-related 
differences discussed earlier, such as age-related weight loss can almost be 
discounted because the weight in the type 2 diabetic group, which was the eldest 
group, was significantly higher than the control group.  The differences in BMI, 
waist and hip measurements were expected due to the significantly higher mean 
weight of the IGT and type 2 diabetic participants compared to the controls.  There 
was no significant difference found in either height or waist to hip (WHR) ratio 
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between groups.  The use of WHR as an anthropometric indicator to assess adipose 
tissue distribution was validated by in-vivo methods (Ferland et al.  1989).  Results 
have varied between studies; Daniel et al (1999) found no differences in WHR 
between normal and clinically obese individuals and concluded at higher BMIs, 
overall adiposity was a better indicator of poor glycaemic status than abdominal 
obesity.  On the other hand, Snijder et al (2003) concluded opposing results and 
suggested that WHR is a strong predictor of type 2 diabetes.  The current study 
indicates that WHR was not an important indicator of IGT and type 2 diabetes but 
that abdominal obesity, measured by waist and hip measurements certainly did 
indicate poor glycaemic status. 
 
4.3 TASTE 
 
Previous research has indicated that taste has a genetic origin (Blakeslee and Salmon 
1931).  This was originally tested with the bitter compound PTC and went on to be 
tested on a second bitter compound PROP.  It was established that humans can be 
separated into three taste status groups; nontasters, tasters and supertasters 
(Bartoshuk 1991).  Tasters and supertasters were found to dislike the bitter PROP 
compound and correspondingly they were reported to avoid foods containing this 
compound in their everyday food choices.  Tepper and Nurse (1998) studied the 
effect of fat perception with PROP taster status and found that tasters and 
supertasters could discriminate differences in the fat content between salad dressings 
(10% fat and 40% fat) whereas the nontasters could not.  Tasters and supertasters 
showed no preference for either dressing however the nontasters preferred the high 
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fat dressing.  The importance of the ability to discriminate food elements in the 
process of food intake is imperative.  A preference for high fat foods, or the lack of 
distinction between low and high fat foods, may result in a positive energy balance 
on a daily basis.  A consistent positive energy balance is known to result in obesity 
which can lead to IGT and overt type 2 diabetes.  
 
In the current study it was to be determined if IGT and type 2 diabetic participants 
follow the same taste status trends as previous results which have, in general, been 
undertaken on normal healthy subjects (Tepper & Ullrich 2002; Stein et al.  2003; 
Duffy 2004).  If previous research has been precise, non-tasters would be the 
heaviest participants because they cannot detect bitter content and corresponding fat 
content, differences in foods.  The resultant food preferences (Tepper and Nurse 
1997) would be expected to consist of both a higher energy density and fat content, 
so overall a greater average daily energy intake would be expected to be consumed in 
nontasters, than tasters and supertasters.  Conversely, the supertasters of PROP 
should have a dislike for bitter foods and high fat foods and therefore the aversion 
would cause a lower energy density diet, lower fat intake and overall lower daily 
energy intake.  In reality, the current study demonstrated that half (5 out of 10) of the 
nontasters were IGT participants and all except one of the nontasters were either IGT 
or type 2 diabetic.  This was expected and did conform to previous research to 
demonstrate that obese participants may be nontasters of bitter/fat content.  The 
result of the current study exposes that IGT participants are more likely to be 
nontasters of PROP. This suggests that IGT and type 2 diabetics participants, due to 
their lack of sensitivity to bitterness and fat have a propensity to avoid bitter foods 
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and consume fatty foods readily which, if continuous may consequentially result in 
positive energy balance and weight gain.  The results also suggest that nontasters are 
pre-disposed to gain weight.  Taste status may be a used as a prediction tool, along 
with physiological markers, to screen healthy or perhaps overweight individuals 
(BMI>25) to determine a pre-disposition for obesity.  Furthermore, all except one of 
the supertasters were control participants.  The results demonstrate significant 
intergroup comparisons between taste status and subjective ratings on the taste scale.  
Overall, 20% of the participants were nontasters, 64% were tasters and 16% were 
supertasters.  A study by Bartoshuk (2000)  stated that the frequency of non-tasters, 
tasters and supertasters was 25%, 50% and 25% respectively but that the figures 
must be adjusted depending on the dominancy of males or females in the sample, 
because more females are supertasters than are males (Bartoshuk et al. 1994).  There 
is no research which states how the ratios should change with gender however 
considering both the small sample of this study and that the patients were procured 
with a known metabolic disorder, it would be acceptable to have a lower percentage 
of supertasters.  Given the research, there would not be a high expectation of 
supertasters within the IGT and type 2 diabetic groups because of the relationship 
between PROP taster status and BMI (Tepper and Nurse 1998).   
 
Differences were found between IGT, type 2 diabetics and control participants and 
taste sensitivity.  The differences in the comparisons between groups and the taste 
scale for PROP were significant.  In reviewing the literature there were very few 
studies which investigate the influence of PROP on IGT and diabetic patients, 
therefore it is novel to observe that a group with metabolic disease do fit in to the 
 193
profile of the research which has been undertaken on healthy control subjects.  In the 
current study the IGT participants were significantly less sensitive to PROP on the 
taste scale and also identified PROP at a significantly higher concentration than 
control participants.  The type 2 diabetic patients were intermediary in the detection 
of PROP and were therefore not significantly different from either control or IGT 
participants. It is noteworthy to mention that IGT is known to be a lesser condition 
than type 2 diabetes and yet IGT patients were found to be more likely to be less 
sensitive to the bitterness of PROP.  With greater study numbers this result may have 
been observed more explicitly in type 2 diabetics.  An explanation for why the 
differences were found between IGT and type 2 diabetic participants may be that the 
IGT participants in this study were recruited after first diagnosis of their condition 
whereas the type 2 diabetics may have been diagnosed some time ago.  Therefore, it 
appeared that the type 2 diabetics had adapted to the presence of their condition and 
secure in their ability to control their diabetes, more so than the IGT participants.  
Consequently, the type 2 diabetics may have had greater habitual control over their 
diet and therefore their blood glucose.  It may be possible that once a level of control 
is established over blood glucose and insulin levels that taste sensitivity improves, 
analogous to the improvement in diabetic symptoms with good glycaemic control.  
Poor insulin sensitivity found in type 2 diabetic patients has been attributed to 
diminished taste for PROP bitterness (Moran et al, 2007; Williams & Cummings, 
2005).  Furthermore, reduced postprandial ghrelin suppression has also been 
associated with diminished taste for PROP bitterness (Moran et al, 2007; Williams & 
Cummings, 2005).  The blood results do show that the IGT participants appeared to 
have a diminished level of plasma ghrelin postprandially, whereas the type 2 diabetic 
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participant levels did not decrease to such a large degree.  Although the results in 
ghrelin concentrations were not significant between IGT and type 2 diabetics this 
may attribute to the difference seen in the taste results as it may denote a lesser 
glycaemic control in IGT participants.  Therefore, the results of this study show that 
a better glycaemic control may lead to improved ghrelin levels. As shown in the type 
2 diabetics and a concomitant improvement in taste sensitivity.  This hypothesis 
would warrant further investigation with both poorly and well managed type 2 
diabetics to determine a definitive answer as to how taste can vary with different 
states of glycaemic control.  In summary, the current study has demonstrated that 
IGT participants are more likely to be non-tasters and are unlikely to be supertasters.  
Also, taste status has the potential to be utilised as a prediction tool for obesity and 
may help the prevention of IGT and type 2 diabetes if weight gain can be avoided. 
 
The intake of fat and sugar have been implicated as being influenced by the taste 
sensitivity to PROP due to sharing similar pathways in the body that sense bitterness 
(Drewnowski 1997a).  In the current study, fat intake was not significantly different 
between IGT, type 2 diabetics and controls or between taster groups (nontasters, 
tasters and supertasters).  However, there was a decreasing trend observed between 
the taster groups in fat intake with increasing taste sensitivity (nontasters are least 
sensitive to taste, whereas supertasters are the most sensitive).  The average fat intake 
was 80g/day for non-tasters and 76g/day for both taster and supertaster groups.  
Furthermore, there was a similar trend in the intake of SFA.  Nontasters had a 
28.8g/day intake, tasters had a 27g/day intake and supertasters had a 25.5g per day 
intake.  The differences were not large enough for them to be significant differences 
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between taster groups and this may be an indicator of the compliance shown in the 
control of the habitual diets by IGT and type 2 diabetic participants in this study.   
 
Total fat intake in IGT participants was comparable with control participants but IGT 
participants had the highest amount of SFA in their diet whereas, type 2 diabetic 
participants had a lower fat intake and a correspondingly lower SFA intake.  The 
intake of fat was not significantly different between groups, however, again these 
small aberrations observed in IGT participants in the current study may have 
synergistic effects in the control of food intake and energy balance.  The occurrence 
of differing control over metabolic systems between IGT and type 2 diabetic 
participants is emerging.  IGT participants had the highest SFA intake and highest 
sugar intakes which habitually indicates less well controlled blood glucose levels.  
Thus, proposing the hypothesis that sensitivity to taste may be affected to a greater 
degree in an individual with poor glycaemic control than in an individual where 
glycaemic control is well managed.  This demonstrates how important a healthy 
habitual diet is, particularly in IGT and type 2 diabetics.   
 
4.4   HABITUAL FOOD INTAKE AND ENERGY EXPENDITURE 
 
4.4.1 Nutrient Intakes Assessed by Diet Diary  
 
The habitual dietary intake of the groups in the current study were examined to 
determine differences between groups.  Diet diaries were returned for all participants 
which was significant as it demonstrated the participants’ commitment to the study.  
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Differences included a significantly lower sugar intake (g/day) in type 2 diabetic 
participants when compared to IGT and control participants.  Also, control 
participants showed a lower percentage intake of protein (14%) when compared to 
IGT (17%) and type 2 diabetic (18.5%) participants.  It was important to consider 
how habitual diet would influence long term energy intake in the normal settings of 
these groups.  Food intake was assessed in this study by the use of four day estimated 
diet diaries. Although seven day weighed diaries were considered for use it was 
decided that this may be too onerous a task in addition to the other components of the 
study.  Diet diaries were used to determine any causative factors that may lead to 
positive energy balance and weight gain commonly seen in the IGT and diabetic 
patient groups (Klein et al.  2004).   
 
The type 2 diabetic participants had the lowest intakes (in grams and also percentage 
intake) of total fat and also saturated fatty acid (SFA).  Although this result was not 
significant, it is important because diabetes is associated with a high dietary fat 
intake (Rolls et al. 1994) and high fat intake may be key in the aetiology and 
maintenance of obesity.  The fat intake is important because it reflects the fact that 
the diabetics in this study were in contact with a dietician and were gaining dietary 
advice.  The IGT participants in the current study were not yet in contact with a 
dietitian as they were newly diagnosed.  The study investigated saturated fatty acid 
intake because it is known to be detrimental to body insulin sensitivity (Marin et al. 
2005) which is vital to the good (or bad) management of IGT and type 2 diabetes.  
When the digestion products of fat, FFA are elevated for prolonged periods it is 
known to lead to the progression of insulin resistance because elevated FFA affects 
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cellular glucose uptake and oxidation.  Elevated FFA cause a lowering of the RQ and 
the propensity to store rather than utilise fuel.  Therefore, the hypothesis can be made 
that the high total fat and SFA observed in the IGT participants may result in lower 
RQ values and a different ratio of CHO to fat oxidation. 
 
It has not been elucidated if the reduction in SFA desirable in diabetic diets should be 
substituted by CHO or MUFA and dietetic advice does not appear to favour one or 
the other macronutrients.  In the current study it appears that the fat intake may have 
been substituted for protein in IGT and type 2 diabetics.  Type 2 diabetic participants 
had a significantly higher percentage intake of protein (18.55%) compared to control 
participants (14.33%).  Gannon et al (2003) investigated the effect of a high protein 
diet (15%) and found a significantly reduced 24-hr integrated glucose response in 
type 2 diabetic patients and an increase in insulin response and therefore concluded 
that a high protein diet may improve blood glucose control in type 2 diabetic patients 
in the short-term.  Long term studies are required to determine the potential long 
term effects of such a diet.  The dietetic contact in the current study may explain the 
replacement of total fat for protein, particularly in the type 2 diabetic participants.  It 
is difficult to determine if the protein content has changed only when the 
participants’ diets have been under scrutiny or if this is truly a reflection of the 
habitual diet consumed.  However, it certainly appears that the habitual diets of IGT 
and particularly type 2 diabetics were well managed. 
 
The significance of an increased intake of protein in the habitual diet of the type 2 
diabetic participants is in its recorded influence on satiety.  Protein has consistently 
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been reported to be the greatest promoter of satiety (Stubbs 1998; DeCastro 1987).  
The protein effects of satiety are only short term, i.e. meal to meal.  Although 
successful in promoting weight loss (Brown et al.  1983), the effects of a long-term 
high protein diet are still not clear.  It has not been elucidated what the classification 
of a high protein diet is or what harm the effects of prolonged ketosis produces as 
this may be a problem for susceptible individuals.  The significance of a high protein 
diet is in its association with microvascular disease.  AGEs (advanced glycation 
endproducts) induce significant increases in inflammation and endothelial 
dysfunction, which is thought to be a major risk factor for atherosclerosis (Negrean 
2007). Dietary factors such as high protein diets can increase AGE production, when 
blood glucose is elevated, and this is even more important in type 2 diabetics for this 
reason because CVD is already the main cause of mortality.  Therefore, a continuous 
high protein diet may not be beneficial in IGT and type 2 diabetic participants.  
Furthermore, it should be noted that protein intakes are markedly constant when 
comparing one study population with another (Stubbs 1998) and it takes a lot of 
effort to maintain a high protein diet.  This highlights the potential problems 
associated with the misreporting of dietary intakes and it is also possible that 
misreporting may be specific to certain nutrients (Stubbs 1998).  Nevertheless, in 
investigating the self-reported results of the EE with energy intake, it would appear 
that half of the IGT and more than three-quarters of the type 2 diabetics were in 
weight loss because the average daily EE exceeded the intakes.  Whether this is a 
result of increased satiation, due to the increased protein intake, is difficult to say but 
there is certainly an argument to strengthen the hypothesis that protein is the most 
satiating macronutrient.   
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Accurate estimates of the dietary intake of free-living individuals are essential for 
nutritional research.  The degree of underreporting is positively correlated with body 
mass index (Schoeller 1990).  However, there are two explanations of 
underreporting; underrecording is the failure to record everything that is consumed, 
without a change in body mass; and undereating is the consumption of less than 
usual because of the requirement to record food intake, with a reduction in body 
mass (Goris et al.  2000).  Indicators of underreporting are selective underreporting 
of snacks (Livingstone et al.  1990) and fatty foods (Goris et al.  2000).  Poppitt et al 
(1998) studied nonobese women in a metabolic facility.  Subjects had ad libitum 
food intake, which was covertly measured and the next day were asked to report 
everything they ate and drank during the previous 24 hours.  It was found that snack 
foods were underreported, which are mostly carbohydrate rich.  This was another 
reason why the current study implemented the use of recorded food diaries which 
were to be completed at the time of food consumption.  Of course, all dietary 
assessment techniques rely on information supplied by the participants themselves 
and therefore often, their validity is questioned.  No method has been shown to be 
free of systematic error, for example, systematic underestimation of intake using the 
24 hour recall has been reported when compared with records of food consumed 
(Acheson et al.  1980).  Therefore, an independent verification method of dietary 
assessment was developed initially by Isaksson in 1980.  Twenty four hour urinary 
nitrogen showed that a food record and a diet history gave valid estimates of the 
average protein intakes (Isaksson 1980). Consequently, protein intake in the current 
study was validated by the significant relationship found between protein intake 
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(g/day) in the diet and the amount of nitrogen excreted in the urine collection.  This 
gives validity to the accurate completion of the diet diaries.  Only one participant was 
discounted from the study due to over/underreporting (i.e. intakes below 1.2 x 
BMR).  This individual was a control participant.  There were other participants who 
fell into the bracket of under/over reporting however it was decided that intakes 
matched their activity levels or their body weight status and they remained included 
in the study.   
 
The type 2 diabetic participants had the lowest intake (g/day) of sugar of the three 
groups.  Research has consistently shown that high CHO/low fat diets influence 
energy balance (probably by reducing food intake by greater satiety effects, reducing 
energy density and displacing fat from the diet) and thus help in body weight control 
(WHO 2002).  Improved body weight control has been shown in high CHO diets, 
even those containing a higher than normal amount of sugar. Sugar intake has been 
investigated as prevention against weight gain (Saris et al.  2000).  Generally the 
amount of ‘added sugar’ is restricted to <10% of total energy intake  (WHO 2002) 
and the consensus is that the intake of sugars does not appear to have a deleterious 
affect on the primary care of diabetes (Nadeau et al.  2001; Janket et al.  2003).  
Indicating that the IGT participants in the current study, who had the highest sugar 
intake, would not be negatively affected by the level of sugar intake.  However, an 
increase in sugar intake is almost always associated with an increased fat intake as 
well (WHO 2002).  This appears to be verified by the IGT participants in the current 
study because they had the highest intakes of fat and sugar.  As suggested earlier, the 
high sugar intake may be associated with the lack of taste sensitivity found in IGT 
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participants and may signify dysfunction in that mechanism of the metabolic control 
of food intake.  The reason that this may not have been as obvious in the type 2 
diabetics is because their recorded dietary intake seemed to be well controlled, as the 
sugar intake was significantly lower. 
 
While the type 2 diabetic patients had the highest intake of alcohol (g/day) the 
differences were not significant.  Shai et al (2007) studied the glycaemic effects of 
wine intake in diabetic patients who had previously abstained from alcohol intake.  
The results indicated reduced fasting plasma glucose levels but not postprandial (2 
hour) glucose levels.  Lapidus et al (2005) concurred with these results and also 
concluded that alcohol had a significant inverse association with the incidence of 
diabetes. 
 
The results of the percentage intake of the main macronutrients demonstrate that 
none of the groups were achieving the national guidelines set out by the British 
Nutrition Foundation of 50% CHO, 36% fat and 14% protein.  Control participants 
were the closest to meeting the CHO guidelines as their CHO intake was 46% and in 
fact met the fat 36% and protein intake 14% guidelines.  The IGT participants’ CHO 
intake was lower than the guidelines at 45%, their fat intake was 35% and the protein 
intake was higher than the guidelines at 17% and the type 2 diabetics had the lowest 
CHO intake at 44%, a 33% fat intake and the highest protein intake at 19% of the 
total intake.  As discussed earlier, this may be due to the dietary intervention that the 
type 2 diabetic patients received and although no diet is specifically discussed, the 
reduction of fat ultimately leads to an increase in the alternative macronutrient(s).  
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The potentially positive effect of a high protein diet is to increase satiety and 
consequently lower calorific intake.  A high protein intake helps to augment 
postprandial insulin secretion, promoting glucose transport and utilisation and 
thereby promoting improved glycaemic control in type 2 diabetics (Promintzer and 
Kreb 2006).  It has been found that a high protein diet (30%) (Gannon et al.  2003) 
improved 24-hr integrated glucose response by 40% but again the long-term effects 
of such a diet have not yet been identified therefore optimal macronutrient protein 
composition for the treatment and prevention of obesity and related diseases such as 
IGT and type 2 diabetes is not known.  
 
Habitual diet is only one of the considerations in balancing energy intake with 
expenditure.  It has been demonstrated that sedentary living may be related to obesity 
and metabolic syndrome (Hardman 1996).  
 
4.4.2 Differences in Habitual Activity  
 
Activity diaries were used to record the participants habitual activity and total daily 
energy expenditure (kcals/day).  There were no significant differences between any 
of the groups’ daily energy expenditure.  The control group had the lowest overall 
daily energy expenditure (2210 ± 119.14) when compared to the IGT (2666± 204.02) 
and type 2 diabetic participants (2683 ± 131.15). This may be attributed to the higher 
energy costs of sedentary and light activity in the obese which has similarly been 
recorded in previous studies (Blair and Buskirk 1987).  After normalising for body 
weight the three groups had very similar energy expenditure results, as expected.  
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When investigating the types of activities undertaken by each group there were no 
significant differences between groups although an observation was noted between 
the control participants and the IGT groups.  It was observed that the amount of 
strenuous/physical exercise completed by the IGT participants was less than control 
participants.  Daily physical activity guidelines state that adults should accumulate 
30 minutes of moderate intensity physical activity on most days of the week (WHO 
2002).  The similarity in EE between the groups may be explained by dietetic 
intervention as ‘lifestyle’ advice is given concurrently with dietary advice.  Another 
possible reason for the similarity in EE per kilogram bodyweight may be due to the 
average age of the type 2 diabetic participants.  Many of the participants were retired, 
giving them more time for moderately active activities such as walking, gardening 
etc, compared with the control group, all of which worked or were full time students.  
The results may suggest that the type of activity is important in the development of 
obesity and that strenuous physical activity may play a role in preventing weight 
gain.  Further investigation would need to be undertaken to understand the benefits 
of strenuous physical activity compared to moderate physical activity in IGT and 
type 2 diabetic participants.    
 
4.4.3  Biases and Limitations of Energy Intake and Energy Expenditure 
Methods 
 
4.4.3.1 Energy Intake 
Information on the usual macronutrient intakes of individuals is frequently a central 
component of nutrition studies. Such information is used, for example, as the basis 
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for defining relations between macronutrient intakes and morbidity and mortality and 
for determining the role of dietary energy in the development and treatment of 
obesity (Acheson et al.  1980).  Inaccurate information on dietary nutrient intakes 
will therefore lead to spurious conclusions regarding the importance of diet in the 
maintenance of long-term good health.  It is widely recognised that dietary 
assessment methodologies used currently to determine the usual nutrient intakes of 
individuals are open to several general criticisms (Bingham 1985).  In particular, 
subjects may bias the information obtained by not consuming typical amounts of 
food during the period when food intake is being recorded, and in addition, they may 
not accurately report the food that is consumed.  A special concern is that different 
groups of subjects may not exhibit the same degree of over or underreporting relative 
to their usual diet.  Thus, in addition to the widely recognised problem that energy 
intakes determined by a weighed food record tend to underestimate usual dietary 
nutrient intakes of individual subjects (Schoeller 1990), it is also possible that 
differences in group means for reported nutrient intakes may in part simply reflect 
group differences in methodological bias rather than being caused exclusively by 
differences in food consumption. 
 
The lack of detailed information on the bias inherent in different food intake 
assessment methods is due primarily to the absence, until recently, of an accurate 
reference method against which different methods could be compared. The 
successful validation of the doubly labeled water method for measurement of total 
energy expenditure (TEE) has now provided such a reference method (Schoeller 
1988).  Sawaya and colleagues (Sawaya et al.  1996) studied weighed food records 
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and 3 other widely used methods of food intake (24-hour recall (Gibson 1990), 
Willett food frequency questionnaire (Willett et al. 1985) and GHCRC/Block food 
frequency questionnaire (Block et al. 1990)) and compared them with doubly labeled 
water measurements of TEE in young adults and children.  Results of this study 
showed that no method gave accurate information on the usual energy intake of 
individual subjects.  In addition, there was an indication that old age may cause 
different relative biases in the four methods that were evaluated, although further 
studies are needed to confirm this suggestion.  In young women, 24-h recall data 
gave mean energy intakes that were closest to measures of TEE, and food-frequency 
questionnaires provided the only data that correlated with individual values for TEE.  
In older women, the Willett food-frequency questionnaire gave values for energy 
intake that were closest to measures of TEE, but there was no method that gave 
values for energy intake that correlated significantly with TEE.  Seven-day weighed 
dietary intakes, although by far the most difficult and time-consuming 
measurements, were neither more accurate nor more precise than the other, simpler 
methods, although they did provide the most accurate estimate of the mean 
difference in energy intake between the two groups.  The results indicate that EI 
derived by weighed intakes and food frequency questionnaires were in excellent 
agreement with mean EE measured by DLW therefore in the current study weighed 
records were the method of choice due to the low cost in comparison to the doubly 
labeled water method.  Furthermore, as already discussed, there was a positive 
correlation between protein intake and urinary nitrogen which again validates the 
data obtained in the diet diaries in the current study.   However, the correlation was a 
low correlation and this may be due to that some participants in the IGT and type 2 
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diabetic groups may have been in weight loss, which was reflected in their overall 
energy intake values (kcal/day).  Weight loss was not measured within the study and 
to incorporate a dietary restraint questionnaire to eliminate potential restrainers was 
too costly for the current study.  Therefore, it was difficult to eliminate under-
reporters in the current study because it was unclear if the low energy intake was due 
to under reporting or a true reduction in food intake due to dieting.  Consequently, 
only 1 individual was discounted from the study due to under reporting and this was 
a control participant, as it would have been expected that they were in energy balance 
and therefore, within the upper and lower limits of over and under reporting.   
 
4.4.3.2 Energy Expenditure 
The validity of the activity diary method is open to doubt.  It relies on the accurate 
description and timing of activities and their exact reproduction for measurement of 
their cost.  In addition the cost of some activities, the most important being sleep, is 
difficult or impossible to measure in the field, and assumptions have to be made for 
them. 
 
Inherent sources of error in the activity-diary method are incorporated into the 
process of recording activities and the conversion of these activities to energy 
expended.  Additionally, it is unlikely that a normal activity pattern can be 
maintained when activities are being recorded every minute.  Influencing activity 
seriously undermines the validity of any method for measuring habitual energy 
expenditure.  Some investigators have tried to overcome this problem by having 
observers record activities.  This may be feasible and socially acceptable in some 
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situations but not in others.  In the current study this would have been too time 
consuming to consider. The component of error associated with converting recorded 
activities into their energy equivalent is as important as the precision in recording 
activities. In many situations it is not possible to measure the energy costs of 
activities and consequently values found in the literature are used.  Even when the 
energy costs of activities are measured there is no guarantee that intensity and effort 
during measurement will accurately reflect those in a free-living situation.  Because 
both sources of energy costs are subject to error it is important to know whether 
energy expenditure calculated with measured values is more accurate than that 
calculated with the most widely used literature values.  Most of the published values 
used in this study were from studies of women of comparable body weight (Durnin 
1967) which suggests that overweight individuals may have an even higher error 
rate.   
 
4.4.4 Meal Consumption 
 
The test meal chosen was a low calorific meal designed to show a rapid and complete 
postprandial response.  There were no significant differences in the time taken to eat 
the test meal.   This is important because it has been hypothesised that the time taken 
to eat a meal and greater exposure time to food stimulates additional food intake and 
so also a greater total energy intake (Hetherington et al.  2006).  This was an 
important finding because it is one of multiple possible mechanisms that leads to a 
positive energy balance, which may consequently lead to obesity.  Varma et al 
(1999) found that energy intake was influenced by the time taken to consume a meal, 
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causing an increase in meal size.   In the current study a conclusion can be made that 
the feeding behaviour of IGT, type 2 diabetic and control participants investigated, in 
relation to meal consumption, was normal and the time taken to consume the meal 
was not an important factor in influencing food intake.  However, an argument could 
be made that the meal design in this study was not conducive to the discovery of time 
differences as the meal was not large enough to illustrate this effect.  Furthermore, it 
has also been hypothesised that future meals are affected by either high energy 
density (HED) or low energy density (LED) preloads.  For example, Mazlan et al 
(2006) discovered that only partial compensation (~40%) occurs after a HED pre-
load and compensation only occurs at the next meal so any subsequent meals are not 
affected and normal food intake occurs resulting in a short-term positive energy 
balance.  If this positive energy balance is not balanced out over time then it will 
result in slow weight gain.  Again, this is crucial to understand for people with IGT 
and type 2 diabetics because if their habitual diet incorporates sporadic inclusion of 
HED and/or high fat meals, as is common (Schulze et al.  2004), then weight gain is 
implicated over time.  High fat content is a feature of high energy dense foods and 
both are associated with poor glycaemic control (Ello-Martin et al.  2007).  The 
concept of the glycaemic index of food was introduced to distinguish and quantify 
the variability of the glycaemic responses to the CHO in different foods (Jenkins et 
al, 1981).  High glycaemic index foods result in increased blood glucose 
concentrations and an increased insulin demand which Schulze (2004) understood to 
lead to an exhausted pancreas resulting in glucose intolerance and then a 
consequential insulin resistance.  Poor glycaemic control has been associated with 
the risk of developing type 2 diabetes which is particularly important for the IGT 
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participants in this current study.  The discussion of whether IGT is an intermediary 
in the progression to type 2 diabetes is still under investigation.  Various studies 
(Marshall et al.  1994; Saldana et al.  1994) associate the fat intake with the 
progression of IGT to type 2 diabetes.  The current study shows that daily fat intake 
was within guidelines and therefore there should not be high progression rates from 
IGT to type 2 diabetes.  Saldana (2004) stated that a diet containing 41% fat would 
increase the risk of diabetes.  Therefore fat intake, energy density and glycaemic 
control are all important in the influence and control of food intake for these patient 
groups.  Importantly, it is necessary to understand how the effects of glycaemic 
control affects appetite and the ability to cease eating.  The type of macronutrients 
consumed may have a role in influencing subjective feelings of appetite, i.e. satiety 
and prospective consumption.     
 
4.5 VISUAL ANALOGUE SCALES 
 
4.5.1 Hunger and Prospective Consumption 
 
In this study subjective ratings of hunger, satiety, fullness and prospective 
consumption (PC) were measured from fasting levels and then following a test meal, 
of the same content for all three participant groups, to determine whether appetite 
ratings differed between groups and to discover what impact this had in the 
integrated process of food intake.  Prospective consumption is becoming increasingly 
important to record when studying IGT and type 2 diabetic patient groups because as 
previously mentioned obese groups tend to feed on highly palatable foods even when 
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sensations of hunger are low and satiety is high.  The foods tend to be high in energy 
density and so have a high fat content resulting in a positive energy intake, which 
may lead to further weight gain if not controlled over time.  This could contribute to 
the progression of their chronic disease.   
 
The overall hunger response was significantly higher in control participants 
demonstrating that they felt hungrier throughout the study.  Control participants also 
had lower fullness ratings which was only significant at the 90 minute timepoint and 
higher PC ratings when compared to the other two groups.  This may be indicative of 
an overall increase in appetite sensitivity which may be associated with taste 
sensitivity.  Supertasters, which were primarily control participants, demonstrated the 
greatest sensitivity to taste and therefore because the supertaster range of sensitivity 
is greater in taste it may also be the case in measures of appetite.  Furthermore, 
supertasters should consume an overall lower intake of food based on the hypothesis 
that BMI is associated with taste status and this may also contribute to the higher 
feelings of hunger observed in the controls compared to IGT and type 2 diabetic 
participants.  The current study shows that the greater feelings of hunger are not 
associated with a greater food intake, compared by the energy intakes from the diet 
diaries, but are associated with greater sensitivity to appetite. 
 
Hunger ratings were inversely correlated with satiety and fullness in the current 
study whereas prospective consumption positively correlated with hunger which 
validates the parameters of appetite ratings.  Looking at the overall response, type 2 
diabetic participants showed high fullness ratings, low hunger ratings and also rated 
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prospective consumption the lowest.  IGT participants rated high fullness ratings and 
hunger levels as being low.  This was similar to type 2 diabetics however, IGT 
participants recorded higher levels of prospective consumption than type 2 diabetic 
participants although this was not significant. The difference in PC ratings between 
IGT and type 2 diabetic participants may be put down to the subjectivity of the test.  
On the other hand, it is possible that IGT participants are displaying a greater desire 
to consume food when they do not feel particularly hungry which may of course be 
the factor responsible for the positive energy balance which leads to obesity, i.e. 
want versus need.   The appetite results of the current study differed to a similar 
study by Chapman et al (1999) who recorded appetite ratings in obese and non-obese 
subjects.  Chapman’s (1999) study recorded higher hunger ratings in obese patients 
before food intake and then recorded no differences in hunger during feeding.  In 
studying the diet diaries of IGT, type 2 diabetic and control groups, it was noted that 
many participants of both the patient groups missed breakfast out of their daily food 
routine whereas all control participants included breakfast in their habitual diet.  
Missing breakfast may contribute to the lower ratings of hunger observed in the IGT 
and type 2 diabetics on the study morning.  Because it was not ‘normal’ for these two 
groups of participants to eat this early in the day it may have resulted in the overall 
lower hunger sensations.  Meal placement may be a key factor when investigating 
IGT and type 2 diabetics because when food is not consumed in the morning this 
may result in increased hunger intensity and increased ratings of prospective 
consumption later in the day.  It may be that hunger intensities grow throughout the 
day and the amount of food consumed in subsequent meals and snacks may be more 
important than the first meal of the day.  Therefore, further research would be 
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required to determine the effects of meal skipping on the intensity of appetite 
parameters.  Many overweight dieters adopt this strategy of missing breakfast in an 
attempt to reduce their overall daily food intake (Rogers 1997).  However, it is 
unclear how this influences the next meal, food intake over the course of the day and 
if and how the body compensates over coming days.  This is an area that requires 
investigation, in particular in clinical groups such as IGT and type 2 diabetic 
populations.   
 
4.5.2 Satiety and Fullness 
 
Satiety may be defined as the state of inhibition over further consumption and is the 
interval between differing episodes of food consumption (Rogers and Blundell 
1991).  Satiety can be assessed as a behaviour of a physiological response and a 
reduction in satiety creates a stimulus for eating.  Studies have indicated that satiety 
ratings of sweet and fatty foods differ between obese and normal weight individuals 
(Salbe et al. 2004).  Therefore it was essential to determine how ratings differed 
between patient groups following a mixed meal where the content was the same for 
all three groups.  In the current study satiety ratings were highest in the IGT group 
and control participants rated satiety the lowest, which corresponds with the hunger 
ratings.  However, the expected result would have been to observe the highest satiety 
and fullness ratings in the control group because previously it has been shown that 
the satiety response in obesity is attenuated.  The current study indicates that the 
satiety response in type 2 diabetics and IGT participants in this study is normal 
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following the consumption of a mixed meal and is not associated with a reduction in 
satiating effects.   
 
When the satiating effects are diminished in obese individuals then the effect is 
mediated elsewhere in the complex pathways that control food intake.  Alternatively, 
the satiety response may be normal to a meal but the satiety effects may be 
overridden as a consequence of behavioural or sensory factors, such as emotions or 
palatability respectively.  Short-term intake of foods (i.e. snacking) due to 
palatability is associated with high fat, high energy dense foods which are consumed 
out-with mealtimes resulting in satiety responses being overridden (Yeomans et al.  
2005).  In this instance cessation is strongly affected by sensory-specific satiety, the 
intake of a single food relative to the intake of other foods.  Therefore it is also 
important to distinguish between satiety and fullness.  Satiety is a neural response as 
opposed to fullness which is a physiological response to stretch recepters.  The IGT 
participants had the highest fullness ratings, followed by the type 2 diabetics and 
then the control participants.  There was a significant difference at the 90 minute 
timepoint only between control and type 2 diabetic participants where the type 2 
diabetics rated feelings of fullness greater than IGT participants.  The trends 
throughout the study period for IGT participants, as well as type 2 diabetics, showed 
high satiety and fullness and low hunger and prospective consumption, as shown by 
the area under the curve results.    
 
In summary, the appetite parameters were not what was expected however they were 
consistent.  The current study may indicate that control participants display increased 
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appetite sensitivity analogous to increasing taste sensitivity which may lead to a 
greater range of sensitivity i.e. higher when hungry and lower when full, but does not 
appear to result in altered food intake.  Obesity has been associated with 
dysfunctional satiety mechanisms thought to be due to the large storage capacity for 
fat  (Flatt et al.  1995).  Obesity occurs as a result of a high intake of energy from the 
overeating of high fat foods, consumption of a high energy density diet and the high 
palatability and weak satiation of high fat foods (Snoek et al.  2004).  This was not 
observed in the current study, however, as aforementioned a second meal may be 
more suited to elicit the attenuated satiety response that has been reported in other 
studies.  The possible reason for this is due to the irregularity of consuming breakfast 
at all, let alone so early in the day for the IGT and type 2 diabetic participants.  
Consuming food prior to the time a first meal would normally be consumed in the 
day may have resulted in raised satiety levels due to initially feeling less hungry, 
which was the case in this study.  This may have resulted in altered responses for all 
parameters of appetite in the two patient groups.    
 
The measurement of appetite parameters in this type of protocol is important to 
assess the dynamic changes which occur following a meal.  It is the change in 
appetite sensitivity which allows increased energy intake, as well as behavioural 
factors and decreased activity.   
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4.6 CALORIMETRY 
 
4.6.1 Respiratory Quotient and Energy Expenditure 
 
Most individuals maintain a steady body weight for long periods throughout their 
lifetime indicating a good control of energy intake and expenditure.  A steady state is 
likely to be maintained if the fuel mix oxidised in the body is equal in composition to 
the nutrient flux of the diet consumed thus balancing, protein, CHO and fat in the 
body.  The composition of the fuel mix oxidised and therefore respiratory quotient 
(RQ) are influenced by circulating substrate and hormone concentrations, which 
reflect the degree of replenishment of the body’s fuel reserve.  The composition of 
the fuel mix oxidised to drive oxidative phosphorylation changes considerably 
throughout the day.  However, nitrogen content undergoes minimal change and CHO 
content is maintained within a tight range (McDevitt et al.  2000).  Reasons for this 
are due to the important functional roles of proteins and the essential role of the 
body’s systems to sufficiently supply glucose to the brain.  Therefore, changes in the 
fuel mix oxidised alters an individuals overall energy balance primarily with changes 
in fat balance, which can easily accommodate gains or losses due to the large storage 
capacity for fat.   
 
When insulin is released postprandially, this initiates a rise in RQ and promotes the 
storage of nutrients.  Whereas, the release of hormones between meals activates 
mobilisation of the body’s glycogen and fat stores and ensures an adequate supply of 
ATP production and circulating glucose.  The composition of the fuel mix between 
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meals is also influenced by the body’s protein pools, the degree of repletion of its 
glycogen reserves and the size of the adipose tissue mass.  This is a consequence of 
the fact that rates of mobilisation, which are regulated by hormone concentrations, 
have to be multiplied by the size of the adipose tissue mass to which the hormone 
signals are conveyed.  For most individuals this is remarkably effective but the body 
composition for which this adjustment is achieved varies greatly between individuals 
and depends on genetic interactions and circumstantial factors.  Following a CHO-
containing meal RQ increases because CHO is favourably oxidised and after a 
protein-containing meal, amino acid oxidation increases.  However, fat oxidation is 
reduced after food consumption even when the meal contains fat, which suggests that 
control over fat balance is not effective (Flatt 1987).  In the current study RQ 
increased in all three groups postmeal as expected, as the body preferentially oxidises 
CHO and emulates the results of similar studies (Flatt 1995a & b).  Although there 
was no significant difference in RQ between groups, at 15 minutes postmeal the 
largest increase was in the control group.  It is known that when fat is consumed 
together with CHO (as in a mixed meal) it is followed by an increase in CHO 
oxidation and a reduction in fat oxidation, which is resultant of insulin release 
following the ingestion of CHO (Flatt 1995).  A study by Acheson et al (1987) in 
lean and obese subjects found that RQ rose similarly postmeal in both groups but 
dropped earlier and more rapidly in obese individuals.  The current study did not 
show the same results as Acheson et al (1987) as there was an increase in RQ, in 
response to CHO ingestion and oxidation, over all groups but to a greater extent in 
the control group.  The control group then had the larger decrease back to normal 
levels whereas the IGT participant group levelled off and decreased more gradually.  
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The type 2 diabetics also had a gradual reduction following the initial increase in RQ, 
but then increased further towards the end of the study period.  RQ levels did not 
reach fasting levels within the study period.  This study shows that RQ levels in IGT 
and type 2 diabetics did not rise as much as control participants suggesting that fat 
was being oxidised and CHO was being spared.  It was expected that the RQ would 
have remained higher for a longer period in the control group when compared with 
the two obese groups and that IGT and type 2 diabetic RQs would have reduced 
quicker towards fat oxidation.  A study by Schutz et al (1992) found obese subjects 
to have increased fat oxidation postprandially, compared to non-obese subjects, as 
the body attempted to regulate energy and fat balance in the long-term.  Therefore, it 
appears be that fuel oxidation in obese individuals is controlled firstly by their fuel 
stores and what fuel is currently circulating and then secondly by the type of fuel 
consumed by the most recent meal.  This insinuates that the body’s need to regulate 
long-term energy balance may be more important than the short-term regulation of 
food and consequently will also impinge upon the release of neuro-endocrine control 
mechanisms and may alter fuel oxidation.  Further results in the study of Acheson et 
al (1987) recorded a reduced diet induced thermogenesis (DIT) response to food in 
obese subjects.  The current study showed a similar lower DIT response for the IGT 
participants whereas type 2 diabetics had a very similar DIT response to the control 
participants. The IGT and type 2 diabetic participants in the current study had a BMI 
greater than 30 and therefore a blunted DIT was expected as it has previously been 
shown that obesity results in a reduced DIT response and that there is an inverse 
relationship between percentage body fat and DIT (Schutz et al.  1984).  Differences 
seen between this study and previous studies may be due to the smaller size of the 
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test meal in this study.  The differences observed between IGT and type 2 diabetics 
may again be due to the fact that the type 2 diabetics controlled their habitual diet 
well.  Inadvertently, this may have resulted in some weight loss and consequently a 
reduction in fat mass and a reversal in the symptoms of type 2 diabetes.  
 
Obesity is a multifactorial and complex disorder that is characterised by a long-term 
energy intake that is above energy expenditure (EE).  Many studies have examined 
the regulation of both these components to provide an understanding of energy 
balance in obesity.   In the current study daily EE was measured by activity diaries 
and there were no significant differences in EE between IGT, type 2 diabetics and 
control participants.  However, both IGT and type 2 diabetics had higher EE values 
throughout the study day when EE was measured by calorimetry.  This higher EE 
was expected and attributable to their greater weight, which results in high energy 
costs for innocuous activities.  Other studies have also shown EE to be higher in 
obese groups (Marques-Lopes et al.  2001).  To be able to discuss the changes in EE 
independently of weight, EE was normalised for body weight.  EE was significantly 
higher in control participants both in a fasting state and postprandially throughout the 
study period when normalised for body weight.  The overall changes in EE in 
response to the test meal are shown by the AUC.  The control participants’ response 
was significantly higher when compared to IGT and type 2 diabetic participants.  
This indicates a lower DIT in IGT and type 2 diabetics and therefore suggests, 
according to Stock (1997), that they are metabolically more efficient.  This means 
that a far greater proportion of ingested energy is deposited as fat, and much less is 
dissipated as heat, which is thought to be due to a reduced action of the sympathetic 
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nervous system (Stock 1997).   Together the low EE measurements, with possible 
low DIT response, and lower RQ values lead to the conclusion the metabolic 
handling of food results in a propensity to store fat to a greater level than control 
participants.  
 
When evaluating the differences between the resting metabolic rate (RMR) assessed 
by calorimetry and the total EE assessed by activity diaries in the current study, there 
was a positive correlation which validates both the use and the results of the activity 
diaries.  The differences observed in the 3 groups in RMR over the study are not seen 
in total daily EE recorded by activity diaries which suggests that the blunted EE 
response observed following food intake in the IGT and type 2 diabetic participants 
may contribute to a reduced daily EE which in turn may perpetuate weight gain.  On 
the other hand, the observed total daily EE by activity diaries would have been 
expected to have been significantly higher in the control group, particularly given the 
differences in the RMR, however no significant differences were observed.  The 
reasons for observing no differences in the total daily EE between groups may be due 
to the interventions initiated by IGT and type 2 diabetics post diagnosis to counteract 
their condition.  The interventions may have resulted in an increase in the amount of 
daily physical activity in the type 2 diabetic participants.  The activity diaries 
highlighted that some of the IGT and type 2 diabetic participants were reasonably 
active compared to the normal sedentary lifestyle expected to be observed in these 
patient groups: one was an avid cyclist, two participants were in professions which 
involved manual labour and another had recently started brisk walking. 
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4.6.2 Thermic Effect of Food 
 
Energy expenditure or thermogenesis may play a roll in body fatness (Miller and 
Payne 1962) therefore interest in DIT has emerged over time.  Energy balance 
control has always been associated with the regulation of energy intake however, 
animal experiments have shown that at excess energy intake, the regulation of 
thermogenesis is important for the control of body fatness (Thurlby and Trayhurn 
1979).  Numerous studies have been undertaken investigating energy expenditure or 
another component of daily energy expenditure i.e. RMR and DIT, in obese subjects 
with non-obese counterparts.  With respect to DIT, the most significant outcome of 
all these studies was that the DIT might be blunted in obese subjects and therefore 
may be significant in the pathogenesis of obesity (Bessard et al.  1983).  The 
evidence is conflicting (Samueloff et al.  1982) and therefore has had a negative 
effect on the elucidation of the etiology of problems of energy balance.  The 
disagreement in results in this field of study, particularly in postprandial metabolism, 
may be related to the constant reappraisal of the methodology for assessing RMR and 
DIT in humans.  The EE results suggested that there may have been reduced DIT in 
IGT and type 2 diabetic participants.  In the current study RMR and DIT were 
obtained with a ventilated-hood system.  However, no significant differences were 
found in DIT between groups.  This result was unexpected due to the reduced EE and 
RQ values in IGT and type 2 diabetics compared to control participants.  The trend 
was that the IGT participants had a blunted DIT response but the reduction was not 
significant.  Type 2 diabetic participants had a DIT response very similar to the 
control group.  Previous studies have shown that the differences in DIT between 
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control and obese subjects could result from a lower stimulation of the sympathetic 
nervous system in obese subjects due to a low ratio of diurnal/nocturnal nor-
epinephrine (NE) excretion (Schutz et al.  1984).  Schutz et al (1984) specifically 
demonstrated that urinary excretion of NE  during the day and night is increased 
however the relative increment in diurnal NE excretion over sleeping values was 
less, i.e. a lower ratio, in obese than control subjects.  This is important because NE 
is a hormone and neurotransmitter, secreted by the adrenal medulla and the nerve 
endings of the sympathetic nervous system to cause vasoconstriction and increases in 
heart rate, blood pressure, and the sugar level of the blood. Welle (1995) indicated 
that postprandial NE concentrations are caused by an increased spillover from 
sympathetic nerve endings in muscle brought about by glucose induced 
hyperinsulinemia.  Any messages conveyed via the sympathetic nervous system to 
the NTS in the medulla and are then relayed to a variety of other brainstem and 
hypothalamic areas.  A disturbance in the concentrations of NE will result in reduced 
sympathetic nervous system stimulation postprandially (in this case) which results in 
reduced EE.  Another hypothesis is that there may be a resistance to the thermogenic 
effects of NE in obese subjects.  Therefore these studies only go a little way to 
understanding the role of NE and the sympathetic nervous system in the etiology of 
obesity by reduced EE.  One major problem is that comparisons of lean and obese 
subjects cannot tell us whether a difference in sympathetic nervous system activity is 
the cause of or the result of obesity or its side effects, such as hypertension or 
hyperinsulinemia.   
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4.7 SUBSTRATE OXIDATION 
 
4.7.1 Fat Oxidation 
 
Studies have reported that fat oxidation rates reduce in obese individuals 
postprandially (Flatt 1995; Marques-Lopes et al.  2001).  Obesity occurs frequently 
together with both IGT and type 2 diabetes.  They are all characterised by insulin 
resistance, disturbances in intermediary CHO and fat metabolism, and most often by 
an increased adipose tissue mass, increased FFA, as well as increased triacylglycerol 
(TAG) storage within skeletal muscle. Increased TAG storage is thought to be 
observed in the body by a blunted fat metabolism following catecholamine release 
postprandially (Blaak 2003).  These disturbances perpetuate the progression of the 
said diseases (obesity, IGT and type 2 diabetes) because they play a role in the 
development and maintenance of adipose tissue stores, accumulation of lipid 
intermediates (strongly linked with skeletal muscle insulin resistance (Blaak 2003)) 
and TAGs in skeletal muscle, all risk factors for the development of whole body 
insulin resistance and type 2 diabetes.  In the current study there was no significant 
difference in oxidation rates between groups for protein, fat or carbohydrate when in 
a fasted state.  At fifteen minutes postmeal fat oxidation had reduced in all groups 
but to the greatest degree in the control group and then there was an increase in fat 
oxidation in all groups up to 30 minutes postmeal and again the control group had the 
sharpest increase.  Following this the IGT participants fat oxidation slightly reduced 
until 90 minutes and then slightly increased up until 120 minutes whereas the type 2 
diabetics and control participants levels of fat oxidation increased again until 60 
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minutes and then reduced until the end of the study period.  In the current study, after 
normalising for body weight, it appears that there was no tendency for obese 
individuals to have suppressed fat oxidation levels following a mixed meal as 
previous studies have shown (Owen et al.  1986; Acheson et al.  1987).  The current 
study shows that fat oxidation is higher after the meal consumption in IGT and type 2 
diabetics than in control participants.  This corresponds with a study by Astrup et al 
(1996) where obese subjects were found to have higher fat oxidation, however this 
was thought to be due to their increased weight and therefore enlarged body fat 
stores.  The current study corrected for body weight and an increase in fat oxidation 
was still observed.  The RQ of the IGT and type 2 diabetic participants was lower 
than that of the control participants suggesting that they were indeed oxidising fat at 
an increased rate and sparing CHO.  A study similar to the current study by Owen et 
al (1992) investigated oxidation rates for 4 hours following ingestion of a mixed 
meal and also found no differences between obese and lean individuals.  Therefore, 
in the current study fat oxidation does not appear to be one of the mechanisms which 
contributes to a blunted satiety response and dysfunctional feeding behaviour.   
 
4.7.2 CHO Oxidation 
 
In the current study overall CHO oxidation rates were similar between groups, as 
discussed earlier, due to the tight metabolic control over blood glucose levels 
however the control group did have the highest RQs throughout the study period 
suggesting that they were oxidising more CHO than the other groups.  When 
oxidation rates were normalised for body weight, CHO oxidation was significantly 
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higher at certain points throughout the study period in control participants compared 
to IGT and type 2 diabetic participants.  It was important to look at oxidation rates 
when normalised for weight to indicate the difference between groups as a result of 
the disease status.  The literature is sparse surrounding the assessment of oxidation 
rates when normalising for body weight.  It has been reported that in IGT and type 2 
diabetes there is impaired metabolic flexibility (Storlien et al.  2004), for example, an 
impaired switching from fatty acid to glucose oxidation in response to insulin 
(Phielix and Mensink 2008) which is again associated with insulin resistance and in 
particular skeletal muscle insulin resistance which impairs the cellular uptake of 
glucose causing an accumulation of lipid inside the muscle cell.  This process is 
under positive feedback control so as FFA levels increase in the cell, glucose uptake 
is further inhibited and in fact it is not clear if FFA is a cause of reduced cellular 
uptake or if it is the effect of it.  The impairment however, would be ever more 
apparent in IGT and type 2 diabetic patients when glycaemic control is poor and the 
positive feedback effect perpetuates the problem.  Furthermore, the lower CHO 
oxidation rates in the current study in the two patient groups may be driven by the 
body’s lack of metabolic need and drive to generate ATP for metabolic function.  
This may be a consequence of low levels of physical activity which is common in 
obesity (McGough et al.  2001).  Flatt (1995c) suggested that oxidation rates are 
dictated by the body’s need to generate ATP used in performing metabolic functions, 
in moving and in physical activity.  Therefore, if leading a sedentary lifestyle the 
requirement to sustain ATP regeneration will be minimal and oxidation rates will 
fall.  Conversely, it may be the amount of physical activity that is driving the fuel 
mix towards an increase in CHO oxidisation in the control participants.   
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In summary, the IGT and type 2 diabetic participant levels of CHO oxidation was 
lower than control participants once normalised for body weight indicating that this 
is one of the dysfunctional mechanisms involved in the complex interplay of 
mechanisms controlling food intake.  The impairment may be due to insulin 
resistance which impairs the uptake of glucose from the blood.  Therefore, the 
current study measured indicators in the blood which give information about the 
digestive process.     
 
4.8 BLOOD PARAMETERS 
 
4.8.1 Glucose 
 
In the current study the CHO content of the testmeal was 58%.  A similar study by 
Wolever and Miller (1995) investigated different CHO contributions in a meal (5%, 
30%, 45% and 60% CHO) and found that the meals with the highest CHO content 
produced the lowest blood glucose response.  This is significant because the dietary 
management of IGT and diabetes aims to optimise blood glucose control and to 
decrease the risk for the long-term complications associated with diabetes, i.e. retinal 
eye, kidney and nerve and cardiovascular disease.  In the current study, as expected 
when fasted, the control participants had a lower blood glucose concentration than 
the 2 patient groups and post meal all three groups’ blood glucose concentration rose.  
Wolever and Miller’s (1995) study showed no difference in blood glucose between 
type 2 diabetic and control groups with the 60% CHO meal.  However, in 
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contradiction, the blood glucose concentrations in the IGT and type 2 diabetics in the 
current study rose to a high level and at 60 minutes there was a significantly greater 
blood glucose profile in the two patient groups compared to control participants. 
Other studies have shown results similar to this study (Manders et al.  2005).  The 
raised blood glucose profile suggests that the IGT and type 2 diabetic groups in the 
current study had disrupted glucose uptake via GLUT 4 transportation, which is 
known to be a cause of insulin resistance (Bilan et al.  1992) and may be the cause of 
the previously noted low RQ, CHO oxidation rates and EE.  There was no significant 
difference between IGT and type 2 diabetic participants, however the type 2 diabetic 
participants had an intermediary blood glucose profile between the IGT and control 
participants.  The results expected would perhaps have shown the IGT participants to 
have the intermediary blood glucose levels because it is known to be a less severe 
disease, however the results remain consistent because it is likely that the outcome is 
due to the well controlled diets of the type 2 diabetics and may also be associated 
with the lower taste sensitivity identified in the IGT participants, but not in the type 2 
diabetic participants.  When good glycaemic control is achieved in type 2 diabetes 
the short term responses change i.e. increased satiety, improved insulin profile and 
therefore improved glucose transport.  Furthermore, the long term micro and 
macrovascular complications are improved as shown by the UK Prospective 
Diabetes Group (U.K.P.D.S) who has published literature investigating blood 
glucose and blood pressure in over 5000 people with type 2 diabetes.  
Hyperglycaemia and hypertriglyceridemia can lead to oxidative stress and 
endothelial dysfunction, which in itself is a known cause of cardiovascular disease 
(CVD) (Negrean et al.  2007).  In diabetes, endothelial dysfunction is triggered by 
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the production of advanced glycation end products (AGEs).  AGE concentrations are 
elevated in type 2 diabetes and come from the uncontrolled non-enzymatic reaction 
of sugars with proteins, particularly when blood glucose levels are high.  Increased 
AGE concentrations have significant pro-inflammatory (cause increased cytokine 
levels) and pro-oxidative effects, therefore play an important role in the development 
of diabetic complications as discussed earlier.  Insulin resistance is an effect of the 
inflammation associated with AGE concentrations, perhaps due to damage to specific 
neurons which sense plasma glucose levels and control insulin release from the 
pancreas.  Therefore it is imperative that glycaemic control is maintained and when 
hyperglycaemia is prevented some of the postprandial effects can be minimised 
which can reduce the long-term complications of diabetes. In the current study the 
type 2 diabetic participants and in particular the IGT participants should look to 
improve blood glucose control to prevent the progression of their disease.  Certainly, 
it appears that an aberration in blood glucose profile may contribute towards 
dysfunctional food intake and may be one of the triggers which causes alterations in 
consequent physiological parameters, such as EE, RQ and CHO oxidation, in the 
regulation of food intake.   
 
Of course, the crucial component in glucose transportation into the body cells is in 
insulin.  Therefore, it was important to record insulin levels in the study participants 
to  determine if: a) these participants had the traditionally high levels of insulin found 
in obese subjects and b) if this contributed as one of the dysfunctional pathways in 
the control of food intake. 
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4.8.2 Insulin 
 
Insulin sensitivity is central to IGT and type 2 diabetes.  Studies have shown that 
fasting insulin levels are higher in IGT and type 2 diabetic populations than in 
healthy, normal weight individuals (Wolever and Mehling 2002). The current study 
also showed that control participants had lower fasting insulin levels.  However, the 
postprandial insulin levels increased significantly more in the control participants in 
this study and were actually higher than the IGT and type 2 diabetic participants.  
This result was not anticipated.  The insulin concentrations followed that of the blood 
glucose changes except at 60 minutes when the insulin levels continued to rise in the 
control subjects when the blood glucose concentrations had fallen.  The overall 
glucose AUC response for control subjects was the lowest whereas their AUC for 
insulin was the highest.  The AUC for glucose in IGT participants was the highest 
and their AUC response for insulin was the lowest with the type 2 diabetic 
participants having the intermediary result.  It is assumed that in obese individuals 
regulation of the normally high insulin response is desirable but in this case with a 
high CHO mixed meal, a higher insulin response would have been expected in the 
patient groups. A reason for the response seen in the IGT participants is that the 
body’s response to a high carbohydrate meal, including the insulin response, is 
influenced by the rate of absorption of the meal (Collier and O’Dea 1982).  The AUC 
for insulin suggests that the insulin secretion in IGT participants in the current study 
was less sensitive to the meal than in control participants.  It is known that the release 
of insulin is a satiety factor and causes inhibition of feeding (Havel 1999).  If, 
however, the insulin response is blunted and satiation does not occur the result may 
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be abnormal ratings of appetite parameters i.e. reduced satiety and fullness, also 
increased hunger and prospective consumption.  This may potentially account for an 
increase in food intake and weight gain.  In the current study, although a reduced 
insulin response was seen in the IGT participants, a corresponding change in the 
appetite parameters was not observed and the reason for that is not clear.  A possible 
explanation for the low hunger and high satiety ratings may be a result of the low 
insulin response may slow down glucose uptake because the glucose uptake 
mechanism is insulin-induced.  This may have resulted in an overall slower 
processing of the breakfast.  The opposite may be true of the control participants, the 
high hunger and low satiety ratings may be a result of the high insulin response 
which promoted quick glucose storage and therefore quicker ingestion of the 
breakfast.  It is also possible that the dietary intervention which was received in the 
type 2 diabetic participants may have resulted in the improved insulin profiles 
observed when compared to the IGT participants.  A study by Mann (2000) has 
shown similarly improved insulin profiles as a result of dietary intervention, although 
further long-term studies are required to elucidate the mechanisms surrounding this 
change.  
 
Insulin is a known mechanism in the suppression of food intake (Blom et al.  2005) 
and exerts its action via the central nervous system.  In contrast, ghrelin also exerts 
its action via the CNS however has an opposite role to that of insulin, in the 
stimulation of food intake.   
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4.8.3 Ghrelin 
 
Ghrelin has an important role in food intake therefore it is important to understand 
the relationship between glucose, insulin, ghrelin and also appetite.  Plasma ghrelin 
concentrations rise gradually before a meal and decrease rapidly (Cummings et al, 
2001) following a meal in normal weight individuals.  Obese individuals have been 
shown to have reduced ghrelin concentrations (Shiiya et al.  2002) and furthermore, 
plasma ghrelin levels fail to decline following food intake (English et al.  2002).  The 
lack of suppression, following food intake, in obese individuals may contribute to 
increased food intake and potentiate obesity.  Plasma ghrelin concentrations are 
known to decrease after oral and intravenous administration of glucose whereas lipid 
or high fat diets suppress the postprandial ghrelin concentration less effectively 
(Blom et al.  2005).  The current study testmeal contained a high CHO content to 
assist the observation of plasma ghrelin changes.    Postprandially, IGT participants 
showed reductions in plasma ghrelin levels at both timepoints.  The type 2 diabetics 
only showed a very small reduction in plasma ghrelin levels at 30 minutes 
postprandially as expected, but then ghrelin levels increased at 60 minutes suggesting 
that the type 2 diabetic participants would have accepted further food intake at this 
stage. The control participants did not show a reduction in plasma ghrelin levels.  
Insulin is essential for meal-induced ghrelin suppression and to acutely increase 
leptin in healthy persons (Saad et al.  1998).  An inverse relationship has been found 
between leptin and ghrelin (Kalaitzakis et al.  2007) and it has been proposed that 
leptin is important in the suppression of basal ghrelin concentrations in 
normoinsulinaemic individuals.  Therefore in obese individuals ghrelin 
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concentrations have been found to be reduced which is thought to be due to being in 
a state of positive energy balance (Mingrone et al.  2006) and is caused by insulin 
resistance which is due to consistently high blood glucose levels.  Furthermore, the 
lack of ghrelin suppression following food intake may contribute to abnormal 
appetite parameters in obese individuals such as individuals with IGT and type 2 
diabetes.   Changes in ghrelin levels did not correspond with other studies.  In the 
current study the lack of suppression of ghrelin concentrations observed in the type 2 
diabetic participants may affect the satiety cascade by promoting reduced satiation 
and suggests that ghrelin is involved in the dysfunction of the satiety cascade and 
therefore also in the pathophysiology of obesity.  It was possible in the current study 
that the ghrelin assay was compromised and that these results may be distorted.  
Therefore it is impossible to make any genuine statements about the contribution of 
ghrelin in the control of food intake.  There was no correlation between plasma 
ghrelin levels and appetite parameters as would perhaps have been expected due to 
the suppression of ghrelin concentrations postmeal.  However as has often been 
observed, particularly in obese individuals, people do not always eat when they are 
‘hungry’ and do not always refrain from eating when ‘satiated’ (de Graaf et al.  
2004).  Therefore, it is imperative to understand the integrated responses involved in 
the process of food intake i.e. those which combine to initiate feeding and the 
mechanisms which contribute to the cessation of feeding. 
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4.9 INTEGRATED RESPONSES 
 
The integrated responses in the control of food intake are probably the most 
important to understand because there are a constellation of adverse metabolic, 
psychological and physiological changes that occur in chronic diseases such as IGT 
and type 2 diabetes.  Increased knowledge about the underplay of events involved in 
food intake may help in the prevention and treatment of such conditions.  Much of 
the research has focused on individual components in the process of food intake and 
this ongoing research is imperitive to fully understand the explicit involvement of 
each component i.e. how knowledge about fluctuations in ghrelin concentrations may 
be a feeding indicator.  However, it is now vital that researchers understand how 
these components interact to control food intake.  Every individual eats episodically 
therefore the ‘end point’, which in this case is cessation of eating, is universal.  Each 
person has the capacity to be satiated or has the means to initiate feeding, whether 
this occurs for different reasons in obese individuals compared to normal, healthy 
individuals and to what extent is not fully known.  The current study aimed to 
investigate the interactions between components to determine if the ‘end point’ is 
reached by similar means in IGT, type 2 diabetics and control participants.   
  
4.9.1 Influences of Taste, Appetite and Habitual Diet 
 
Appetite, in humans, appears to be unique to the species and to the individual person.  
Phylo-genetically this specificity relates particularly to the evolution of the cerebral 
cortex system and the complex interplay of the limbic and neocortical brain.  Such 
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specialised nervous and psychological control is not available to humans when they 
are born (Hamburger 1960) and therefore is learned by associated psychological 
factors such as emotional conflict and personal gratification.  Consequently, the 
nutritional aspects of appetite are sometimes distorted.  Taste can influence appetite 
because it is clear that some individuals can consume foods even when they do not 
‘feel’ hungry.  In this scenario, investigators have shown that often the food eaten is 
high in fat content which is consistent with the idea that fat tends to be less satiating 
than protein and CHO respectively (Chapman et al.  1999).  There is compelling 
evidence for innate preferences for sweet tastes and aversions to bitter tastes 
(Yeomans 2006).  In this study the relationship between taste and appetite was 
investigated by looking at taste status to bitterness and the amount of fat consumed in 
the habitual diet and then by how taste is correlated with subjective feelings of 
hunger, satiety, fullness and prospective consumption.  Looy and Weingarten (1992) 
were the first to suggest a link between sweet taste preferences and obesity and 
investigators have continued on to explore how appetite is influenced by PROP taste 
status.  Results have shown that PROP supertasters and tasters have an aversion to 
bitter and sweet food items and are more sensitive to the fat content in foods leading 
to avoidance of these food items.  Therefore supertasters and tasters tend to be 
normal weight whereas non-tasters have a propensity to be overweight as they are 
not sensitive to fat content and so do not have aversions to sweet/high fat foods.   
The current study exhibited no correlations between taste and appetite parameters, 
however does demonstrate that control subjects tasted PROP at a significantly lower 
concentration when compared to IGT participants.  The trend also showed that 
control participants tasted PROP at lower concentrations than type 2 diabetic 
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participants, however the result was not significant.  All control participants were 
either tasters or supertasters and there were no control participants in the non-taster 
status group.  Conversely, there were no IGT participants in the supertaster group 
and only one type 2 diabetic in this group.  These results provide further evidence 
that body weight is indeed related to taste status.  Salbe et al (2004) found a positive 
relationship between weight gain and hedonic responses to sweet and creamy 
solutions in Pima Indians.  Therefore, it was important to determine how taste status 
affects an individual’s habitual diet.  In the current study there was no relationship 
between habitual fat intake and taste status as some literature has suggested (Salbe et 
al.  2004).  However, a significant negative relationship between sugar intake and 
taste scale was found; in that the stronger the taste for the PROP compound was 
rated, the lower the dietary sugar intake.  Given that the supertasters rated the PROP 
compound the strongest, this result can be extrapolated to mean that supertasters had 
the lowest dietary sugar intake whereas non-tasters had the highest sugar intake in 
their diet.  This high sugar intake may in fact perpetuate obesity and the related 
cardiovascular disease.  Yudkin (1964) proposed in the early 1960s that the Western 
diets that were high in fat were also high in sugar and he proposed that the sugar 
intake may also play a role in cardiovascular epidemic.  In the current study, 
although no significant differences were recorded in fat intake from the 4-day diet 
diaries, IGT participants did record the highest fat intakes.  Recently, in the UK, 
although a low fat intake has been promoted, rates of obesity have continued to 
increase as has sugar intake (FSA 2008).  Even in children non-milk extrinsic (NME) 
sugar intakes increase with age.  The main contributors to NME being non-diet soft 
drinks along with confectionary, cakes, biscuits and pastries (FSA 2008).   Earlier, it 
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was discussed that sugar may actually prevent weight gain however the current study 
shows conflicting results.  This study shows that when taste sensitivity is poor this 
may cause an increase in the amount of sugar consumed in the diet.  This may mean 
an increase in cakes and biscuits which can result in positive energy balance and 
obesity.  By decreasing sugar intake a resultant reduction in the energy imbalance 
between intake and expenditure would be expected and overall may make a positive 
contribution to the prevention of obesity.   
 
4.9.2 Influences of Appetite and Substrate Oxidation 
 
The oxidation of nutrients will lead to either the storage or utilisation of nutrients and 
will ultimately lead to satiation.  The fuel mix is important and will determine the 
release of biomarkers which affect satiety (de Graaf et al.  2004) so it was essential to 
investigate the relationship between oxidation and appetite.  Appetite was analysed 
in relation to substrate oxidation in the current study, to assess if the differences in 
fuel usage are reflected in the appetite parameters.  The relationship reflects the 
metabolic profile of each group.  The aim of the current study was primarily to 
investigate the differences between IGT, type 2 diabetic and control participants.  
Therefore it was important to investigate the correlations between appetite and 
substrate oxidation between groups (IGT, type 2 diabetics and controls).  
Correlations were performed taking away the influence of body weight so that any 
differences observed were a result of the disease status.  This was important because 
the effects of obesity are different to the effects of IGT and type 2 diabetes.  This 
much is clear because there are obese individuals who never develop these 
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conditions and therefore it would be expected that the metabolic responses to food 
are different.   
 
Correlations were performed on AUC calculations taken from fasting until the end of 
the study period.  There were no significant correlations between fat oxidation and 
any of the appetite parameters in the current study.  Some studies suggest that the 
ability to induce satiety is influenced by the ability of fat to be readily oxidised 
(Bendixen et al.  2002).  In obese subjects basal fat oxidation has been shown to be 
reduced (Solomon et al.  2008) when compared to healthy control subjects.  This 
reduction is thought to be due to the accumulation of free fatty acids and results in 
increased intracellular fatty acid metabolites and disrupts insulin-signalling pathways 
which lead to insulin resistance and IGT.  The current study did not show differences 
in fat oxidation between either of the obese groups (IGT or type 2 diabetics) and the 
control participants, so although there were differences in the appetite parameters 
between groups it does not appear to be due to differences in the oxidation of fat.  It 
seems that the ratio of CHO to fat oxidised is more important than the fat oxidation 
itself.  
 
IGT participants demonstrated that hunger and prospective consumption reduced as 
CHO oxidation increased, whereas an increase in fullness and satiety increased.   
Conversely, type 2 diabetic and control participants showed an increase in hunger 
and prospective consumption as CHO increased and a corresponding reduction in 
satiety and fullness.  Therefore IGT participants in the current study are showing a 
response similar to those which Astrup et al (1996) recorded in normal control 
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participants.  Because of the high levels of satiety recorded in the current study it 
would be expected that the duration of satiety, i.e. the period between meals, in the 
IGT participants would be greater than in type 2 diabetics and control participants.  
To determine the effects of appetite and oxidation on subsequent meals further 
investigation would be required.  In contrast to CHO oxidation increasing in direct 
response to CHO intake, fat oxidation is not directly linked with intake (Astrup et al.  
1996) and this results in less accurately maintained fat balance.  In the current study 
the relationship between fat oxidation and appetite varied between groups.  The IGT 
participants again, for the most part, showed contrasting results to the type 2 diabetic 
and control participants.  As fat oxidation increased in IGT participants so did hunger 
and prospective consumption, whereas satiety and fullness reduced.  In type 2 
diabetics as fat oxidation increased, hunger and prospective consumption reduced 
and satiety and fullness increased.  Finally, in control participants as fat oxidation 
increased hunger reduced and satiety, fullness and prospective consumption all 
increased.  The results demonstrate the lack of any definitive relationship between 
appetite and fat oxidation.  A possible hypothesis that the increased fat oxidation 
postmeal observed in the IGT and type 2 diabetic groups, although not significant 
may be associated with the increased levels of satiety ratings recorded.  Although the 
differences in fat oxidation were not significant there was a notable increase post 
meal compared with the control group.  This hypothesis has been previously 
suggested back in the late 1990’s by Himaya (1997) however it does not appear to 
have been avidly pursued.  The current study may necessitate a re-evaluation of the 
satiety value of fat.  It clearly indicates that research aimed at providing an insight 
into the physiological and biochemical phenotypic expressions of the obesity genes 
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and how they interact with dietary fat should be conducted with caution as the results 
are extremely difficult to interpret.  
 
It is however, important to determine associations between measured processes in the 
control of feeding behaviour and subjective measures because it gives an idea of the 
influence that psychology has in food intake and the role that subjective feelings 
have in the control of food initiation and cessation.  Hence, associations were 
completed with appetite and taste, oxidation rates and biological markers. 
 
 
 
4.9.3 Influences of Appetite and Blood Parameters 
 
4.9.3.1 Glucose and Appetite 
 
As expected, in the current study, carbohydrate oxidation was higher in the control 
participants compared to the other two groups.  This was also reflected in the blood 
glucose profile as a subsequent lower concentration of glucose was found in the 
control participants.  Consequently it was noted that a decrease in blood glucose 
concentrations result in decreased hunger and satiety levels.  This does not concurs 
with previous research in that the drive to consume food is promoted following a 
decrease in blood glucose (Mayer 1960; Van Itallie and Hashim 1960) which is 
thought to reflect a sudden decrease in the supply of immediately available glucose 
(Melanson et al.  1999). The correlations with hunger, fullness and prospective 
consumption were not significant and demonstrate conflicting results from the 
anticipated outcomes.  The results of the current study showed that hunger and 
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prospective consumption increased, whereas satiety and fullness decreased as a result 
of an overall increased glucose response.  Perhaps the meal was not large enough to 
elicit large changes in the subjective responses even though the physiological 
changes were there.  The glucose response was greater in both the IGT and type 2 
diabetic groups however, the correlations between appetite ratings and the blood 
glucose response were different.  The type 2 diabetic participants correlations 
followed the same pattern as control participants whereas IGT participants 
demonstrated opposing results, as the blood glucose response increased, there was 
reduced hunger, satiety and prospective consumption and increased fullness, 
although these results were not significant.  So to summarise, all three groups 
demonstrated a negative association between satiety and blood glucose although the 
result was only significant in the control group, that is as the blood glucose response 
increases, satiety reduces.  It is thought that if blood glucose is modulated, there is a 
subsequent effect on satiety which is the basis for the glucostatic theory of food 
intake regulation (Mayer 1953).  Conversely, satiety and the termination of eating 
will only occur following an increase in blood glucose.  A study by Anderson et al 
(2002) demonstrated that high GI carbohydrates more effectively promote subjective 
feelings of satiety and reduce feelings of hunger at 60 minutes postmeal.  The current 
study does not concur with the glucostatic theory that a meal which results in a high 
glucose response suppresses food intake.  In fact, this study demonstrates that as the 
blood glucose response increases, satiety reduces, concurring with the hypothesis 
that foods which elicit a large glucose response, i.e. high GI foods, promote 
excessive energy intake.  This hypothesis is based on the hypothesis that meals 
which produce a quick initial glucose response, i.e. high glycaemic index (GI) foods, 
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then produce a corresponding postprandial dip in blood glucose, which again initiates 
feeding (Anderson et al.  2002).  The current study did not observe a corresponding 
correlation between the glucose response and prospective consumption which 
suggests that there was no corresponding dip in blood glucose in the participants.  
The reason for this is unclear.  The type 2 diabetic and control participants did 
demonstrate a positive relationship between PC and blood glucose but this was not 
significant.  The IGT participants showed a negative relationship between PC and 
blood glucose which again was not significant.  The current study is consistent with 
studies which identify a strong satiety response with low GI foods.  Therefore the 
participants in this study would benefit from a low GI meal, thus reducing blood 
glucose levels, reducing the glycaemic response and lowering food intake.  
Therefore, the habitual diet of IGT and type 2 diabetics should include foods which 
will help to control blood glucose levels because consistently high blood glucose 
levels increase the risk of metabolic syndrome and cardiovascular disease.  This is 
also consistent with the idea that an improved, or lower, glycaemic response may 
improve secretion of ingestive hormones such as GLP-1 and CCK which help to 
promote the suppression of food intake.  A weak satiety response as a result of a high 
GI meal may promote the early initiation of feeding and the response is likely to be 
different to a healthy individual who is not concerned with blood glucose levels.  A 
healthy individual may make a different CHO choice and have a full and sustained 
satiety response.  Granfeldt et al (1994) investigated the response of low GI foods, 
which had high levels of resistant starch and is digested and released slowly and so 
helps to control blood glucose levels, for up to 180 minutes after feeding.  The results 
of this study showed a greater overall satiety response with the low glycaemic food.  
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However, this response was compared with white bread rather than a mixed meal.  
The comparisons between the different types of resistant starch were comparable to 
the study by Anderson et al (2002) in that the differences in satiety were only 
observed in the late phase, denoted from 95 minutes onwards and similarly 
demonstrated that in the short-term there is no ‘satiety’ benefit to consuming either a 
high or low GI diet.  Granfeldt et al (1994) concluded that long-term GI foods may in 
fact promote satiety however, further research would need to be done before it could 
be concluded that overall daily or weekly energy intake was influenced.  It is 
important to stress that these two studies have been carried out on normal subjects 
therefore the same conclusions cannot be assumed for subjects with IGT and type 2 
diabetes as their responses may differ.  Therefore, it is important that future research 
investigates the appetite and blood responses to different types of meals over both the 
short and long term.  Arguably a long term study is more important to determine if 
energy balance is achieved and maintained.  The answers may also explicitly lead us 
to conclusions about what food sources can more easily promote negative energy 
balance and weight loss.   
 
4.9.3.2 Insulin and Appetite 
 
It is well established (Lavin et al.  1998) that there is an increase in insulin secretion 
following a meal causing a rise in plasma insulin.  In the current study the overall 
insulin response measured by AUC was significantly lower in the IGT participants 
and intermediary in the type 2 diabetic participants compared to the controls.  A 
study by Lavin et al (1998) on normal subjects where insulin was initially injected to 
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simulate the conditions of type 2 diabetes investigated appetite levels following intra 
duodenal glucose infusions.  Results showed that the appetite ratings of hunger and 
fullness were not affected by the simulated condition of hyperinsulinemia and that a 
‘normal’ satiety response was seen following duodenal glucose infusions in that there 
was a reduction in hunger and fullness and subsequent food intake (Lavin et al.  
1998).  Lavin et al (1998) concluded that insulin was not a physiologic mediator of 
satiety.  In the current study there were no significant relationships between appetite 
parameters and the insulin response in IGT or control participants.  However, in type 
2 diabetics there was a significant inverse relationship between hunger and the 
insulin response, that is as insulin increases, hunger consequently reduces and a 
positive relationship between prospective consumption and the insulin response. 
Thus, as the insulin response increased so did the desire to consume food in type 2 
diabetics.  Therefore, the current study agreed somewhat conflicted with the results 
of Lavin et al (1998) because there were correlations between insulin concentrations 
and appetite parameters.  The claim that foods which promote a reduced insulinaemic 
response, i.e. low GI foods, have a positive effect on fuel oxidation by reducing CHO 
oxidation and fat storage and by increasing fat oxidation (Astrup et al.  1996).  The 
current study showed that a high insulin response resulted in an increased desire to 
consume more food in type 2 diabetics therefore the participants would benefit from 
aiming to achieve a reduced insulinaemic response by choosing appropriate food 
items to elicit a low glycaemic and insulinaemic response.  However, in the current 
study the inverse correlation between hunger and the insulin response is conflicting 
and suggests that as the total insulin response increases, hunger reduces.  Warranted, 
for satiety to occur an increase in insulin concentration must occur however, as stated 
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earlier in the discussion of the glucose results, it has been demonstrated that a low 
insulinaemic response helps to maintain satiety and prevents further food 
consumption.  Therefore, this result was unexpected and may be put down to 1) the 
complexities of metabolic disease or 2) the biases observed in the completion of 
visual analogue scales, discussed earlier.  However, throughout the study period 
there were differences in appetite ratings between control participants and both IGT 
and type 2 diabetic participants.  This suggests that other studies which simulate 
conditions of  diabetes may not give the same results as studies including patients 
who actually contain the disease.  This is because in IGT and type 2 diabetes there 
are known to be a number of dysfunctional mechanisms that interact and lead to the 
development of IGT and type 2 diabetes.  The lower insulin response identified in the 
IGT participants therefore may have contributed to the differences observed in 
appetite parameters i.e. satiety and hunger.  The possible mechanism for this is 
because of the low insulin levels, this resulted in slower glucose utilisation and 
storage and delayed the meal processing, leading to increase in satiety.  The reason 
for a failure to demonstrate a correlation may be due to the small sample size.  The 
current study has shown that insulin may not have a primary role in the differences 
established in subjective appetite ratings because of the erratic pattern of correlations 
observed.   
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CHAPTER 5 - FINAL DISCUSSION  
 
Impaired glucose tolerance and type 2 diabetes are now common chronic diseases 
which have resulted in copious amounts of research that aim to investigate both the 
prevention and treatment of these conditions.  The most important element in the 
prevention of these diseases is the ability to maintain a balance of energy intake with 
energy expenditure.  Research has primarily focused on the side of energy intake due 
to the innumerable mechanisms which influence food intake including; 
physiological, sensory, cognitive and behavioural mechanisms.  The longer term 
complications of IGT and type 2 diabetes can lead to morbidity, reducing the quality 
of life or mortality and this makes the current and ongoing research so very 
important.  Understanding the factors which contribute to the long-term 
complications of IGT and type 2 diabetes may help to predict or prevent the onset of 
disease and lead to a reduction in the number of people with IGT and type 2 diabetes.  
Alternatively, an understanding will allow more effective treatment of the symptoms 
and reduce the associated morbidity and mortality.   
 
Obesity is a key component in both these diseases and results in changes in the 
metabolic handling of food.  The aberrant responses in the metabolic handling of 
food affects consecutive food intake and therefore may perpetuate the problem of 
weight gain.  The IGT and type 2 participants in the current study were all classified 
as clinically obese and were therefore a suitable sample to compare the effects of 
food intake with a control group of healthy participants.  The test meal given was a 
mixed meal and identical for all participant groups.  This was important to enable the 
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investigation of the responses to food intake in an everyday situation in IGT and type 
2 diabetic participants and to determine if the response differs to healthy controls.  
Previous studies have investigated single components or perhaps two components i.e. 
the sensory and biological components of food intake.  The current study aimed to 
assess as many of the factors which influence the control of food intake without 
being overly invasive for the participant.  The sensory element investigated was 
specifically taste, the physiological element investigated included blood hormones 
and oxidation rates, and the cognitive element investigated were participants’ 
subjective feelings of appetite.   
 
The current study demonstrated the complexities involved in the investigation of 
food intake.  The mechanisms involved in food intake and satiety comprise of a 
complex interplay of events which result in either the desire to consume food or the 
inhibition of further food intake.  The similarity of food intake in the habitual diets of 
IGT and type 2 diabetic participants to the control participants was unexpected given 
the BMI of the two patient groups.  However, this may have been better assessed if 
patients were currently in weight loss.  If weight had been recorded in both sessions 
in the current study this knowledge would have allowed a definitive answer as to 
whether patients were in weight loss or not.  The two main differences between the 
groups’ habitual diet were in percentage of protein and sugar intakes of the 
participants.  Type 2 diabetic participants had the highest protein intakes followed by 
IGT and then control participants with the lowest protein intakes and type 2 diabetics 
had a lower sugar intake compared to IGT and control participants.  These two 
results in themselves were significant as they conveyed a message regarding self-
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mediated changes made to the participants’ dietary intake following diagnosis.  For 
type 2 diabetic participants this may have been associated with the dietary advice 
gained within the diabetic clinic.  Furthermore, the activity recorded by diaries was 
also very similar in all groups showing that the two patient groups were not leading a 
sedentary lifestyle as was anticipated.  There were differences in the intensity of 
activity undertaken, as the IGT participants had undertaken approximately a third 
less the amount of time undertaking strenuous exercise when compared to the control 
participants, however IGT’s executed more moderate activities such as housework 
and walking.  Therefore, including strenuous activity into their lifestyle may be an 
important factor to consider in IGT and type 2 diabetes as this may help to improve 
blood glucose profiles and oxidation rates.  Although this difference was not 
significant it may go some way to explain the behavioural disparity between groups 
as it is commonly known that exercise plays an important role in the maintenance of 
weight loss, prevention of weight gain and (Anderson and Konz, 2001) promotion of 
long-term healthy living (Klein et al.  2004). 
 
The taste results demonstrated that the IGT participants first tasted PROP at a higher 
concentration compared to the control participants.  The IGT participants were also 
less sensitive to the bitterness than PROP compared to type 2 diabetic and control 
participants.  Therefore, IGT participants were likely to be nontasters and were 
unlikely to be supertasters, whereas control participants were likely to be supertasters 
in the current study.  Tepper and Nurse (1998) suggested that nontasters had a 
preference for fat.  Therefore it was important to test that hypothesis and look at the 
habitual diet to determine if there were differences in fat intake between IGT, type 2 
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diabetics and control participants.  The current study demonstrated that the sugar 
intake of IGT patients is influenced by a lack of taste sensitivity and this may lead to 
an associated increase in fat intake although this was not definitive because there was 
no significant difference in self-reported dietary fat intakes.  The relationship may be 
more complex or indirect and would be worth further investigation at a more basic 
level.  This is because the effect of taste may manifest itself to a greater degree when 
making individual food choices such as in-between meals and snacks.  Whereas a 
main meal, such as lunch or dinner, may be considered ‘healthier’, per say, because it 
is a planned nutritive meal to appease a whole family.  Food preferences in IGT and 
type 2 diabetes would also merit investigation as it is imperative to understand how 
the effect of taste changes with these conditions and how this has an influence on 
habitual food choices. 
 
Appetite ratings showed the changes in satiety in response to the test meal.  In the 
current study the differences in appetite parameters between IGT, type 2 diabetic and 
control groups were observed particularly in subjective feelings of hunger, satiety 
and PC.  It is unclear why the differences were not observed in feelings of fullness.  
Significantly different results were observed in control participants compared to IGT 
and type 2 diabetic participants and this may be linked with the differences 
distinguished in taste status.  Increased taste sensitivity may intimate an increased 
sensitivity to appetite, as observed in the control participants without a simultaneous 
increase in food intake.  The opposite may be true of IGT participants i.e. lack of 
taste sensitivity may indicate a lack of appetite sensitivity.  Additionally the reduced 
hunger and PC and increased satiety observed in IGT and type 2 diabetics may be a 
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consequence of reduced EE compared to control participants.  The energy expended 
was an average of 24kcals/kgBW in control participants compared to 20 kcals/kgBW 
in IGT and type 2 diabetics therefore this may account for the associated differences 
seen in the subjective feelings of hunger.  The process by which these effects may 
transpire may be due to afferent signalling which provides information on nutrient 
intakes and status.  Furthermore, the results show that IGT and type 2 diabetics both 
had lower rates of DIT, RQ and CHO oxidation compared to control participants.  
These results, although not all significant are important and go some way to 
facilitating the understanding of the mechanisms which are influencing energy 
intake.  It appears that a reduced DIT and CHO oxidation, which will cause a 
reduction in RQ (because if more fat is being oxidised then it is sensible to assume 
that less CHO is being oxidised) somehow inhibits the stimulation of the sympathetic 
nervous system, which causes reduced EE.  This however does not explain the 
appetite ratings as the opposite results would have been expected, especially given 
the results of the physiological components but those differences may be related with 
sensitivity to taste and appetite.  The current study may indicate however that 
subjective markers of appetite do not appear as accurate as the physiological 
markers.  This may be due to IGT and type 2 diabetic participants conforming to 
what results they think the researcher wants them to feel rather than what they 
actually feel.   Reporting biases are commonly discussed with regards to the 
underreporting of food intake in the obese, however it has also been noted that there 
is a lack of data concerning the psychometric properties of VAS to assess weight 
related biases in this tool (O’Connor et al. 1996).   
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Low fat oxidation rates have been suggested to be associated with an increased risk 
of weight gain.  This was not demonstrated in the IGT and type 2 diabetics in the 
current study.  In fact when observing oxidation rates as a result of the disease and 
independent of weight these two patient groups had an increased level of fat 
oxidation.  This concurs with a study by Astrup et al (1994) where 24hour 
calorimetry demonstrated that overweight and obese subjects had a higher level of 
oxidative fat energy compared to control subjects.  Astrup et al (1994) then 
concluded that this was due to overweight and obese subjects consuming a diet 
higher in fat content.  However, in the current study the results were two-fold as this 
may have been true of the IGT participants and would then demonstrate why the 
oxidative fuel mix differed to control participants as a result of the disease.  The 
same pattern was not observed in type 2 diabetic participants as they had the lowest 
fat intake, although this difference was not significant.  What is clear is that the result 
of the aberrant changes in fat and CHO oxidation rates affected appetite levels 
differently in the two patient groups (IGT and type 2 Diabetics).  IGT participants 
demonstrated greater satiety as CHO oxidation increased and less satiety as fat 
oxidation increased.  Type 2 diabetics showed decreased satiety as CHO increased 
and increased satiety as fat oxidation increased.  The reason for the differences 
observed between groups is not clear because the test meal was the same for all 
groups.  Given that the overall levels of fat and CHO oxidation postmeal were 
similar, and not significantly different, the explanation for the differences in the 
correlations between appetite parameters and oxidation levels reflect that their 
body’s were reacting differently to the same meal.  The reasons for the differences 
observed may indicate differences in the ratio of CHO to fat oxidised which would 
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undoubtedly be controlled by the body fuel stores.  Therefore, it appears that the 
body fuel stores, at the time of food consumption, continue to influence to the 
greatest degree, the macronutrient which will be oxidised, following a mixed meal.  
The increased fat and reduced CHO oxidation may play a role in the low RQ and EE 
observed postmeal in IGT and type 2 diabetics compared to control participants and 
this may be attributable to the increased glucose response to the meal.  The raised 
blood glucose profile suggests disrupted uptake of glucose via GLUT-4 transport in 
IGT and type 2 diabetics, associated with insulin resistance and elevated FFA levels.  
The low RQ’s also promote preferential fuel storage over oxidation and this may 
potentiate further weight gain, in already obese individuals.  The current study 
demonstrates the complexity of mechanisms involved in the satiety cascade and the 
control of food intake.    
 
Metabolic parameters have been implicated in the control of ingestive behaviour by 
their availability in the circulating pool.  Metabolites associated with the ingestion of 
food (glucose, insulin, and ghrelin) were investigated and indicated a higher  glucose 
response, measured in IGT and type 2 diabetic participants compared to control 
participants.  The control group had significantly lower fasting insulin levels and 
significantly higher postmeal insulin levels which resulted in a significantly higher 
AUC response in control participants compared to IGT participants, who had the 
lowest insulin response.  The glucose response was expected however the postmeal 
insulin response was surprising.  It is difficult to elucidate the reasons for the insulin 
response observed postmeal in the current study however one conceivable theory 
may be related to the acute insulin response.  Insulin resistance is a core component 
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in the development of IGT and type 2 diabetes and a compensatory hypersecretion of 
insulin is the normal response but β-cell dysfunction is also a pre-requisite for the 
development of IGT and type 2 diabetes (Kahn, 2003).  Individuals who progress 
from normal glucose tolerance to IGT and type 2 diabetes are characterised by a 
lower first-phase insulin response (up to 30 minutes postmeal (Laaksonen et al.  
2005)) and an additional decline with time in the acute insulin response, even though 
the second-phase response is initially exaggerated.  In contrast, nonprogressors 
generally show little decline in β-cell function (Osei et al.  2001).  Improvement in 
the acute insulin response in the absence of deleterious changes on insulin sensitivity 
may therefore lower the risk of worsening glucose tolerance and the development of 
diabetes.  Thus, the lower 30 minute insulin levels in IGT and type 2 diabetics may 
suggest a lower acute phase insulin response due to β-cell dysfunction in these 
participants.  The result of the reduced insulin response may have caused a reduction 
in insulin-induced glucose transport and an overall lower CHO oxidation response to 
the meal.  Furthermore, the reduced insulin response may be responsible for the 
increased satiety and reduced hunger observed in the IGT and type 2 diabetic 
participants.  It is important to note that the current study does not give a true 
reflection of the full second phase insulin (which can last up to 180 minutes postmeal 
(Chiu et al.  2004)) response.  Assays were completed up to 60 minutes only and 
insulin levels were still increasing at this time.  It is possible that in observing the full 
insulin response, subjective ratings of appetite may have been more in line with what 
was expected in the IGT and type 2 diabetic groups.   
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CHAPTER 6 – CONCLUSIONS 
 
Many of the results have shown subtle differences in the metabolic handling of food 
in IGT and type 2 diabetics.  The results suggest that the overall response of IGT and 
type 2 diabetic populations deviate from the normal and this may be a result of the 
said diseases.  In the current study, it is clear that the dysregulation of the pathways 
observed, which contribute to the process of food intake (taste, DIT, EE, oxidation 
and blood profiles), leads the body to relay erroneous afferent messages to the brain 
which may lead to further metabolic changes which are to the detriment of 
maintaining energy balance.  A definitive answer cannot be made from the current 
research as to which mechanism(s) of the pathway is (are) most influential as that 
will require further extensive and detailed studies.  However, the influence of taste 
sensitivity in IGT and type 2 diabetics was one of the most significant findings.  
Taster status can be used as a tool in the treatment of IGT and type 2 diabetes as this 
study has shown that it may pre-dispose individuals to an increased sugar, and 
perhaps fat intake.  Having this knowledge makes it easier to tackle dietary issues 
found in IGT and type 2 diabetic nontasters.  Also, the current study highlights that 
subjective ratings do not appear to be as useful a tool as thought because the 
differences seen in biological markers of appetite were not conveyed in the 
subjective ratings.  The differences observed in metabolic status between controls 
and the two patient groups were enough to make inferences about the dysfunctional 
mechanisms which occur in these diseases.  The most prominent aberrations were 
observed in the IGT participants and were found in the pathways of taste, DIT, CHO 
oxidation and blood glucose levels.  These abnormalities between IGT and type 2 
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diabetics, although not conclusive to determine how progression of the diseases 
results in an altered physiological and metabolic response, did give an insight as to 
how individuals view the severity of their disease. The results also highlight that 
deviations in metabolic pathways may potentially be reversed, as observed in type 2 
diabetics, and with good management of IGT and type 2 diabetes the diseases can 
definitely be managed.  This was an interesting aspect of the study and showed that 
the severity of the disease did appear to be associated with the level of management 
(dietary and activity levels) of the disease.  Knowing how the body changes with 
progression of the disease is fundamental when looking at opportunities to reverse 
this advancement and is a key component in the prevention of IGT and type 2 
diabetes.  Furthermore, not all components of energy intake are within the human 
limits of control, such as taste, but understanding how the genetic implication of taste 
elicits changes in food choices can ameliorate the management of habitual diet which 
will go a large way to facilitate in the control of energy balance.  This may be 
particularly important in the control of IGT and type 2 diabetes. 
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APPENDIX 1 
 
Dear ‘patient’, 
 
I am writing to you on behalf of Jill Somerville of Queen Margaret University College who is a 
research nutritionist and is working on her PhD.  Jill has to complete a research project for 
this and is looking to recruit volunteers for a study she is doing looking at food intake in 
people with higher than normal blood sugar levels who do not have diabetes.  This letter 
explains what it is all about.  I would emphasise that there is no commercial interest in the 
study and it has full ethical approval.  The study does not involve you participating in 
anything painful, unpleasant or dangerous. 
 
Any decision that you might make about whether you take part or not will have no impact on 
the treatment you receive from the practice in the future. 
 
We would like to see patients between 20 and 70 years of age who are controlling their 
condition by diet. 
 
Volunteering for the study would involve 2 visits to the Wellcome Trust Clinical Research 
Facility at the Western General Hospital.  The first visit will take no longer than 30 minutes 
and the second visit will take a morning (3-4 hours).  Parking arrangements will be made for 
you at the Research Facility on the days of your visit.  The first visit to the clinic will involve 
completing the following tests: 
• Question/answer session 
• Have height, weight, waist & hip measurements taken 
• Completing a urine sample 
• Completing a diet diary 
• Completing a taste test 
• Have activity monitored. 
  
Research suggests that by losing weight, or preventing further weight gain, you can slow 
down the development of your disease. The advantage to you in taking part is that you will 
benefit from diet advice and will receive feedback on your diet and exercise.  The help given 
will aim to make it easier for you to balance your daily food intake against the energy you 
use, helping you to maintain a healthy lifestyle and good eating habits.  
 
If you would like to help with this study, or if you have any questions, please contact Jill 
Sommerville on the telephone number or email address below, or complete the Patient 
Details Form attached and return it to Jill on the address below and she will contact you: 
 
Jill Sommerville    Tel: 0131 317 3525 
Research Nutritionist   Email: jsommerville@qmuc.ac.uk 
Queen Margaret University College 
Clerwood Terrace 
Edinburgh, EH12 8TS 
 
Thank you for taking the time to read and respond to this. 
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APPENDIX 2 
 
19 January 2005        Version 1 
 
 
Patient Details Form 
 
 
Name:       Date of Birth:    
 
 
Address:      Gender:  M / F 
   
 
       Smoker/Non Smoker 
 
 
 
Tel:       Email: 
 
Mobile: 
 
 
 
When is a good time to contact you? 
 
 
Medication: 
 
 
 
 
 
 
 
Questions: 
 
 
 
 
 
 
 
Send to: 
 
Jill P. Sommerville 
Queen Margaret University College 
Department of Dietetics, Nutrition & Biological Sciences 
Corstorphine Campus 
Clerwood Terrace 
Edinburgh, EH12 8TS 
Tel: 0131 317 3525 
Email: jsommerville@qmuc.ac.uk 
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APPENDIX 3 
7 March 2005                                     
Version 2 
 
Integrating Components of Energy Intake in Impaired Glucose Tolerant and Non-
Insulin Dependant Type 2 Diabetic Populations 
 
 
Patient Information/Consent Form 
 
 
I would like to invite you to take part in a nutritional study that will examine 
responses to feeding. As you may know, overweight and obesity is known to be a 
health risk and we are keen to have a better understanding of the role of the main 
components involved in the feeding process so we may be able to help subjects who 
find it difficult to lose weight.  The study will particularly explore subjects who have 
normal blood glucose levels and subjects with blood glucose higher than normal, 
which results in impaired glucose tolerance (IGT) and type 2 diabetes.  
 
The aim of this research project is to compare subjects who have IGT and type 2 
diabetes with healthy control, non IGT, subjects to determine if there are any 
underlying reasons for increases in weight that come about as a result of a difference 
in the systems operating to control food intake. 
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The study is designed to investigate:      
• The differences in appetite following a meal, which may be predicted by 
certain hormones (chemicals) in the blood between IGT, type 2 diabetics and 
control subjects. 
• The inherited control of taste and its influence on food intake. 
• Information to be used in the treatment and prevention of Impaired Glucose 
Tolerance, type 2 diabetes and obesity. 
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What will be your level of participation in this study? 
 
1. We would like to ask you to attend two sessions that are convenient to you. 
The first session will last approximately 1-2 hours and the second session will 
last approximately 3-4 hours. (Travel expenses will be reimbursed). 
2. We would ask you to undergo a taste test, body weight, height and waist:hip 
ratio measurements and to complete an Eating Inventory. 
3. Between sessions you will be asked to complete a 4 day weighed intake of 
foods eaten, a 4 day physical activity diary and a 24hour urine sample. 
4. We would like to ask you to fast (12 hrs) the night before the second session 
of study and you will be required to consume a test meal. 
5. A needle will be placed in your arm to allow blood to be withdrawn (which 
may cause bruising), just over 5 level tablespoons of blood (80mls), over a 2 
hour period.  This will allow the monitoring of responses to the test meal. 
6. Your energy expenditure will be determined by measuring how much oxygen 
you use and how much carbon dioxide you expel at various time points 
throughout the study.  
• For this procedure we would like to ask you to lie down (without 
falling asleep) with your arms by your sides and would ask you to be 
silent throughout the procedure. 
• This will involve the wearing of a light hood, initially for 30 minutes 
to get a stable reading and then 5 subsequent measures lasting 10 
minutes each.   
7. We would like to ask you some questions about your level of hunger. 
 
(Please can you let me know if you are allergic to latex (or have any other known 
allergies)). 
 
The information obtained from this study may be used to aid weight loss or reduce 
weight gain therefore promoting a positive effect on blood glucose levels. 
 
May I remind you that participation is purely voluntary and you are free to withdraw 
at any time without giving a reason.  If you would like to enter this study you are 
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required to sign a consent form.  Altogether the participation time will be 6 hours, 
not including the food and activity diaries.  If you object to your GP being informed 
of your participation in this study please let me know.  
 
Should you wish any further details please contact – Jill Sommerville, Queen 
Margaret University College, Department of Dietetics, Nutrition and Biological 
Sciences, Corstorphine Campus, Clerwood Terrace, Edinburgh, EH12 8TS, or 
telephone on 0131 317 3525.   
 
The study’s independent adviser is: 
 
Dr Ewan Crawford 
Clinical Director North West Edinburgh LHCC 
Murrayfield Medical Centre 
35 Saughton Crescent 
Edinburgh 
EH12 5SS 
 
Email: ewan.crawford@lothian.scot.nhs.uk 
 
 
Tel: 0131 334 5713 
 
Dr. Crawford is a suitably qualified person who can advise you on the study but is 
not directly involved in the study and therefore will act independently, to give you 
sound advise, regarding the research.  Please do not hesitate to contact him or myself 
if you have any questions or require clarification about any part of the study. 
 
QMUC indemnity will not cover non-negligent (no fault) harm- a side effect or harm 
that comes about due to no-one’s fault. 
 
Thank you for taking the time to read this. 
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Nutritional Study/Consent Form 
 
 
I                                                                                   have had this study fully 
explained to me and agree to participate. 
 
 
 
Signed:                                                                       Date: 
 
 
 
Witnessed by:                                                             Date:                                                               
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Reimbursement of Expenses Form 
 
 
 
 
I agree that I have received the travelling expenses from my home, which were 
incurred whilst coming to take part in the above study. 
 
Please try to provide receipts. 
 
 
 
Amount of expenses 
 
 
 
Signature of subject                                                                  Date 
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APPENDIX 4 
Integrating Components of Energy Intake in Impaired Glucose Tolerant 
and Non-Insulin Dependent Type 2 Diabetic Populations 
15 February 2005          Version 2 
 
 
COLLECTING A 24 HOUR URINE SAMPLE 
 
• To collect a 24 hour sample of your urine you should get up in the morning at 
your usual time, empty your bladder and discard the urine but take note of 
the time. 
 
• Enter the time that you passed urine on the label of the container.  After this 
time until the same time the following morning put all the urine you pass into 
the container. 
 
For example 
 
• If you get up at 8.00am, empty your bladder as soon as you can after getting 
up.  DO NOT PUT THIS URINE INTO THE CONTAINER -  this is 
overnight urine and is not part of your test BUT 8.00am would be the start 
and end TIME ENTERED ON THE LABEL. 
 
• Collect all the urine passed after 8.00am and put it into the container.  Even if 
the bowels move, try to collect urine separately. 
 
• Get up at the same time the following morning (8.00am) and empty your 
bladder.  COLLECT THIS URINE AND PUT IT INTO THE 
CONTAINER. 
 
That is your twenty four hour collection of urine complete!  Please 
remember to complete the label on the container by entering the start and 
end date and time and your name. 
 
 
Please note 
If you happen to miss putting urine in the container or a mishap occurs, please can 
you empty the container and begin the test again.  It is better to begin the test again 
rather than obtain inaccurate results. 
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APPENDIX 5 
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APPENDIX 6 
 
 
The following verbal instruction were read to aid completion of the suprathreshold 
scaling test and to establish the perceptual context for the ratings of taste intensity: 
 
In making your judgements of the taste, you should rate the stimuli relative to other 
tastes of all kinds that you have experienced.  Thus, ‘strongest imaginable’ refers to 
the most intense sensation of taste that you can ever imagine experiencing. This 
includes such varied sensations as those produced by a fresh lemon, a piece of 
celery, or spicy mustard.  Note that by ‘taste’ we do not mean the pain produced by a 
physical trauma like biting or burning your tongue.  Simply rate the samples relative 
to tastes that you experience in daily life (Green et al.  1996). 
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APPENDIX 7 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
Start Date:________________________ 
 
Finish Date:_______________________ 
 
Diet Sheet Number:_______________ 
 
 
 
 
4 DAY  
DIETARY RECORD  
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Guidelines for Recording Dietary Intake 
 
All the information you need to fill in this record should be in 
this booklet,  
but if you have any difficulties please phone for help. 
 
0131-317-3525 (ask for Jill) or 
jsommerville@qmuc.ac.uk (e-mail)  
  
 
Do’s 
• do fill in this record each time you eat or drink 
anything 
• do take your booklet with you if you will be 
eating or drinking away from the home 
• do record everything you eat and drink for the 
whole day from waking to sleeping  
• do use as many pages as you like 
• do record any vitamin / mineral supplements you 
take 
 
 
Dont’s 
• don’t write from memory at the end of the day - 
you may forget some foods that you have eaten 
• don’t forget to record any between-meal snacks 
like sweets, chocolate, crisps, nuts, ice-cream, 
fruit, cups of coffee etc... 
• don’t include leftovers, write only what you 
actually eat 
• don’t forget to write the date and day on every 
page 
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How to describe the type and amount of foods eaten 
Amounts 
 
You can use general kitchen utensils to record your foods e.g. 
• teaspoon (tsp.)  - quarter, half, one, two etc.. heaped or level 
• dessert spoon (dsp.) - quarter, half, one, two etc.. heaped or level 
• tablespoon (tblsp.) - quarter, half, one, two etc.. heaped or level 
• ladel - quarter, half, one, two etc.. heaped or level 
• teacup 
• mug 
• wine glass 
• tumbler (half pint/pint) 
• soup bowl - small/medium/large 
• dessert bowl – small/medium/large 
• cereal bowl - small/medium/large 
• dinner plate - small/medium/large 
• side plate – small/medium/large 
 
Detail 
 
Try to give as much detail as possible e.g.: 
• Bread - was it white, brown or wholemeal?  Was it thick, 
medium or  
     thin sliced?, large or small loaf?, pre-sliced or did you cut it 
yourself? 
• Milk - was it full fat, semi-skimmed or skimmed? 
• Meat - what type of meat?, what cut of meat?, was it fatty or 
lean?,  
     roasted, fried or grilled? 
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Brand Names 
 
Write down the brand names of makers of foods where possible 
e.g.: 
• Robinson’s unsweetened orange juice 
• Heinz baked beans in tomato sauce 
• Safeway Cheese & Onion Crisps 
• Flora Sunflower Margarine 
 
Cooking Methods 
 
Give details of the cooking methods used e.g.: 
• Potatoes - were they boiled, mashed or baked or chipped? 
• Fish - was it grilled, poached, steamed or fried? 
 
Commercial Foods 
 
These include soups, meat and fish products, ready prepared 
meals,  
puddings, sweets etc..  Please write down: 
• The volume or weight written on the product or 
• the number of pieces/spoonfuls/slices/items 
 
Meat, Fish and Poultry 
 
When describing meat or fish write down: 
• the type of animal or fish 
• the cut of the meat and whether lean or fatty 
• the number of slices/portions/pieces/rashers 
• the part of the animal e.g. leg/drumstick/breast 
• the cooking method 
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Fruit & Vegetables 
 
When describing fruit and vegetables write down: 
• Whether raw or cooked 
• Whether peeled or eaten with the skin on 
• Whether the vegetables were old, new, frozen or canned 
• The number of spoonfuls/pieces/segments of whole fruits 
eaten 
 
Pasta & Rice 
 
Pasta includes spaghetti, lasagne, macaroni, noodles etc..   
Rice may be sweet or savoury, long or short grain, brown or 
white etc. 
Write down: 
• The type of pasta or rice 
• The number of spoonfuls/bowls (small, medium or large 
portion) when cooked 
 
Soups & Stews 
 
Write down the number of ladels/spoonfuls/cups 
 
Sauces 
 
Please don’t forget any sauces used e.g.:   
Tomato ketchup   Brown sauce 
Cheese or White sauces Salad Dressing 
Mustard    Gravy 
Salt, Pepper,    Spices, Herbs 
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Breads, Rolls & Crackers 
Write down: 
• The type of bread and the thickness of the slice 
• The number of slices/rolls/crackers 
• Is anything spread on the bread/roll/cracker? Is it thickly or 
thinly spread? 
 
Breakfast Cereals 
These include Cornflakes or other ‘box’ cereals, porridge, 
muesli etc.   
Write down: 
• The type or brand name of the cereal 
• The number of spoonfuls/bowls (small, medium or large 
portion) 
• Don’t forget to note the type and amount of any milk used 
 
Milk & Milk Products 
These include milk, cream, yoghurts or sauces.   
Write down: 
• Milk or cream put into tea and coffee etc. (e.g. small dash or 
milky coffee) 
• The amount drunk in spoonfuls, glasses, cups or fractions of a 
pint 
 
Cheeses 
Write down: 
• The type of cheese (e.g. cheddar, edam, brie etc.) 
• The size of  a piece, e.g. compared to a matchbox 
• The strength of the cheese (e.g. mature, medium, mild) 
 
Eggs 
 Write down the size, number and cooking method 
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Fats, Spreads, Jams, Sauces, Pickles 
Write down the number of teaspoons or portion packs used 
 
Confectionery, Savoury Snacks, Biscuits, Cakes 
Write down: 
• weights from the packet 
• small/medium/thick slice of cake or fraction of whole cake 
• number of biscuits/sweets 
Sugar 
Write down the type of sugar and the number of teaspoons, 
level or heaped. 
Drinks 
These include soft drinks e.g. tea, coffee, squash, juice, cola, etc.. 
as well 
as alcoholic drinks (see below).  Write down: 
• The type of drink 
• The number of cups, glasses, pints, cans, bottles etc.. 
• Diet or non diet, sugarfree 
 
Alcohol 
Write down: 
• The type of alcohol, number of measures and any mixers 
added  
     e.g. dash of diet coke  
 
Made-up Dishes 
There is space at the end of this booklet for you to write the 
recipes  
of homemade dishes.  Also, please write down or cut out and 
keep 
the Nutritional Analysis from the labels of ready prepared foods. 
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Recipes and Labels 
 
 
 
 
Please write below any recipes you have used while filling in this 
record. 
 
 
 
Please cut out the Nutritional Information from the labels 
of any commercial made-up foods you have eaten, not forgetting 
the name 
and brand of the item. 
 
Please attach recipes and labels to this diary and hand in with 
the 
completed record. 
 
Thank you for all your help and co-operation. 
 
 
Please could you return this record to myself at: 
 
JILL SOMMERVILLE 
Research Nutritionist 
Queen Margaret University College 
Clerwood Terrace 
Edinburgh 
EH12 8TS 
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Queen Margaret University College 
 
Energy Expenditure Assessment 
 
 
 
 
 
 
 
 
 
 
Name …………………………………………………… 
 
 
Start Date ……………………………………………… 
 
 
Finish Date …………………………………………….. 
 
 
 
 
 
 
 
 
4-Day Activity Diary 
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EXAMPLE ACTIVITY DIARY
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Activity Codes 
 
SL Sleeping   W Walking 
L Lying, awake   HW House work 
S Sitting still   DR Driving 
SA Sitting activities  J Jogging 
ST Standing   AE Aerobics 
STA Standing activities  S Squash 
MW Manual work    G Gardening 
PN Personal needs (i.e. washing, getting dressed, etc) 
 
 
If you are frequently involved in some activity which is not coded 
for, please make your own code (i.e. Martial Arts = MA). 
 
 
 
 
 
 
 
 
 
 
Guidelines for Recording Physical Activity 
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All the information you need to fill in this record should be in this 
booklet, but if you have any difficulties please phone (e-mail) for 
help on: 
 
0131-317-3525 (ask for Jill) or 
jsommerville@qmuc.ac.uk (e-mail)  
 
1. Using the codes on the previous page, record your activities in 
the daily sheets provided. 
 
2. Your activities will start from when you awake in the morning 
and will finish when you go to bed at night.  It is important 
therefore to carry the activity record sheets with you at all 
times. 
 
3. Record your activity each time you change activity, to the 
nearest minute using the codes on page 2. 
 
For example- (see overleaf): 
You get up to wash and dress at 8.02am,walk to work at 8.43am, 
start work at 9.00am (e.g. standing in a shop), sit for lunch at 
1.00pm, and re-start work at 13.30pm, walk home from work at 
17.15pm  and sit down to watch television at 17.35pm.  
In an hour you get up to make a meal.  When your meal is ready 
and you sit down to eat at 19.10 etc.  
 
4. Please record your activities in as much detail as possible. 
 
5. Please use centre pages of booklet for any notes 
Guidelines for Recording Physical Activity 
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APPENDIX 9 
 
